Big companies are targeting South Africa. Top economies of the world are turning their eyes to the region. Why? Because there are lot of investment opportunities there and a growing potential for a successful market. This makes South Africa an interesting target for venture capital firms.

New technologies and good communication are two of the strong fields where things can stir up rapidly. We can figure this out only by looking at figures. Internet penetration was only 10.8% in 2009. The costs for a 1 MB bandwidth are huge, even 100 times more than in US. Still, the demand is high and people’s need for communication is increasing every day. The proof: companies from the mobile industry are doing well and mobile Internet usage is increasing mostly in the urban areas. There is plenty of room for businesses to grow and for venture capital firms to invest.

One good example is Neotel, one of the largest network providers in South Africa who raised a $455.5 million loan from a local consortium to develop their network. Google, Microsoft or Intel who recently signed a deal with MTN Group, made their moves. As other emerging markets experiences showed, the presence of big names is building trust for other businesses to come and raise the needed money for the development of new projects.

Other industries are in demand for investments, for example: mining, constructions or even software development, all of them looking for five or ten figures funds. 10 South African startups are on the short list of Seedcamp for Seedcamp Week in London this year. Companies like 10Layer, FloCash or Obami have the chance to receive $30-50,000 as a first boost for their development. On the other end, Motjoli, a mining company is seeking for $1,5 billion to develop an Iron Ore Project close to Zwaziland.

These are just a few examples but there are many more out there. Actually, some of the local investors are really complaining that venture capital firms in South Africa are not so active as they would need and that local investors do not have always the force to support all industries and projects, even if there are positive examples like Evolution One Fund who recently announced they raised $94 million to invest in clean technology businesses.

Started back in 2005, Puppet Labs have seen a rapid growing after the first funding round of about $2 millions in 2009 from True Ventures and Radar Partners who also participated in this new funding round. Actually, Kevin Compton from Radar Partners also joined these days the board of Puppet.

The announcement of the new funding is coming together with the release of new Puppet software 2.6, the newest version with new features like Preliminary Windows Support, Rest API or Event Model and many more designed to make systems administrators manage tasks lot easier. All these come to strengthen the position of Puppet labs on the data server management market where start-ups like Linaro, Karmasphere or Opscode are turning into a strong competition.

Amoung the list of Puppet customers we can find heavy names like Digg, Twitter, Shopzilla or Oracle and together with thousands of users of the open source management software, they are making Puppet the number one provider in data center automation. This position and the huge potential of this market attracted Kleiner Perkins Caufield & Byyer in supporting the round B funding.

KPCB is best known for its iFund who recently reached $200 million, venture capital raised mainly to support application development for Apple family, iPod, iPad or iPhone. Among the companies founded by KPCB through iFund is Zynga allowing the good farmers from Farmville to control their crops also on iPhone.

KPCB is very well involved also in green technology through its project Greentech. One of the KPCB Partners is Al Gore, the most famous environmentalist. Through Greentech, KPCB funded companies like Bloom Energy or Great Point Energy. Recently they participated in a $63 million funding in Emphase Banks along with PCG Asset Management and other investors.

Started in 2002 by Mike Cannon-Brookes and Scott Farquhar with the main goal of creating innovative software for its customers to solve problems through brilliant simplicity, Atlassian was a fast growing company even in the first year as in 2006 was already selected by Deloitte in their ranking of Technology Fast 500.

Not truly an open source software company but open source oriented, they manage to sell their products exclusively through their online platform. With more than 20,000 customers all over the world, a strong product portfolio and an open policy towards their clients, Atlassian secured a good position in software industry over the years looking for further development.

This $60 millions funding from Accel Partners is the first funding they receive since 2002 when the company was founded and who knows what the future will reserve for the company in the funding field. Atlassian managed to have a healthy, positive income during the years but this money were needed to ensure liquidity, expand their portfolio, support their expansion in Europe and maybe even looking into other startups acquisition.

For Accel Partners, is not their first funding in software field as during the last years they supported or acquired a lot of companies. They were the first ones who funded Facebook – the well known social network company – and we all know how good that money was spent. Metro PCS is another hit. They also supported Admob who recently was acquired by Google. Silicon Valley is one of their main focuses but Accel have offices also in London, supporting the European market, China and India, two very interesting markets from capital ventures firms’ point of view.

Accel is covering a lot of industries like Energy, funding companies like SunRun or GS Solar, Retail supporting companies like Diapers or Dovetail Furniture to Healthcare and Biotechnology where we can mention Healthcare Magic, MitraBiotech or Perfint Healthcare. They are always aiming the industry leaders that are trying to innovate and change the world.

Following this investment, Karen Buckner, partner at MK Capital will secure a seat in the board of TopSchool joining other investors like Stewart Alsop from Alsop Louie Partners who participated in both Series A and Series B funding or David Gold from Access Venture Partners and Chris Girgenti from New World Ventures who participated in Series B funding only a year ago.

TopSchool’s leading product is SLM, the Student Lifecycle Management system based on SaaS, a Software Service model designed to help colleges in managing data about students all the way from the very first contact to admission, enrollment and even to job placement. SaaS is a management model replacing the classical student information systems and allows TopSchool’s customers to be more efficient and reduce costs without worrying about software updating, hardware maintenance or database management. One of the key points of TopSchool solution is the flexibility and the ability to be easily integrated with other applications. Not to mention the savings up to 50% compared with traditional hard to manage college informational systems.

The new series C funding from MK Capital is aimed to support SaaS model development and to prepare the company to face new challenges and offer new solutions for student information management systems.

Puppet Labs announced they closed the Series B funding with $5 million to secure the company’s growth by expanding its engineering team.

Started back in 2005, Puppet Labs have seen a rapid growing after the first funding round of about $2 millions in 2009 from True Ventures and Radar Partners who also participated in this new funding round. Actually, Kevin Compton from Radar Partners also joined these days the board of Puppet.

The announcement of the new funding is coming together with the release of new Puppet software 2.6, the newest version with new features like Preliminary Windows Support, Rest API or Event Model and many more designed to make systems administrators manage tasks lot easier. All these come to strengthen the position of Puppet labs on the data server management market where start-ups like Linaro, Karmasphere or Opscode are turning into a strong competition.

Amoung the list of Puppet customers we can find heavy names like Digg, Twitter, Shopzilla or Oracle and together with thousands of users of the open source management software, they are making Puppet the number one provider in data center automation. This position and the huge potential of this market attracted Kleiner Perkins Caufield & Byyer in supporting the round B funding.

KPCB is best known for its iFund who recently reached $200 million, venture capital raised mainly to support application development for Apple family, iPod, iPad or iPhone. Among the companies founded by KPCB through iFund is Zynga allowing the good farmers from Farmville to control their crops also on iPhone.

KPCB is very well involved also in green technology through its project Greentech. One of the KPCB Partners is Al Gore, the most famous environmentalist. Through Greentech, KPCB funded companies like Bloom Energy or Great Point Energy. Recently they participated in a $63 million funding in Emphase Banks along with PCG Asset Management and other investors.

As one of the world’s leading venture capital funds for companies, Sequoia Capital invests in all different types of startup companies from energy to technology to healthcare services. They also invest $1-$10 million in early stage startups across the board. Sequoia also invests in growth stage companies of the same spectrum.

Sequoia invests millions of dollars per year so that companies can have the financing to take their ideas to the next level. Most of the founders of this venture capital firm were developers of products from all these different categories as well. So, they know the difficulties of finding the Venture Capital to get a business idea off the ground.

Some of the companies that this Capital fund has financed are those such as Luxim, GameFly, HealthCentral, WeatherBug, FireEye, Rock You, You Tube, Widgetbox, MotoSport, and Rayspan among many others.

These companies were merely ideas and business plans when Sequoia Capital came into play and made them the businesses that they are today. Much the same as AEROSPAN and the company of Acton Pharmaceutical was not much more than an idea when they introduced themselves to this huge venture capital firm.

There are hundreds of venture capital firms that offer funding in the pharmaceutical industry. However, the competition is generally steep when it comes to receiving funding for a new drug because this industry is one of the biggest in the U.S. Pharmaceutical companies from around the world are marketing new drugs every day which need the funding of these firms.

You can read much more about Acton Pharmaceutical and what they stand for at their website: http://actonpharmaceuticals.com/. This website shows the company business plan and what they plan to do. They became established two years ago and are actively growing due to the funding from venture capital firms.

Acton was founded by Daniel L. Kreisler and John W. Simon in 2008. Forest Laboratories, Inc. is the partner which Acton has entered into the agreement with to develop and commercialize their new, environmentally safer inhaled corticosteroid (ISC).

The pharmaceutical industry is well known for being a huge industry with plenty of room for growth. The market is thriving in the United States where this company is located due to the increasing interest of the people in life extension and the treatment of diseases to make this extension of life possible.

Proceeds from both funding sources will go to help the company expand in the rapidly growing technology market. The new funding will also help PlumChoice to improve its infrastructure and underwrite further development in its technologies.

According to PlumChoices CEO, President, and founder, Ted Werth; the fact that the company was able to raise such an amount in debt capital in such a difficult financial climate is a major achievement. Mr. Werth further added that the fact that PlumChoice was able to raise this debt capital can be attributed to the company’s business model and the technology platform that the company has developed, as well as the grade of customers that uses PlumChioce’s services. Furthermore, Silicon Valley Bank saw the value created in PlumChoice’s offering.

According to Kevin Rhodes, PlumChoice’s CFO; this latest round of funding completes the current fundraising efforts. He further added that PlumChoice is fully capitalized to run its operations during the next year.

According to Jack Gaziano, Managing Director of Corporate Finance at Silicon Valley Bank, PlumChoice is definitely a leader in the remote technology repair sector and the team at Silicon Valley Bank will be looking forward to helping the company in the future.

Founded in 2001, PlumChoice is a leader in remote technology repair service and tech support for some of the nation’s highest grade telecom, ISPs, retailers, and etailers. Offered under the Partners’ brand, PlumChoice is designed to generate new revenues in this growing new innovative energy sector. Some of the services the company has to offer include one-time, one-minute, and subscription services for desktop and laptop computers, MP3 players, and more. These services can be accessed anytime anywhere with 24/7 access. PlumChoice offers its services through companies within the United States and you can find out more about PlumChoice by clicking here.

Silicon Valley Bank is a leading corporate bank that provides debt capital to companies in the IT, tech, life sciences, venture capital/private equity, and fine wine industries. Click here to read more about Silicon Valley Bank.

BMEYE B. V. is one of Europe’s leaders in creating cardiovascular monitoring technologies which are both non-invasive and easy to use. The intent of this technology is not only to improve the quality of care that the cardiac patient receives while in the hospital, but also to reduce time spent in the hospital and the rising cost of medical care. The company both develops and markets the technology and allows for the technology to be used in a whole myriad of applications it the clinical environment. The primary function that BMEYE takes the most care to enhance is the non-invasiveness and user friendliness of the technology which is implemented in hemodynamic cardiovascular monitoring. BMEYE’s main product line is the Nextfin line of monitors, which provide a user friendly interface and a monitor that has highly sensitive finger sensors that can read the beat to beat rhythm of the heart from a finger. The Nextfin line of devices can measure heart beat, pulse, and blood pressure and the monitors provide the medical aids easy to use touch screens to easily read the data output of the machines.

The outlook for BMEYE is good, since the Nextfin product line has been approved by both the CE of the European Union and the FDA of the United States. This round of funding will allow the company to aggressively market the Nextfin product line and conduct future product development as well as improve its sales channel. Founded in 2005, BMEYE had closed a series A funding round in 2006, which was led by Life Science Partners.

According to BMEYE’s CEO, Rob de Ree; the team at BMEYE is very excited to have completed this round of funding during these tough financial times. Furthermore, the technology that BMEYE is developing is revolutionary and meets many unmet needs in the cardiology community. The fact that the company was able to win such a large investment truly validates its technology and product line.

As part of the agreement of this round of funding, Early Bird’s Thom Rasche will join the company’s board of directors. Mr. Rasche further stated that BMEYE truly has a product that is revolutionary and the success of the company can duly be attributed to the diligence of its top-notched management team. Furthermore, the fact that BMEYE’s technology passed tests and cleared all the requirements from both CE and the FDA, the company’s technology can have a cutting edge in the markets of both Europe and the United States.

The other lead investor is 360 Capital and Diana Saraceni, associated with 360, will continue to be a member of BMEYE’s board of directors as part of the funding agreement. She further added that the company’s technology is truly validated by the fact that it has cleared all the necessary requirements and is currently in use in many hospitals and clinics in both the United States and Europe.

Early Bird Venture Capital is one of Europe’s most successful vc firms and currently manages over €400 million ($590,002,693.94). The vc firm primarily invests in companies who are highly innovative and have serious management teams. The vc firm further invests in those companies who are in high growth industries and have the intention to expand into international markets. The geographical preference of Early Bird Venture Capital is the European Union, the United States of America, Switzerland, and the United Kingdom. Some other companies in Early Bird’s portfolio include ABAxx Technology AG, Azeti Networks GmbH, Identify Software, Alantos Pharmaceuticals AG, and others.

360 Capital is a vc firm that primarily invests in European companies and is managed with a team of seasoned venture capitalists. Currently, 360 has over €200 million ($295,001,346.01) under its management. Some other companies in 360’s portfolio include E-Blink, Electro Power Systems, Invendo Medical, VuPen, and others.

For more information about BMEYE B. V., click here.

Founded in 2007, Epizyme is a company that is dedicated to making discoveries in genetic science and develop genetic drugs and other agents to treat a wide array of debilitating genetic diseases. Some of the diseases that Epizyme is looking to treat or cure with its new discoveries include cancer, inflammatory conditions, and metabolic and nuro-degenerative disorders. The team at Epizyme has discovered that epigenetics is one of the culprits of many diseases and goes beyond simple oncology.

According to Epizyme’s CEO, Dr. Kazumi Shiokasi, PhD; amazing progress has been made at a quick pace at Epizyme, and the company is already developing a pipeline of first class inhibitors of HMT, or histone methyltransferase enzymes, which are one of the key causes of cancerous mutations. Furthermore, the fact that the company is experiencing such tremendous support from its investors, Epizyme is ready to progress in more leads of this field of study.

One of the biggest discoveries that the team at Epizyme has made is that epigenetic enzymes are one of the key players in the formation of cancer. Furthermore, epigenetic enzymes do not need to be observed only for oncology, but for other genetic mutative disorders as well.

As part of the agreement with this round of funding, Bay City’s Dr. Carl Goldfischer, MD will join the company’s board of directors.

Dr. Goldfischer further added to what Dr. Shiosaki said and stated that Epizyme’s innovative approach to making drugs that inhibit HMTs can develop revolutionary therapies in the oncology field of the medical industry. Furthermore, the company has an amazing team of scientists who are devoted to their work, which validates the investment that Bay City Capital has made in the company.

Founded in 1997, Bay City Capital is a vc firm that boasts of a $1.5 billion in capital under its management and has since its inception invested in over 70 companies. The vc firm primarily invests in the life sciences industry. Other companies in Bay City Capital’s portfolio include Aqua Bounty Technologies, Avera Pharmaceuticals, Calypso Medical Technologies, Hyperion Therapeutics, and others.

For more information about Epizyme, click here.

Founded in 2006, TransEntrix is a subsidiary of Synecor, LLC and was founded for the specific intention of creating extremely disruptive technologies in one of the largest medical and drug device industries. TransEntrix works together with some of the United State’s most prominent physicians to develop medical devices and surgical procedures which are minimally invasive. What is paramount to TransEtrix’s success in the marketplace is the fact that the company relies extensively on hands-on clinical trials and working together with some of the most seasoned surgeons to boost up learning. Furthermore, the team at TransEntrix also believes fully in rapid prototyping of products to get them out to market on a fast pace.

Currently, TransEntrix is working on its latest project, which is a multichannel laparoscopic surgical platform that is known as the SPIDER platform. This platform is designed to give surgeons true triangulation and other advantages that are not possible with conventional laparoscopic surgery. The acronym, SPIDER actually stands for Single Port Instrument Delivery Extended Reach, which literally means that surgeons to some of the least invasive surgeries in the abdominal region.

As part of the agreement of this funding round, Aisling Capital’s managing partner, Dr. Andrew Schiff, Intersouth Partners’ general partner, Dr. Garheng Kong, and Quaker BioVentures’ Dr. Matt Rieke will join the company’s board of directors.

According to the president and CEO of TransEntrix, Dr. Todd M. Pope; the company is overjoyed to have such prestigious investors who are so confident in the company’s product. Dr. Pope further added that the technology that TransEntrix offers is powerful technology that can provide the medical community with a whole new procedure that has the potential of changing the way laparoscopic surgeries are performed.

Aisling Capital is one of the largest private equity firms in the world and currently has over $1.6 billion under its management. The private equity firm primarily invests in companies that develop technologies or global businesses that benefit the healthcare industry. The team of investors that manage Aisling Capital are up to date in the latest technologies and that is key in making Aisling Capital one of the key players in the investor community. Some other companies in Aisling’s portfolio include Adma Biologics, Armgo Pharma, Dynova Laboratories, HerbalScience, Natural Dentist, and others.

For more information about TransEntrix, click here.

One of the most dangerous hazards on America’s roads are distracted drivers. Seeing people on the phone, texting, or playing with other mobile devices, while driving to work is becoming commonplace. Furthermore, distracted drivers can annoy other drivers, because distracted drivers tend to drive slower than everyone else or vier into the neighboring lane. Other distracted drivers can also stand at an intersection even after the traffic light turns green, because she is busy talking on the phone. According to DriveFocused.com, distracted driving is becoming a hazard that is equal to, if not greater than intoxicated driving. The site further states that distracted driving is a behavioral problem that needs more than laws and education to address it. The article further states that ZoomSafer is providing innovative solutions to address this growing problem.

According to ZoomSafer’s CEO, Mike Riemer; distracted driving is a complex behavioral problem that is primarily caused by the constant development of mobile technology. Furthermore, most of municipal and state laws that punish distracted driving do not seem to have an effect on the public who is increasingly being dependent on modern wireless technology to communicate. This proves that people need more solutions to correct their driving habits besides strict laws. ZoomSafer has developed a whole array of contextual solutions that make people drive more focused. Mr. Riemer further added that the proceeds from this round of funding will allow the company to continue its quest in researching and developing solutions for safer driving.

Some of the products that ZoomSafer offers include its free Zoom Free, which is a program that is installed in your cellphone and automatically detects when you are driving and will lock the keypad on your phone, preventing you from making calls or sending text messages while you are driving. This program even goes so far as letting a driver’s friends know by either SMS, Twitter, or Facebook that the person is on the road. Other services include the ZoomMate, ZoomMail, and ZoomBiz; which are all pay services.

The CEO of Safe Kids, Mitch Stoller stated that he has been testing ZoomSafer for several weeks and he believes that this is a great solution to distracted driving. Mr. Stoller further added that the service that ZoomSafer has changed his perspective as a driver, furthermore, the company’s solutions automatically detect when he gets into the car. Mr. Stoller stated that this technology truly made him a safer driver.

ZoomSafer first launched its beta test version for Blackberry smart phones in September 1, 2009, and plans to have this program go into the second phase of beta testing, which will be more enhanced than the program in the first phase. The second phase of beta testing will launch in October 20, 2009.

For more information about ZoomSafer, click here.

ALung Technologies is a company that is developing the new age of artificial lungs and work to advance the cures of respiratory diseases. Currently the company is developing a new platform, known as the HemoLung System that is designed to aid or even replace the ventilator for respiratory patients. Ventilators are usually used on patients who have respiratory failure and what the HemoLung System is designed to do is to eliminate all the invasive techniques that a current ventilator requires. Furthermore, when a patient is on the HemoLung System, he will not need to be sedated; allowing him to be awake, alert, and able to eat. Furthermore, the traditional ventilator can cause pneumonia and other dangerous complications that are associated with ventilators, which makes a respiratory patient spend a long time in the intensive care unit. The HemoLung System can eliminate all that too, because it also allows for artificial respiration without injury to the trachea or the larynx. Furthermore, the company has already advanced the development of the HemoLung System and plans to start clinical trials this fall.

The HemoLung System is an innovative system that does all of the above mentioned by use of a smaller catheter which is inserted in either the jugular or femoral vein, mimicking the process used in acute kidney dialysis. The difference is that the catheters deliver the blood to a mechanical lung which removes the carbon dioxide and replaces it with oxygen, much like the real lung does. The catheters allow for a much easier artificial respiration process than the cumbersome ventilator which requires a tube that is surgically inserted into the trachea.

According to ALung’s chairman and CEO, Peter M. DeComo; the potential that ALung Technologies has to improve the quality of care for severe respiratory patients is tremendous. The company’s HemoLung System will greatly reduce time in the ICU and dangerous complications associated with regular ventilators and further improving the patient’s care by allowing him to be alert and the most important thing, less time in the ICU also means greatly reduced healthcare costs.

In the United States today, there is an estimated 450,000 patients who are currently being ventilated as a result to chronic and acute respiratory failure. Furthermore, with the current cost of ICU hospitalization being estimated to range in between $5000 to $7000, the cost of respiratory patients can be overwhelming. Furthermore, the clinical trials that ALung’s patented HemoLung System prototype will determine whether the HemoLung System will replace or be a supplement to conventional ventilation.

As far as the company’s COO, Nick Kuhn, is concerned; currently the team at ALung Technologies is very enthusiastic with the current near-term clinical trials of this new system. Furthermore, the HemoLung System is currently undergoing clinical trials in both Germany and India.

For more information about ALung Technologies, click here.

Founded in 1999, Semtek is a company that has been a leader in the magnetic industry since its inception. Semtek serves customers who are both in the private and public sector and who need fixed data components for their wireless devices and fixed based data processing systems. One of the key systems that Semtek has been working on since 2004 is to improve the magnetic stripe that is found on the backs of millions of credit and debit cards. In this day and age, the magnetic stripe is beginning to become a major component in electronic payment for most merchants. These magnetic stripes are located in the back of credit and debit cards, and when you pay for something in the store, your credit card is swiped through a device that reads the stripe and obtains the information about your credit card account. This magnetic stripe is becoming an instrumental component of electronic payment for merchants worldwide, because the new credit card swipers require the magnetic stripe to make the purchase.

One of the major problems with credit cards today is that there are a large number of criminals who are computer and electronically savvy and work hard to counterfeit credit cards, costing merchants and credit card companies billions of dollars. Semtek has been pioneering the credit card security industry and the company’s technology is designed to make the counterfeiting of credit cards more difficult for the increasingly tech savvy criminal. To combat the growing problem of credit card fraud and counterfeiting, Semtek has both developed and commercialized a whole suite of technologies that are effective in increasing the security and stopping theft and counterfeiting. The partnership that Semtek has acquired with Verifone is a partnership that will benefit both companies, because Verifone is one of the first companies that pioneered end to end encryption of electronic data.

The partnership with Semtek and Verifone is not that new, however. Verifone and Semtek originally secured their partnership in April of 2008, when the two companies entered into a commercial agreement, where Semtek would be involved in developing key components of a new product that Verifone is putting together, known as the VeriSafe Protect. Verifone’s new technology is based on technology that is based on the technology that was developed by Semtek. Furthermore, this technology that is under the Verifone brand has experienced breakneck success throughout the United States, that the commercial partnership in between the two companies will continue and now includes a global initiative to market VeriSafe Protect technology in other markets around the world.

This partnership between the two companies also has great benefits to Semtek, because it allows Semtek to make its technologies available to other hardware companies that can use this technology on their products or platforms.

According to the CEO of Verifone, Douglas G. Bergeron; the people at Verifone are very happy with their relationship with Semtek. The relationship has been growing over the past year, and the company looks forward to future successes with Semtek. Semtek’s CEO Patrick Hazel also added that the role in which Verifone is playing is very important role in some of the technologies that Semtek has developed. Furthermore, Verifone’s leadership is key in this historically difficult market to penetrate.

Founded in 1994, RRE Ventures is a vc firm that has been devoted to help diligent management teams build exceptional companies who are in the software, communications, and software industries. The vc firm currently has over $850 million of assets under its management. Other companies in RRE’s portfolio include AdaptiveBlue, BetaWorks, Drop.io, GoMobo, Kashless, Pontiflex, and others.

Originally established as the vc arm of the Rockefeller Family, Venrock is a vc firm that has a global presence, with offices in Menlo Park, California; New York City; Cambridge, Massachusetts; and Israel. The vc firm has invested in over 400 companies and has over $1.9 billion under its management. Some other companies in Venrock’s portfolio include IM Logic, DataPower, DoubleClick, MediaMetrix, and others.

For more information about Semtek, click here.

Arginetix is a biopharmaceutical company that is devoted to the development and commercialization of revolutionary medications that can consist of small molecule inhibitors of the enzyme, arginase. Arginase is an enzyme that competes with endothelial nitric oxide synthase for using the common substrate, L-arginine. In theory, elevated argonase in the body will lower the level of L-arginine in the body, which can result in the reduction of necessary oxygen production. What is even more dangerous is that when there is an elevated level of arginase in the body, it can also trigger fibrosis and hyperplasia, which is a result of excellerated cell division.

Proceeds from this round of funding will go to help Arginetix continue its research and in developing one of the first class solutions that inhibit the arginase enzyme. The current inhibitor that Arginetix is developing is to be used in inhibiting both cardiovascular and pulmonary indicators. The scientific foundation of the company’s research is based on the proprietary intellect of Arginetix’s cofounders, Dr. David Christianson, PhD of the University of Pennsylvania and Dr. Dan Berkowitz, MD at the John Hopkins University.

According to Arginetix’s CEO and third cofounder, Gary Lessing; this round of funding is a great endorsement for the company and the important research and developments it is doing in working with the arginase enzyme. Mr. Lessing further added that Arginetix is fortunate to be working with a group of investors who are both experienced in the field of molecular biology and talented in both their business strategy and industry knowledge. The fact that both of the company’s new investors have broad experience in developing new drugs and their proven track record of past successes will be a very valuable asset to Arginetix.

According to Dr. Geeta Vemuri, Managing Director of Medlmmune Ventures; Arginetix is currently investigating clinical studies for the treatment of both cardiovascular and pulmonary diseases with its revolutionary molecular solutions. Furthermore, the fact that Arginetix has some innovative solutions to treat cardiovascular and pulmonary diseases. This further validates the investment that Medlmmune Ventures has placed in Arginetix.

Devoted to the life science industry in the mid-Atlantic states, Quaker BioVentures is a vc firm that has more than $700 million under its management. The vc firm has led investments in all sectors of the life science industry. Quaker BioVentures invests in all stages of a company’s life. Some other companies in Quaker BioVentures portfolio include Amicus Therapeutics, Biolex, BioRexis, Celator Pharmaceuticals, Cellatope, Cempra, DiscoveryLabs, and others.

Medlmmune Ventures is the vc arm of AstraZaneca Group, which was established to enhance the research, discovery, and commercialization of biotechnology products and solutions. Furthermore, the AstraZaneca Group also provides the funding for such endeavors. Medlmmune Ventures primarily invest in early to late stage companies in the biotech industry. The vc fund invests in both privately owned and publicly traded companies.

For more information about Arginetix, click here.

Adimab is a leader in human antibody research tools. Its platform, which is an integrated antibody discovery and optimization platform that allows for scientists to be able to research everything from antigens to purified human IgGs. Adimab provides scientists and medical researchers the basic advantages by bringing to attention different panels of therapeutically relevant antibodies that can be used in treating a wide array of different diseases. According to Adimab’s corporate website, up to now, there are several different methods to approach and discover human antibodies. The thing that all three of these approaches have in common is that they all need a specific host to work. Some of these hosts include mice, E. Coli, CHO, and NSO. Furthermore, all these approaches require several different reformatting steps that can cause the quality and the accuracy of the discoveries to deteriorate. Adimab’s website goes on further to say that the company has taken extra steps to improve the discovery of human antibodies. The company site goes on to state that Adimab’s approach works by accomplishing a full integration of all the aspects of antibody discovery, ranging from library design and manufacturing. Furthermore, Adimab also stresses the importance of developing screening and presentation technologies which can search all relevant aspects of antibody quality and function. The corporate site also explains more of the unique platform that Adimab offers.

According to Bill Maris, Managing Partner of Google Ventures, vanguard technologies in the life sciences industry can be computationally intensive. Furthermore, Google Ventures will continue to back Adimab and its revolutionary technology in human antibody discovery technology. Google will also back Adimab’s bid to become the world leader in human antibody discovery and research. Mr. Maris further added that he believes that the technology that Adimab’s technology is definitely revolutionary and is happy that Google Ventures will join the company’s existing investors in backing this company.

According to Adimab’s CEO, Errik Anderson; the company has been looking at several investment propositions and finally came to the decision that Google Ventures was the best investor to complete this round of funding. The people at Google Ventures understood the value that Adimab has placed in its human antibody discovery platform. Furthermore, this prolific discovery platform can have an even greater effect when incorporated with computational tools.

Google Ventures is the vc arm of Google, one of the world’s largest search engine companies. The sole mission of Google Ventures is to seek and find new companies and help them grow into large global corporations. Though Google itself is an internet company, its vc arm, Google Ventures invests in a broad range of industries which include consumer internet, software, hardware, life sciences, clean tech, bio tech, and healthcare. Google believes in helping companies grow from the entrepreneur’s garage or basement to a major corporation with a multinational presence. Google Ventures invests in all stages of a company’s life from seed all the way to mezzanine funding.

For more information about Adimab, click here.

Growing out of the Bioengineering Department of the University of Utah, TMS is a privately owned company which develops and manufactures technologies for ultrasound breast diagnostics. Furthermore, during the company’s inception, TMS has received grants from Utah’s Governor’s Office of Economic Development or GOED. One of the flagship products of TMS includes the Svara system. This is a system that employs ultrasound which uses a Warm Bath Ultrasound or WBU. This procedure allows for the ultrasound to create accurate 3D images of the breast. The Svara system is designed to help physicians in the diagnostics of breast cancers and other pathologies of the breast by providing them with new imaging of the anatomy of breast tissue.

According to TMS’s CEO, David C. Robinson; the timing of this round of funding and the agreement with Esaote validates the quality and the potential of market disruption of TMS’s product. The global financial crisis has almost dried up the funding for startup companies, but the fact that the Warm Bath Ultrasound platform has promise and the company’s investors have great hope for the potential of this platform and the Svara system.

The Svara system itself has a unique origin. The name of this system comes from the Hindu goddess of sound and the system works by completely submerging the breast in a warm bath of water, which then enables the ultrasound transducers to emit sound waves that travel through and in the breast, creating the imaging needed to provide physicians with the necessary diagnostic data.

The imaging system developed by TMS has won applause from many in the medical community and the company has, since its inception, received over $24 million in equity financing and $5 million from the National Institutes of Health and the National Cancer Institute. Furthermore, the Svara system is still limited to use only in research until it clears inspection and wins the approval of the FDA.

Esaote is a world leader in the development and manufacturing of medical diagnostic devices. Some of the devices that Esaote manufactures include ultrasound devices, MRIs, non-imaging ECG, and even diagnostic devices for veterinary medicine as well. Esaote is headquartered in Genoa, Italy and also has offices in other places in Italy, as well as in France, Germany, Russia, Spain, the Netherlands, Belgium, the United Kingdom, the United States, Argentina, Brazil, Hong Kong, China, and India.

For more information about TechniScan Medical Systems, click here.

ThermalTherapeutic Systems is a developer of innovative solutions to treat hypothermia victims. Currently the company is in the final stages of its latest product, the TTS Hyperthermic Perfusion Device. This device is designed to raise the temperature of certain areas of people who are suffering hypothermia, which is a condition when a person’s body temperature falls dangerously below the normal 98.6 degrees Fahrenheit. The TTS Hyperthermic Perfusion Device is designed to raise the temperature of the thoracic and peritoneal areas of the body to warm the body back to normal body temperature.

Proceeds from this funding will go to further the advance and marketing of the new TTS Hyperthermic Perfusion Device.

According to ThermalTherapeutic’s cofounder and CEO, the financial support that the company has received from Originate Ventures is very valuable and as yet another milestone that ThermalTherapeutics Systems has accomplished. Along with this milestone, another big achievement that ThermalTherapeutics has attained was submitting the application for this product to the FDA in July. Furthermore, in August, the company had closed $750,000 from several undisclosed private investors. These achievements can benefit both physicians and investors. Physicians can benefit, because of the company’s innovative systems to treat a growing number of patients, and investors can reap their returns and have the ability to participate in an industry that has the potential to explode in a multibillion dollar industry which can reach international bounds.

According to Mike Gausling, Managing Partner at Originate Ventures; the vc firm values its investment in ThermalTherapeutics, because the company does not only fit Originate’s investment profile, but the TTS Hyperthermic Perfusion Device is destined to be a product that can disrupt the marketplace and provide enormous returns for the vc firm.

With offices in Bethlehem, Pennsylvania, Originate Ventures is a vc firm that primarily invests in early stage companies who are in the Pennsylvania geographic area. The vc firm invests in companies that have products or services in the healthcare, consumer, and some limited web-based and distribution industries. Some other companies in Originate’s portfolio include Adhezion Biomedical, South 49 Solutions, Proton Media, Rights Flow, and others.

For more information about ThermalTherapeutics Systems, click here.

Founded in 2007, EnticeLabs is a pioneer in developing products for online advertising and recruiting. The company was originally backed by funding from the founder of Omniture. Furthermore, the management team of EnticeLabs is one of the most top-notched teams in the industry. EnticeLabs’ success is credited to its flagship product, TalentSeekr, which is a platform that is an automated one-stop program that is disrupting the recruiting and talent seeking industry. TalentSeekr uses targeted ads and cutting edge artificial intelligence to recruit and find talented individuals who are either actively or passively looking for jobs in the websites and social networks where they spend most of their time online.

Proceeds from this round of funding will go to advance the marketing efforts and technological innovations at EnticeLabs.

According to Neal Bruce, the people at First Advantage are very impressed with EnticeLabs’ innovative technology and ability to recruit talented individuals and the headway the company is making in the HR industry. Mr. Bruce further added that EnticeLabs is definitely changing the online recruiting industry with its flagship product, TalentSeekr. The key to EnticeLabs’ success is that the management of the company understand the needs of their clients and know how to develop technology and methods to meet those needs.

According to EnticeLabs’ CEO, Ryan Caldwell; The management team is very happy to have such a strong supporter, such as First Advantage. The fact that First Advantage is investing in EnticeLabs is living proof that the successes that the company has had and the quality of the company’s product and service to its clients is validated. Mr. Caldwell further stated that he is looking forward to the expansion opportunities that the investment from First Advantage will afford the company.

First Advantage is an employer recruitment company that has a suite of tools that employers can use to recruit productive and talented employees by reducing time, cost, and risk. First Advantage does not only seek and recruit employees for companies, but also tracks the applicants who apply through their service.

Omniture is an online marketing service that helps improve its customers with their marketing ROI. The product that Omniture offers is the Omniture Online Marketing Suite. This suite can optimize your website’s usability, improve your marketing ROI, and more.

For more information about EnticeLabs, click here.

TargetCast Networks is a company that develops and purveys digital TV technologies for out of home television. TargetCast’s technology allows venue operators to both create and broadcast their own custom promotional content on TV screens that their clients have in their establishments. The company also provides local, regional, and national advertisers, who can target a large audience with customized television sets at a much lower rate than conventional advertising methods.

According to the president and CEO of TargetCast Networks, Jerry Hall; proceeds from this new funding round will go to establish new strategic partnerships and create a new internal advertising sales team. Mr. Hall further stated that TargetCast’s investors have a proven track record of seeking exceptional media opportunities. Furthermore, the company’s investors understand that the company’s management has a superior domain experience in the industry and TargetCast also has patented technology and all this together puts the company ahead in a crucial time in the media and advertising industry.

Nat Goldhaber, Managing Director of Claremont Creek Ventures stated that TargetCast Networks is leading the way in a growth category that marketers are looking for in new media options, since that the more traditional media, which people have been accustom to for the past century is dying out. Furthermore, the company’s management team is run by highly diligent people who have a deep understanding of the media industry today.

This extra round of funding is not the only thing that TargetCast has announced today. Along with the joint funding with Claremont River Ventures and DFJ, the company also announced that Mr. John Fisher, who is the Managing Director of DFJ will also come on board as a new member of TargetCast’s board of directors. Mr. Fisher will join other board members, who include Claremont River’s Nat Goldhaber and Paul Straub; TargetCast’s CEO, Jerry Hall; and Dr. Peter Sealey, who was Coca Cola’s CMO and a well known advertising media expert.

According to DFJ’s John Fisher, the advertising on out of home digital television networks is becoming a growing platform. This platform is not only a new platform, but is also growing at not only the local level, but at the national level as well. Mr. Fisher further added that the loud sucking sound of dollars draining out of the sinking traditional media industry and going into the new digital media of the 21st Century makes TargetCast Networks a good investment and a great opportunity for all of its investors.

With over $305 million under its management, Claremont Creek Ventures is a vc firm that primarily invests in seed and early stage companies who are in the energy management and conservation, IT, healthcare, security, and tech industries. Claremont Creek Ventures is a prominent vc firm that is based in Oakland, California. Some other companies in Claremont Creek’s portfolio include Adura Technologies, Arcxis Biotechnologies, Gene Security Network, Lefora, Sentilla, and others.

DFJ, or Draper Fisher Juvertson, is a globally renowned vc firm with its headquarters in Menlo Park, California and other offices in New York City, China, and India. In the vc firm’s 24 year history, DFJ has invested in over 500 companies; some of which are well known household names, such as Hotmail, acquired by Microsoft; Skype, and others. Other companies in DFJ’s current portfolio include 4Info, Abuzz, AltoBeam, AppStream, BinOptix, and others.

For more information about TargetCast Networks, click here.

Nesscap, Inc is a company that is leading the South Korean market in producing ultra capacitors and power storage units for long term energy storage. The company features a large array of different products that are a standard in the industry. Nesscap offers products that range from three to five thousand farads and have organic electrolytes that are recognized by the electric power storage and ultra capacitors industry. Furthermore, Nesscap states that its products have both cells and modules that are for the transportation, power, and consumer industries.

According Nesscap’s chairman and CEO, Dr. Sunwook Kim; both he and the management are very pleased that the company has the support of such a strong investor, such as I2BF Venture Capital. Dr. Sunwook further stated that the support from I2BF demonstrates the support of Nesscap’s technology and proof that it is doing well in the marketplace.

Based in London, United Kingdom, I2BF Venture Capital is a high class vc firm that has a mission of supporting companies that are in the energy industry. I2BF Venture Capital was founded in 2005 with a mission to improve the energy sector in the United States, Europe, Asia, and the South Pacific. I2BF is a subsidiary of Arbat Capital Management, which is one of Russia’s top vc firms. Currently, I2BF Venture Capital has over $90 million of assets under its management. Along with venture capital, I2BF Venture Capital also has a hedge fund that is worth over $25 million. The primary focus of I2BF Venture Capital is in renewable energy, and on their website they show a diagram of the different sectors of the energy industry the vc firm focuses on. Some of the sectors include wind, hydrogen, solar, and ocean energy. I2BF Venture Capital also invests in biofuel companies and companies who are in the water purification and energy efficiency industries. Some other companies in I2BF’s portfolio include Primafuel, Solix Biofuels, Prism Solar Technologies, Epuramat, Solar Silicon, PowerBeam, and others.

For more information about Nesscap, click here.

LS9, Inc is a privately owned company that specializes in renewable petroleum. LS9 creates renewable petroleum by employing biotechnology to develop commercial fuels and chemicals. Synthetic biology can meet the growing demand for alternative fuels by producing fuels that have the same properties of petroleum based fuels and are compatible with the existing consumer infrastructure. The fuels that are produced by LS9 are very clean and produce very low carbon when consumed. The fuels are made from sugar-based products, such as sugar cane and cellulosic biomass.

LS9’s fuel is developed from a one-step fermentation process that converts plant-based material into reliable fuels and high value sustainable chemicals.

According to LS9’s Vice President of Research and Development, Stephen del Cardayre; the company provides a fuel that is highly clean and safe for the environment. Furthermore, these fuels are not only low carbon emitting, but are also of high quality and cost effective. Mr. del Cardayre further added that proceeds from this round of funding will go to expedite the development of more of these new biofuels and chemicals that can benefit many industries on a broad scale.

LS9’s technology is so innovative that by 2010, the company estimates to have a biofuel available that is practically identical to diesel and jet fuel, but less dirty. LS9 is unique because it has been able to show how it can manipulate the genetic makeup of microbes to taylor them to the needs of the productions of LS9 products.

CTTV Ventures LLC is the vc arm of the Chevron Technology Ventures, which is an investment branch of Chevron Oil. Chevron Technology Ventures invests in energy innovators who have the potential to benefit the Chevron Oil Company.

Founded in 2000, Flagship Ventures is a well respected vc firm that is devoted to the funding and realization of innovative companies. Flagship Ventures primarily invests in companies which have an innovative proprietary technology or service in the therapeutics, life sciences, tools & diagnostics, bio energy, and clean tech industries. Some other companies in Flagship’s portfolio include Advanced Electron Beams, Oasys Water Novomer, Zegen, and others.

Khosla Ventures is a vc firm that believes that an entrepreneur is a person who “dares to dream and who is foolish enough realize those dreams.” Khosla Ventures does not only offer financing to companies, but also strategic advice and help to entrepreneurs who are diligent enough to realize their ideas and extend them to new potentials.

Lightspeed Venture Capital is a vc firm that has a global presence with offices in Silicon Valley, China, Israel, and India. The vc firm currently has over $2 billion in committed investments and has opened its seventh fund of $800 million. Other companies in Lightspeed’s portfolio include Ask Laila, 99Bill.com, Aerohive, Bling Nation, Car Domain, CoalTek, and others.

For more information about LS9, Inc., Click here.

Vuclip has developed the one of the biggest video search engines for mobile phones. Furthermore, Vuclip’s video portal is the only video portal that can transcode and transcribe all web videos to any mobile phone across almost any wireless network worldwide. The service that Vuclip is free, but carriers may charge the users of that particular service for bandwidth costs. Vuclip also allows publishers to publish their web video content through their white labeled Vuclip Video API program.

According to Vuclip’s CEO and founder, Nickhil Jakatdar; Vuclip’s service was built on a browser that address all the technical problems that some mobile phones might encounter with web videos. The solution that Vuclip offers gives media companies the opportunity to have a global audience and allows for the mobilization of these videos online.

To date, the service that Vuclip provides has already reached over 1,000,000 people in over 150 countries throughout the world. Vuclip also has many different partnerships with some of the world’s premium media and advertising companies. Advertisers can use Vuclip as a vehicle to reach millions of consumers.

Founded in 2003, JAFCO Ventures is a vc firm that has over $350 million under its management. The vc firm primarily invests in companies who are in the communications, internet, semiconductor, and software industries. JAFCO Ventures is based in Palo Alto, California and also has offices in Asia and invests in the United States, China, and Japan. Some other companies in JAFCO’s portfolio include 41st Parameter, Aster Data Systems, Calypto, ClairMail, and others.

New Enterprise Associates, or NEA is one of the leading vc firms, who’s primary mission is helping entrepreneurs build new powerful enterprises. NEA was founded in 1978 and has several principles that it bases its investments on. The first principle that NEA bases its investments on is helping and supporting the entrepreneurs in whom the vc firm invests in. The second principle is to participate in the profession of the industries in which the vc firm invests in and earning the highest respect in the industry. Currently, NEA has over $8.5 billion of committed capital under its management. NEA also has offices in both China and India. Some other companies in NEA’s portfolio include Amicus Therapeutics, 3Com, Actelis, Argon Networks, Ascend Networks, Astral Point Communications, and others.

For more information about Vuclip, click here.

PrimeraDx is a company who is in the growing molecular biological medical industry, and the company has an amazing ability to attract many investors. The main focus of PrimeraDx is in the field of molecular diagnostics to help physicians and clinicians diagnose many kinds of serious diseases. The success in PimeraDx is its unique platform, which is automated and designed to be multiplexed and cost effective. Furthermore, these tests can be very accurate and the whole platform is based on PrimeraDx’s proprietary technology, STAR Technology, which is employed with the ICEPlex instrument.

The STAR Technology is actually short for Scaleable Target Amplification Routine, and it is a new method to test the nucleic acids of several different cells at the same time. This new technology is based on an innovative technology that is PCR and CE. PCR is an acronym for Polymerase Chain Reaction and CE is short for Capillary Electrophoresis. The way that STAR Technology works is that it targets the nucleic acid of multiple cells and the targeted acids are then monitored by taking a sample of the PCR reaction and during the cycle, this technology separates and quantifies the PCR products by the CE.

According to PrimeraDx’s president and CEO, Martin L. Verhoef; the company is very excited to welcome CHL Medical Partners aboard. The fact that PrimeraDx is able to attract as many investors as it has validates that its revolutionary STAR technology can disrupt the marketplace. Mr. Verhoef further added that proceeds from this round of funding will go to continue the commercializing of PrimeraDx’s proprietary technology. The funding will also advance regulatory strategy and broaden the quantitive multiplex test menu to run the company’s IcePLEX system.

According to Richard Lennox, partner at CHL Medical Partners; PrimeraDx is a superb investment opportunity. There are many unmet needs in the molecular diagnostics industry, and PrimeraDx seems to be meeting these needs. Furthermore, there are some crucial needs that are not met in this particular industry and PrimeraDx seems to be meeting those needs with great success.

CHL Medical Partners is a world-class vc firm that seeks both entrepreneurs and inventors who are working on innovative technologies for the molecular diagnostic, healthcare, and medical devices industries. Currently the vc firm has over $120 million under its management in its sixth fund. Some other companies in CHL’s portfolio include Still River Systems, Valeritas, Medicus Insurance Company, Fidelis Seniorcare, SemperCare, and others.

For more information about PrimeraDx, click here.

The ice cream industry is estimated to be a $60 billion industry and the proprietary technology that MooBella offers is revolutionary and sets out to disrupt the entire ice cream market. What makes MooBella stand out from other ice cream makers is that the company has a technology that allows the consumer to make ice cream cones in their own flavors in a hard ball cone. The machine works by instantly freezing the ice cream itself, while at the same time giving the ice cream the needed aeration and its flavor. Furthermore, the machine that MooBella has created freezes the ice cream into premium hard ice cream balls for cones. Another achievement that MooBella has achieved is winning the INNY Award from the Tech Museum of Innovation in San Jose, California. The company has also won awards for its technology from the National Restaurant Association, which awarded MooBella the 2006 Kitchen Innovations Award. MooBella also won awards from other organizations, such as the Food Network, and others.

According to MooBella’s president and CEO, Bruce Ginsburg; by having a partnership with a world class investment firm, such as Inventages, MooBella has been able to successfully complete a highly demanding process of building up the company and perfecting its technology and is now positioned to launch its product commercially later this year. Currently, MooBella is to strategically place its machines in highly populated areas in New England, especially in shopping centers and malls where there is a lot of consumer traffic.

According Inventages’ Erich Sieber, who also sits on MooBella’s board of directors; during tough economic times, like the times we live in today, only the most innovative and competitive companies get secure funding from investors. Furthermore, MooBella’s technology is not only innovative, but because of its ability to allow the consumer to generate ice cream in customizable flavors and dispenses the ice cream into premium hard frozen ice cream balls; the company is able to start a paradigm shift in the ice cream industry. Furthermore, once consumers see that the ice cream that they are making from the machines is fresh and their own flavor, they will come back for more. This fact poises MooBella for success in the marketplace.

Based in Geneva, Switzerland, Inventages is one of the world’s largest and best known investment firms that invests in the healthcare, life sciences, and nutrition industries. The firm currently has over $1.5 billion of capital under its management. Investages also has offices in London, Aukland, and Nassau. Some other companies in Investages’ portfolio include Accera, Atonomics, Boowl, Cavis, CM&D, Cryolog, EnCoat, EverNutrition, and others.

For more information about MooBella, click here.

Calypso Medical is a medical device company that has developed a tumor localization system which uses implants to continuously, accurately, and objectively track tumors for radiation therapy. The implants used in this system are known as Beacon electromagnetic transponders, which together with the company’s proprietary system are designed to track tumors which can be treated by radiation therapy throughout the body. Furthermore, the technology was approved by the FDA to be used in prostrate and post operative prostrate cancer patients. Another thing that makes Calypso Medical attractive to investors is because of the strategic partnerships the company has made with some of the major companies in the medical industry, which include Siemens, Elekta Corporation, Varian Medical Systems, and others.

Proceeds from the funding will go to finance Calypso’s expansion both domestically and internationally. Along with expansion, this round of funding will also go to fund the development of new products for clinical indication of tumors as well as the continued integration of these products with Calypso’s proprietary technology, the Calypso System platform with other radiation therapies.

The Calypso System is based on the company’s platform, the GPS for the Body, which uses Beacon transponders to provide some of the most accurate information where tumors are in the body during an external radiation beam when a patient with the implanted Beacon transponders undergoes radiation therapy. The main problem with traditional radiation therapy, is that should a patient move slightly, the radiation beam could miss the tumor and radiate some healthy tissue instead. These transponders aim to eliminate that problem, by enabling the radiation beam to target the tumor, even when the patient moves.

According to the Managing Director of Skyline Ventures, John Freund; the team at Skyline believes that the proprietary technology which Calypso Medical has can potentially revolutionize the way radiation therapy can be implemented in the future. In all cases of cancer treatments using radiation, location of the tumor is critical in successfully treating the cancer and not damaging healthy tissue. Use of the Beacon transponders to constantly locate the tumors will simplify the radiation therapy and make the treat all that much more effective. Calypso’s technology platform allows for oncologists to increase the dose of radiation because the tumor is constantly on target.

According to Calypso’s president and CEO, Eric Meier; this new round of funding validates the value of the technology that Calypso has to offer in advancing radiation therapy by constantly targeting the tumor to be radiated. Furthermore, having a technology that can accurately target the tumor every time the patient moves, has excellent potential in the marketplace.

According to the second managing partner of Skyline Ventures, Glenn Reicin; the people at Skyline believe that the Calypso System, which is designed to accurately target tumors that are set for radiation therapy will grow in considerable importance when more oncologists discover that being able to constantly target the tumor and have more chance to target the tumor and not accidentally hit healthy tissue.

According to the general partner of Frazier Healthcare Ventures, Trevor Moody; being one of the founding investors of Calypso Medical, he is pleased to be able to jointly invest together with such first rate vc firms, such as Interwest Partners and Skyline Ventures.

Founded in 1997, Skyline Ventures is a vc firm that is well known in the United States and its specialty is making investments in companies who are in the healthcare industry and have a unique proprietary technology that has the potential to revolutionize the healthcare industry and disrupt the markets. Proving the dedication of Skyline Ventures is the fact that each of the vc firm’s principals holds either an MD or a PhD in the medical field. Other companies in Skyline’s portfolio include Acel Rx Pharmaceuticals, Advion, ARCA Biopharma, Dow Pharmaceutical Sciences, InteKrin Therapeutics, and others.

Founded in 1991, Frazier Medical Ventures is a leading investment firm that provides both venture funding and equity to companies in the healthcare industry in the United States. Frazier Medical Ventures has a mission to partner up with entrepreneurs who are diligent and want to build strong and enduring companies in the healthcare industry. Some other companies in Frazier’s portfolio include EBR Systems, Vivus, WIRB, Incontrol, Informed, Xoft, Zymo Genetics, and others.

For more information about Calypso Medical, click here.

NextBio provides researchers in the life sciences industry a unique and innovative platform to research, discover, and share knowledge which is in both the public and private data bases. NextBio’s platform provides powerful tools to researchers that seamlessly combine with content that is unique and corrolated, changing information and data to knowledge; which can lead to new discoveries and new breakthroughs in medicine and other sectors where the life sciences come into play. NextBio’’ platform come in as an SaaS or Software as a Service and helps organizations and businesses communicate and share data over geographic boundaries. Currently, NextBio boasts of having some of the top grade clientele, who include the Burnham Institute for Medical Research, Johnson & Johnson, Merck, Stanford University, and others.

Proceeds from this funding round will go to fund the company’s continuing growth in sales, expansion into international markets, and technology leadership. Since NextBio launched its research platform, it has been widely used by some of the major research and academic institutions worldwide. Furthermore, NextBio has also joined into a partnership with a well renown life sciences publisher, Elsevier, which will make the company more powerful and its information available to subscribers of such publications as ScienceDirect.

According to the Managing Director of Newbury Ventures, Bruce Bauer; the combination of innovative technology, an exceptional management team, and its unique value brought on by partnering up with leading science publications makes NextBio a compelling investment. Furthermore, with all of NextBio’s achievements, the company could potentially be poised to be a market leader in both the IT and life sciences industries.

According to Nextbio’s cofounder, Saeid Akhtari; the team at NextBio is delighted in the confidence that the company’s existing and new investors have in the company and decided to go on with this round of funding. Furthermore, this investment also provides the company with sufficient funds to continue to grow its sales and expand into new markets.

Founded in 1992, Newbury Ventures is a vc firm that primarily invests in early stage companies who are in the IT, security, networking, and mobile industries. Currently, Newbury Ventures has over $500 million in committed capital under its management. Some other companies in Newbury’s portfolio include ACC, Divio, Laurel Networks, MetaLINCS, Paradigm, and others.

For more information about NextBio, click here.

Pervasis Ptherapeutics is a company that clinically tests and develops a wide range of clinical biologically active pharmaceuticals and therapies. Currently, Pervasis is working on some groundbreaking therapies that involves endothelium and how it works to naturally heal disease. Furthermore, the team of scientists at Pervasis Therapeutics have also made some discoveries that can highly improve the results of some common vascular interventions, such as angioplasties, stents, and both peripheral and coronary bypasses. Endothelium can curtail failures that can occur in some cases with the current procedures, and these failures can cause serious health complications and a dramatic increase in medical costs. Furthermore, Pervasis’s most advanced drug, Vascugel, has proven to be both safe and proof of concept in two Phase 2 clinical trials, when it was tested on patients who underwent arteriovenous treatments.

Vascugel is the newest development by Pervasis, which involves tissue engineered allogenic endothelium, which has effects that are currently being studied on how it can benefit patients with severe renal disease and are undergoing arteriovenous procedures.

Other than the above mentioned investors, other investors also participated in this current round of funding. Some of these other investors include the Richter Family Fund, which is funding Pervasis for the first time. Furthermore, on the heals of this funding round, Pervasis Therapeutics also announced that several new people will join the company’s board of directors. One of these people who is joining the board of directors is Dr. Yoram Richter, PhD., who is the Vice President of Research and Development at BIOrest, Ltd.

According to Dr. Richter, the proprietary endothelial technology that Pervasis Therapeutics provides creates a new platform that physicians can use to treat patients with vascular diseases. Furthermore, this new product platform also has the potential to treat ailments and diseases which are outside of the cardiovascular realm.

According to the president and CEO of Pervasis Therapeutics, Frederic Chereau; the team at Pervasis is very happy that both the company’s existing and new investors has chosen to go ahead with this new round of funding. Their investments are a confidence vote in the company and is testament to the fact that the products that Pervasis has the potential to revolutionize the medical and healthcare industry. Mr. Chereau also welcomed the appointment of Dr. Richter to the company’s board of directors. Dr. Richter will be an invaluable asset to Pervasis, because on his extensive knowledge in the field of medical devices and cardiovascular care.

Founded in 2000, Flagship Venture Partners is a vc firm that believes in building innovative companies. The vc firm primarily invests in early stage companies who are in the therapeutics and life sciences industries. Currently, Flagship has over $600 million under its management. Some other companies in Flagship’s portfolio include Selecta, Bind Biosciences, Alvine Pharmaceuticals, GCI Pharmaceuticals, and others.

Founded in 1996, Polaris Venture Partners is a vc firm that invests in all stages of a company’s life. Polaris Venture Partners primarily invests in companies who are in the healthcare, media, communications, business services, and tech industries. Currently Polaris has over $3 billion under its management and has invested in over 90 companies since its inception. Some other companies in Polaris’s portfolio include 1366 Technologies, Aepona, Apnex Medical, Art.com, and others.

Founded in 1988, Highland Capital Partners is a vc firm that primarily invests in seed, early, and growth stage companies who are in the consumer, healthcare, IT, and internet & digital media industries. Currently, Highland has a series of different funds under its management which total to a sum of over $2.7 billion. Some other companies in Highland’s portfolio include Castor & Pullex Pet Works, City Sports, Life Gear, Mix 1, AccentCare, Codon Devices, and others.

For more information about Pervasis Therapeutics, click here.

Perfecto Mobile is a leader in providing remote access and automated testing of mobile devices and has a platform that is called the Handset Cloud. This service allows developers and testers to access a wide range of mobile devices from anywhere in the world by use of the internet. Furthermore, testers and developers do not need to sit in front of a computer to do the testing. Perfecto provides special handsets that both developers and testers can use to do the testing. These handsets can also allow developers and testers to communicate and collaborate from anywhere in the world and can also monitor mobile devices.

According to the CEO of Perfecto Mobile, Eran Yaniv; the team at Perfecto Mobile is excited about this new round of funding from its long term investors. In this day and age, there is a new emergence of all kinds of new mobile technologies, such as apps, app stores, and open device platforms. Though these technologies are great, sometimes they may not function properly and the need for testing becomes a major concern. Furthermore, since these new technologies are located throughout the world, the need for mobile testing devices is practically imperative. This provides Perfecto Mobile the ability to be a global leader.

According to Raina Shainski, General Partner at Carmel Ventures; the team at Carmel Ventures is confident that Perfecto Mobile is able to take advantage of the large and growing market that is unfolding in the mobile industry. Perfecto has a strong management team and a compelling service enables the company to lead the market because of its ability to increase the quality of the new mobile technologies that are becoming increasingly available to users.

According to Ehud Levy, Managing Partner of Vertex Venture Capital; Perfecto is perfect, because it has a great management team and a service that is needed and already has some well established mobile companies, such as Vodafone and Swisscom, is proof that Perfecto’s technology and service meets an unmet need in the mobile industry.

Carmel Ventures is a vc firm that likes to turn great ideas into exceptional companies. Furthermore, Carmel Ventures also turns great and ambitious entrepreneurs into great leaders. Currently, Carmel Ventures has more than $600 million under its management and invests primarily in the tech industry. Other companies in Carmel’s portfolio include Amadesa, Coppergate, DesignArt Networks, Imagine Communications, Payoneer, and others.

Vertex Venture Capital is one of Israel’s top tier vc firms that invests in all stages of a company’s live. Vertex primarily invests in companies who are in the information networking, software, and other emerging tech industries. Some other companies in Vertex’s portfolio include Actelis, Flash Networks, Telegate, Zeugma, Percello, HyperRoll, and others.

For more information about Perfecto Mobile, click here.

Despite the fact that the travel industry is growing on the internet with online travel agencies which book e-tickets for flights and provide online reservations for hotels and restaurants, Oyster Hotel Reviews has its own niche in the market, because it is the only online service that provides in depth and objective reviews about hotels throughout the world. The reviews that Oyster provides stand out from other internet travel related services, because these reviews are written by trained journalists who know what to look for in writing a good objective review. What makes Oyster Hotel Reviews unique in the market place is that it uses its proprietary method, known as the hotel review method. By adhering to some of the highest standards possible, Oyster Hotel Reviews is able to have some of the most comprehensive hotel reviews both online and offline. These reviews are not just written articles about the hotels that are reviewed by the company, but are also accompanied by photos that are unedited and clearly show how good or bad the hotel is. Furthermore, Oyster’s name is already well known and has been featured with positive reviews from some of the most prominent press worldwide, including the New York Times, Men’s Journal, and the Wall Street Journal to name a few. Currently, Oyster Hotel Reviews writes reviews about hotels in Aruba, Las Vegas, Miami, New York, Jamaica, and the Dominican Republic.

According to Ajay Agarwal of Bain Capital, the need for clear, comprehensive, and objective reviews are very necessary for travelers and this is quite evident by the response that Oyster Hotel Reviews after being launched. Mr. Agarwal further stated that the team at Bain Capital Ventures looks forward to helping the company in future endeavors to expand its reviews.

Proceeds from this funding, along with last year’s funding; Oyster Hotel Reviews plans to expand its reviews to include more hotels on West Coast destinations. Oyster Hotel Reviews is also aggressively hiring people and is already positioned to become one of the largest media outlets for travel in the United States by the end of the year.

According to Oyster’s CEO, Elie Seidman; the team at Oyster Hotel Reviews is thrilled to have such a large name and prestigious firm, such as Bain Capital back it. Mr. Seidman further added that the company still remains dedicated to providing the most in depth and objective reviews of some of the major hotels in the country.

Bain Capital Ventures is the vc arm of Bain Capital and is dedicated to provide funding to companies from seed stage all the way to the later stages of the company. Bain Capital Ventures primarily invests in companies who are in the software, wireless, internet, information, healthcare, and tech industries. Some other companies in Bain Capital Ventures’ portfolio include Regulatory Data Group, AdReady, Ameritrade, Blip TV, Camera World, and others.

For more information about Oyster Hotel Services, click here.

Ozmo Devices is a leading provider of low power WiFi solutions which enable all kinds of devices to hook up to public WiFi networks. In today’s world, there are many devices that need a WiFi network to function, ranging from laptop computers to multimedia players and smart phones. Furthermore, with many businesses having their own WiFi LAN and PAN networks, many shared printers are connected wirelessly as well as head sets and other peripheral devices. The technology that Ozmo Devices provides is to provide a seamless connection and interaction with all peripheral devices and laptop computers in an office situation. Ozmo Devices allows for WiFi networks to expand their capabilities. Furthermore, this revolutionary wireless coverage runs on low power and brings tremendous savings to its users.

Another achievement that Ozmo Devices has accomplished is being part of the Intel Developer Forum, which will take place on September 22 through 24, 2009. At this forum, Ozmo Devices will demonstrate its technology. The Intel Developers Forum is scheduled to be held at the Mascone Center, West in San Francisco, California.

According to Len Rand, Managing Partner of Granite Ventures; the leadership that Ozmo Devices is demonstrating in the WLAN and WPAN arena and its IC products are starting to outperform other wireless connecting signals for peripheral devices, such as Bluetooth provides the company with a strong foundation for future growth. Mr. Rand further stated that Ozmo Devices has a revolutionary technology and has already sealed some strong business partnerships with powerful tech giants, such as Intel and Avago Technologies. The team at Granite Ventures is happy to continue to back Ozmo Devices in its future endeavors.

According to Ozmo’s CEO, Dave Lyon; this new round of funding will allow the company to expand its sales, as well as field its engineering efforts to develop new state-of-the-art technologies for the WiFi industry.

Founded in 1992, Granite Ventures is a vc firm that primarily invests in early stage companies who are in the tech industry. Currently, Granite Ventures has over $1 billion in committed capital under its management and since its founding has invested in over 90 privately owned companies. Some other companies in Granite’s portfolio include Agilence, AirTight Networks, Digital Fountain, GigaNet, NetBoost, NetEffect, and others.

Tallwood Venture Capital is a vc firm that is dedicated to the semiconductor industry and to other technologies that might affect the semiconductor industry. Tallwood currently has over $500 million under its management and the people at Tallwood believe that this fund puts the vc firm on par with the semiconductor industry. Some other companies in Tallwood’s portfolio include Abound Logic, Alphion, Astute Networks, Audience, Calypto Design Systems, Marvell Technology Group, and others.

Intel Capital is the vc arm of Intel and mainly invests in promising companies in the tech industry which can be of benefit to Intel. Intel Capital invests worldwide and has its goals on spurring entrepreneurial spirit, while generating financial gain at the same time.

For more information about Ozmo Devices, click here.

Founded in 1998, Actelis is a leader in the development of ethernet equipment and cables. Actelis has a product portfolio that has a wide range of solutions to serve ethernet companies worldwide. Some of these solutions include the First Mile technology platform. Many of the products that Actelis offers to its customers are highly flexible and cost effective. Furthermore, Actelis products can be used for point to point as well as point to multipoint configurations, allowing for speeds that are acceptable for today’s internet demands.

Proceeds from this round of funding will go to help Actelis to support its further growth and continuing deployment of its ethernet networks in the First Mile technology platform by telecommunication and IT service providers throughout the world. Furthermore, Actelis ethernet products are also being used more in the educational, healthcare, and private enterprise IT markets. Furthermore, Actelis technology is also being used by a growing number of municipalities who are in the process of upgrading their transportation networks with new intellegent transportation systems or ITS to oversee and control all aspects of municipal public transportation.

According to the president and CEO of Actelis, Tuvia Barlev; as far as the telecom industry is concerned, the carrier ethernet market is one of the fastest growing markets within the industry. Mr. Barlev further stated that the EFM solutions that Actelis is developing can provide many different opportunities for the company.

Currently, Actelis is experiencing record growth with the acquisition of new contracts world wide. Some of the major contracts that Actelis has recently sealed include a contract with Slovenia’s telecom company, Telekom Slovenije and France’s France Telecom-Orange.

Although Actelis has won these big contracts, the company also wants to focus on markets in the United States. Proceeds from this funding will also enable Actelis to seize opportunities that have been presented to the company with the presentation of a $7.2 billion broadband stimulus package that is offered by the Obama Administration’s American Recovery and Reinvestment Act, which was passed in 2009.

The one problem, however, is that the financial situation that Actelis is finding itself in is a rather embarrassing situation for its investors. Over the past eleven years, the company has raised over $150 million and this has raised the question to some of Actelis’s investors about how they will make their returns from the company.

Vertex Venture Capital is one of Israel’s top tier vc firms that primarily invests in works closely with the entrepreneurs in which the vc firm invests in. Vertex primarily invests in Israeli or Israel-related companies and invests in all stages of a company’s life. The companies that Vertex Venture Capital primarily invests in are companies who are in the software, information networking, communications, and IT industries. Some other companies in Vertex’s portfolio include Ethos Networks, Expand Networks, Extricom, Zeugma, Percello, and others.

For more information about Actelis, click here.

Hanmi Financial Corporation is a holding company that funds ethnic minority communities in the Los Angeles area and has 27 full service offices functioning in the area that encompasses the Los Angeles, Orange, San Bernardino, San Francisco, Santa Clara, and San Diego counties. Hanmi Bank also has two loan offices in other parts of the United States as well, which are located in both Virgina and Washington State. Some of the financial services that Hanmi Bank and the Hanmi Financial Corporation specialize in include small business administration and commercial loans, as well as trade finance lending. Furthermore, Hanmi has become a leading financial institution in the Bay Area community.

According to Hanmi’s president and CEO, Jay S. Yoo; the people at Hanmi are happy to have received the $9.6 million financing from Korea-based Leading Investments & Securities Co., Ltd.; and Mr. Yoo further stated that his team looks forward to receiving the remaining $4.1 million to complete the $11 million funding round. Mr. Yoo also added that when this entire $11 million funding round from Leading Investment & Securities Company is completed, it will provide Hanmi the extra capital needed to augment the bank’s reserves and will also enhance Hanmi’s ability to weather the current financial crisis and also allow Hanmi to emerge to be well positioned to seize lucrative opportunities as soon as the economy recovers. Hanmi is also very busy working together with other investors as well. Currently, Hanmi is undergoing active negotiations with some other investors from South Korea to try to receive more equity infusion.

Based in South Korea, Leading Investments & Securities Company, Ltd. is a financial service providers that specializes in providing securities brokerage, corporate mergers, and acquisitions. Leading Investments & Securities also specializes in investment banking services as well as a wide range of other kinds of financial services for corporations, institutional investors, and individuals.

For more information about Hanmi Financial Corp., click here.

BPT is a company that develops important chemical membrane based solutions to separate the water from waste water and is emerging as a leader in the industry. The chemically stable membrane technology that BPT produces is becoming more of a key component waste water processing for companies who are in the landfill, mining, bio pharmaceutical, and food industries to help them with the increasingly more strict environmental laws, reuse water, and reduce operating costs. BPT membranes have been proven in the field to drastically reduce costs in purifying some of the most aggressive waste water streams.

According to BPT’s CEO, Nir Kinory, the team of BPT is very pleased to have both USVP and Pitango Venture Capital on board, because both vc firms have extensive experience in building great companies. Along with the company’s existing investors, the experience from these new investors will be of increasing value as BPT continues to grow and expand.

According to USVP’s Jacques Benkoski, USVP for the past six years has been investing in emerging companies who are in the clean tech industry, and the vc firm’s investment in BPT is its first investment in Israel. Mr. Benkoski added that BPT has everything that USVP is looking for and believes that his efforts to lead USVP investment in BPT will be a good opportunity for USVP. BPT is playing a unique role in the clean tech marketplace and offers a product that is projected to take over the waste water cleaning market over in an aggressive manner.

Pitango’s Ittai Harel further stated that the clean tech industry is becoming a growing concern in the global marketplace. In looking at BPT’s profile, the company’s revolutionary technology and its outstanding R&D group has placed it in a great position to play a major role in nanotechnology in water purification technology.

USVP is a leading vc firm that is based in Silicon Valley and is dedicated to turn exceptional entrepreneurs into world class companies that have the potential to lead their industries. USVP primarily invests in early stage companies who are in the various industries that USVP’s partners have their greatest experience in. Some other companies in USVP’s portfolio include 3Ware, 4INFO, Adify, Astute Networks, Fresh Choice, Electric Cloud, and others.

Founded in 1993, Pitango Venture Capital is one of Israel’s leading vc firms and has offices in both Israel and Silicon Valley. Pitango Venture Capital primarily invests in seed, early, and expansion stage companies who are in all sectors of the tech industry. Some other companies in Pitango’s portfolio include Civcom, Surf Communication Solutions, AeroScout, Axis Mobile, and others.

For more information about BPT, click here.

Founded in 2003, Endosense is a medical technology company that is dedicated to improving the efficacy, safety, and reproducibility of the catheter ablation that is used to treat cardiac arrhythmia. Since its founding, Endosense has pioneered this technology with its Touch+ Sensor Technology.

The Touch+ Sensor Technology, that Endosense has pioneered, is a catheter that has a fiber-optic cable attached to it. This new technology is based on already tested and established sensor technology that is already being used in the civil engineering industry. What makes the Touch+ Sensor Technology so accurate is that the fiber-optic sensor that is located on the catheter tip has the sensitivity of less than one g. Furthermore, the sensor technology used has already been proven and has an intuitive interface.

Proceeds from this round of funding will go to fund the European commercialization of the US pre-market testing and clinical trials of the newest technology that Endosense has to offer, the TactiCath. The TactiCath technology has the same sensor as the Touch+ Sensor Technology has, but the difference is that the TactiCath has the latest in the robotic tactical functions that can accurately map the area of the heart where the arrhythmia occurs for the physician.

According to Dr. Oliver Litzka, partner at EdRIP, Endosense’s TactiCath is positioned in a unique place in the marketplace, because of the potential it has to effectively diagnose cardiac arrhythmia. As far as cardiovascular medicine is concerned, catheter ablation is becoming a growing practice for certain cardio-medical procedures and the market for such technology has great potential. Furthermore, the concept of using force measurement curing an ablation procedure can provide for more accurate results and improve the efficacy of treatment as well as the safety of the patient.

As part of the agreement of this series B funding, Dr. Litzka of EdRIP; Gimv’s Executive Vice President of Life Sciences, Patrick van Beneden; and Diego Braguglia of IV Partners will join Endosense’s board of directors.

EdRIP is the vc arm of the group La Compagnie Financiere Edmond de Rothchild and is dedicated to minority investments into privately owned companies. EdRIP’s industry of choice is the life sciences industry and currently has over €750 million ($1,065,902,891.58) of committed capital under its management, that is mainly used for investments in life science venture and growth capital.

Based in Oslo, Norway and with offices in Boston, Massachusetts and Geneva, Switzerland; Neomed Management is an investment firm that is dedicated to investing in the healthcare and life sciences industries. Other companies in Neomed’s portfolio include Abaxis, Actelion, Aderis Pharmaceuticals, Clavis Pharma, and others.

For more information about Endosense, click here.

Calix is one of the largest communications equipment suppliers for broadband companies within the United States. As a matter of fact, Calix is doing well in the markets, because Calix equipment is being used by many of the United States broadband companies to deliver a rich wealth of information, entertainment, and communication. Furthermore, the equipment that Calix provides allows the customers of these broadband companies to access this information, communication, and entertainment.

The people that Calix has appointed to its board of directors include Michael Marks of Riverwood Capital, Adam Grosser of Foundation Capital, and Robert Finzi of Sprout Group.

Mr. Marks brings a wealth of experience to the company’s board of directors, which includes operation, manufacturing, and corporate governance. Mr. Marks is also one of the founding partners of Riverwood Capital and is investment experience does not stop there. Mr. Marks was also a partner and senior advisor at Kohlberg Kravis Roberts & Co. Mr. Marks was also the CEO of Flextronics International, Ltd. which he helped grow from a net worth of $93 million to $25 billion. Calix is not the only company whose board of directors Mr. Marks serves on. Mr. Marks is also on the board of directors of Zappos.com, SanDisk Corporation, and Schlumberger Limited. He also served on some nonprofit organizations such as the V Foundation for Cancer Research and the National Parks Conservation Association.

Mr. Grosser also brings quite a bit of experience in both venture capital success and leadership in innovative companies. Currently, Mr. Grosser’s duties include being a general partner of Foundation Capital and before coming to Foundation Capital, he was president of Excite@Home’s 1400 person subscriber network. Mr. Grosser also worked for and held key positions in such high profile companies as Apple Computer, Lucasfilm, and Sony Electronics. Mr. Grosser also serves on the board of directors of many other companies as well.

Robert Finzi has a wealth of both operational and financial experience which he will be sharing with the board members of Calix’s board of directors. Mr. Finzi currently serves the Sprout Group as the co-managing partner of the vc firm. Mr. Finzi has over 25 years of experience in venture capital and has been working as the co-managing partner of the Sprout Group since 2003, but has been with the Sprout Group for much longer, working with companies in the high tech industry. Before joining the Sprout Group in 1991, Mr. Finzi was with Merril Lynch since 1985. He also worked with Menlo Ventures and other vc firms.

Riverwood Capital is a global private equity firm that mainly invests in high growth companies who are in both the tech and services industries.

Founded in 1995, Foundation Capital is a vc firm that was founded with the sole purpose to build great companies. Foundation’s philosophy is in the belief of the power of an idea. The team at Foundation Capital is experienced in everything that the young entrepreneur should know. Many of Foundation’s partners have served as CEOs, executive managers, and technologists. Some other companies in Foundation’s portfolio include Aktino, Altor Networks, Atheros, Azur Power, BabyCare, Biz360, and others.
Founded in 1969, the Sprout Group is one of the oldest vc firms in the United States and currently boasts of having over $3 billion of committed capital under its management. The primary focus of the Sprout Group’s investments is in emerging companies in a broad spectrum of industries. Some other companies in the Sprout Group’s portfolio include Actel, AMD, CyOptics, Aurora Networks, NetCore, Cisco Systems, and others.

For more information about Calix, click here.

Formerly known as PelletSales.com, WoodPellets.com was founded in 2006 and since then the company has revolutionized the way the wood pellets are to be delivered. As the market for new environmentally friendly sources of energy keeps expanding, wood pellets have become noticed to be an environmentally friendly biomass source of heat and energy. The pellets are small and burn easily and hot, producing little or no exhaust. WoodPellets.com has made the distribution of these wood pellets easy to deliver to buyers. WoodPellets.com has become successful because it has a whole group of affiliates and partners that are able to rapidly deliver the pellets to retailers or even directly to the consumer.

Just during the past year, WoodPellets.com has accomplished a myriad of milestones. First, in 2008, WoodPellets.com experienced some massive organizational growth and expansion by growing revenue over a fivefold that was mainly driven by referrals from satisfied customers and a large network of affiliated wood pellet stove retailers. By having an extended partner and affiliate program, the company was able to build a reliable network of affiliated fuel suppliers and heating system retailers, selling its products to a large market throughout the United States. Furthermore, WoodPellets.com has over 25 production facilities in both the United States and Canada. WoodPellet.com’s wood pellets are also sold in over 150 different stove retailers. WoodPellets.com also successfully engaged in strategic rebranding, changing its name from PelletSales.com to the current name and launching a new toll free number, 1-800-PELLETS.

According to Adam Doctoroff, partner with Monitor Capital Partners; WoodPellets.com has an innovative method of selling wood pellets for heating fuel. Mr. Doctoroff further stated that selling a specific product to a specific market, especially to a specified market that is growing rapidly presents an opportunity for Monitor Capital Partners to place an investment.

According to Liam Donohue, cofounder and partner at .406 Ventures, when the team at .406 met WoodPellets.com, they saw that this company has great potential to do well in the marketplace, and the team at .406 has been very pleased with the progress the company has been making so far. Furthermore, WoodPellets.com has made an innovative way of selling wood pellets online by its network of affiliates and partners.

Founded in 1998, Monitor Capital Partners is a vc firm that has over $2 billion in committed capital under its management, and mainly makes its investments in middle and growth stage companies and buyouts. Some other companies in Monitor’s portfolio include Accellos, Access Communications, Earth Fair, Metro, and others.

For more information about WoodPellets.com, click here.

According to the Senior Managing Director and Managing Partner of OpenView Venture Partners, Scott Maxwell, Balihoo offers a unique local advertising platform to national name brands and franchises, which enhances the brand’s image nationally and at the same time increasing the demand for that particular brand in that local area. Furthermore, Balihoo’s growing customer base is a testament to the uniqueness and effectiveness of Balihoo’s service. This being mentioned along with the top caliber of Balihoo’s management team, the company is poised for success, making Balihoo fit all the criteria to receive an investment from OpenView Venture Partners.

Balihoo’s CEO, Pete Gombert further stated that OpenView Venture Partners stood out from other investors that the company was looking for to finance its ventures. Mr. Gombert further stated that the company has already experienced four quarter periods with double digit compound revenue growth and OpenView Ventures has an impressive track record in helping software companies to quickly meet the growing demand for their products. Mr. Gombert also stated that after Balihoo launched its new LMA platform, the company has experienced huge demand for this platform and as brands are trying hard to get their products marketed to local markets, they have discovered that Balihoo’s new LMA platform seems to be getting the job done, whereas the conventional marketing techniques are not as effective anymore.

OpenView Venture Partners is an expansion stage vc firm which has over $100 million under its management from leading institutional and private investors throughout the world. OpenView Venture Partners primarily seeks high growth companies in the software, internet, and tech industries. OpenView’s team has the entrepreneurial experience to help entrepreneurs expand their business and meet the growing demand of their products. Some other companies in OpenView’s portfolio include Central Desktop, Open-e, ExactTarget, eEye Digital Security, Aelita Software, and others.

Highway 12 Ventures is a vc firm that seeks high growth potential startup companies within the US intermountain geographic region. Currently the vc firm has over $100 million under its management and invests in all industries. Some other companies in Highway 12 Ventures’ portfolio include @Last Software, Alliance Health, CareFX, CradlePoint, and others.

Lacuna Gap Capital is an early stage vc firm that searches to provide that “missing part” to fill the gap in a company’s early life. The vc firm’s landing page shows a diagram of the entrepreneur’s brain and pinpoints all the things that an entrepreneur would be likely to think about.

For more information about Balihoo, click here.

According to the managing director of Shasta Ventures, Robert Conybeer, Mr. Buhr has a keen understanding of evaluating new emerging market opportunities. Furthermore, he has sharp insights into user experience and knows how to transform that experience into a successful business. Mr. Buhr and his skills will be instrumental for the vc firm to continue its investments in the consumer internet industry. Moreover, the people at Shasta Ventures believe that the future growth potential is in the smart phone, social media, and location based capabilities. If one is just to look at the consumer data and the markets, one can see that there is a ferocious appetite for these products and services.

Mr. Buhr’s business experience also goes beyond eBay and StumbleUpon. Mr. Buhr also held some key executive positions for Palm and was also one of the cofounders of Lipstream Networks, which is a VoIP service provider. Mr. Buhr also worked in various software companies, which include Apple, Adobe, and 3DO, where he was in charge of product marketing.

For more information about Shasta Ventures, click here.

According to Candent’s CEO, Terrence J. Gunning, the fact that Candent’s proprietary technology has been the market leader of digital impression solutions for the medical industry is validated by this round of funding. Furthermore, this funding rounding will go to help the company in this new growth stage and bring its powerful technology to dentists worldwide. Mr. Gunning further stated that currently over 3000 dental practices use the iTero Digital Impression System and this number is projected to grow.

According to Candent’s COO, Timothy Mack, since Candent launched the iTero imaging system in 2006, the number of dental practices wanting to use his technology has exceeded all the company’s expectations. The iTero technology is so powerful, because it can allow dentists and orthodontists to create all kinds of dental and orthodontic reparations, such as verniers, crowns, bridges, inlays, and other dental reparation procedures. The company currently is processing over 2000 cases per week, and this number is growing in Candent’s current markets within North America and Europe.

According to Fortissimo’s Yochai Hacohen, Fortissimo Capital decided to invest in Candent, because the company’s revolutionary technology is being used by a growing number of dental practices and is clearly disrupting the marketplace. Furthermore, the fact that the iTero technology is being noticed and used by more dental practices, the team at Fortissimo Capital is pleased to help Candent realize its new growth stage and sees a good opportunity in the company.

According to Amos Goren, executive chairman of Candent and board representative for Apax Partners, three years ago, after Candent launched its iTero Digital Impression System, the company has experienced amazing growth and the team at Candent welcomes Fortissimo Capital aboard.

Fortissimo Capital is a private equity firm that seeks companies that are in growth stage and have revolutionary solutions that are disrupting the market. Fortissimo Capital invests for the long term. Fortissimo seeks a positive partnership with the management teams of its portfolio companies. Some other companies in Fortissimo Capital’s portfolio include AOD Software, Crow Technologies, Emblaze, RadView Software, and others.

For more information about Candent, click here.

Syndiant manufactures small projectors that can project a crisp and clear image using pico technology. These projectors are basically a small light emitting chip that can be installed into practically any electronic gadget ranging from cellphones to small pen-size projectors. Syndiant’s proprietary technology can provide a big screen display from a tiny projector to create killer presentations from anywhere by projecting an image from a micro projector installed in a cellphone or iPhone. The possibilities are endless. With Syndiant’s technology, users can project an increadibly sharp image all the way across from a room.

According to Syndiant’s CEO, Mark Harward; for Syndiant to be able to secure such a large funding round in today’s difficult economy is quite an accomplishment. This funding round from the company’s investors shows that Syndiant’s superior technology and astute business strategy can give out enormous potential. Mr. Howard further added that a strong balance sheet allows for the company to be able to ramp up volume sales at the same time extend its technology to the pico projector markets.

Mr. Harward further stated that the Texas Emerging Technology Fund played a crucial role in this funding round. Mr. Harward is very proud of his company having met such a major milestone to meet the criteria for an investment from the Texas Emerging Technology Fund.

One of the reasons that the Texas Emerging Technology Fund is interested in investing in Syndiant is because it has a mission to expedite the development and marketing of innovative technologies for Texas institutions of higher education.

The Texas Emerging Technology Fund or TETF is a fund that is dedicated to fund new revolutionary technologies that could be of benefit to Texas institutions. According to the TETF official website, the fund believes that good innovative hi-tech companies do not appear over night. In order to develop innovative technologies takes quite a bit of research and experimentation. Some other companies that have received commercialization awards from the TETF include Enthuze, Advitech, BiO2 Medical, Animal Innovations, Nanomedical Systems, Faradox Energy Storage, and others.

For more information about Syndiant, click here.

29 Luxury Goods is a company who is devoted to the sale and marketing of products in the cosmetics, beauty, luxury, and spa industries. Some of the merchandise that 29 Luxury Goods markets include a whole line of women’s cosmetic products that includes lipstick, eye shadow, and other face makeup. 29 Luxury Goods also markets anti-aging products, such as cremes, lotions, and moisturizers. 29 Luxury Goods advertises its goods to be ecologically friendly and do not contain any paraben or other chemical byproducts.

The CEO of 29 Luxury Goods, Lydia Mondavi, stated that since the company was launched, 29 Luxury Goods has experienced amazing sales growth and even in these difficult economic times, this growth does not seem to be slowing down. Ms. Mondavi further stated that since the company has closed this round of funding, it has been able to execute new opportunities and expand 29 Luxury Goods into new markets both domestically and internationally. Ms. Mondavi also stated that proceeds from this funding will allow the crew at 29 Luxury Goods to maximize brand presence and to develop new business strategies to expand the company’s marketing efforts.

According to the Managing General Partner of Williams Venture Partners, John A. Williams, Jr.; 29 Luxury Goods is showing the proof of concept and market penetration that Williams Venture Partners is looking for when investing in a company. Mr. Williams further stated that the current economic climate is filled with great opportunities. When fewer investors want to take a risk, companies that fit the criteria of Williams Venture Partners can yield good profits for both the company and its investors.

Williams Venture Partners is a vc firm that is opportunistic and will invest in those companies that have an innovative product that has the potential to generate great returns. Furthermore, the vc firm insures the success in its investors by actively participating in its portfolio companies. Williams Venture Partners’ investment strategy is to seek and identify companies that have low risk indications and strategic growth opportunities, providing high opportunities for the firm. Some other companies in Williams Venture Partners’ portfolio include Cocobonbons, Mythic Paints, Rent Bureau, and others.

For more information about 29 Luxury Goods, click here.

AdvanDX is a leader in molecular biomedicine and specializes in developing molecular diagnostic tests for life threatening bacterial infections. These diagnostic tests are very easy to use and provide very accurate results quickly. This in turn can greatly improve the patient’s care and treatment and further save lives that could otherwise be lost to bacterial infections that have been diagnosed too late. Furthermore, because these diagnostic test kits that AdvanDX develops and markets can diagnose infections accurately can allow for quicker treatment of infections, reducing both the patient’s hospitalization and healthcare costs. AdvanDX diagnostic products are used both in the United States and Europe.

Along with the funding, the company’s stock holders elected Tina W. Christensen to its board of directors. Ms. Christensen works for Denmark’s health insurance company, “Danmark,” where she serves as the company’s CFO and vice president. Danmark is responsible for providing healthcare to over 2 billion Danish citizens.

According to the CEO and president of AdvanDX, Thais Johansen; more medical institutions are starting to adopt the techniques that AdvanDX is developing and the company is seeing its sales grow. Furthermore the proceeds from this funding will help the scientists working at AdvanDX to develop new tests and diagnostic tools for some of the more serious infections that can afflict people who are hospitalized. Mr. Johanesn further stated that he and the team of AdvanDX is very appreciative of the endorsement of the company’s investors to help them in the future.

SLS Ventures is an interntational vc firm that is devoted to the life sciences industry and is one of the largest vc firms based in Scandinavia. To date, SLS Ventures has over €270 million ($383,866,361.58) of committed capital under its management. Some other companies in SLS’s portfolio include ActionPharma, Atlas Antibodies, Doxa, Gyros, Light Sciences Oncology, Medical Vision, Medicure, OxThera, and others.

With over $10 billion under its management, LD Pensions is one of Denmark’s largest pension funds and has a long term investment strategy that is very selective. LD Pensions likes to invest in unlisted companies that present great opportunities for the fund and the fund has the objective of investing in a particular company for a time period of in between three to five years.

For more information about AdvanDX, click here.

CrimeReports.com is one of the largest and most accurate crime reporting services in the United States and has over 500 agencies nationwide that works closely with local law enforcement agencies to get the crime reports in the regions it serves. CrimeReports.com offers online software to law enforcement agencies and neighborhood watch groups accurately estimate crime rates in their areas. Furthermore, CrimeReports.com also provides communities access to the map on its website and emails community members regular crime alerts.

In the past year, CrimeReports.com defined itself as the leader in web 2.0 quality crime tracking software for law enforcement and the company has experienced record sales growth in the past year. Just in the past two months, CrimeReports.com has expanded its client base expand to over twenty percent. This record growth has been partly because law enforcement agencies have been very enthusiastic about the service that CrimeReports.com provides.

According to the CEO and founder of CrimeReports.com, Greg Whisenant; the company is very pleased to have received this funding round that was led by Austin Ventures. Mr. Whisenant further added that the proceeds from this round of funding will greatly help CrimeReports.com to expand its client base and increase its services into states where CrimeReport.com’s services are not yet available. Furthermore, this funding will also allow CrimeReports.com to be able serve law enforcement agencies of all sizes and budgets.

Mike Dodd, venture partner at Austin Ventures further stated that this round of funding and the commitment that Austin Ventures has placed in CrimeReports.com is a testament that the vc firm is confident that CrimeReports.com can meet the real needs that often go unmet by today’s law enforcement agencies and community watch groups.

Furthermore, as part of the agreement of this funding round, Mike Dodd will also be joining CrimeReports.com’s board of directors.

Austin Ventures is both a vc and private equity firm that is dedicated to backing talented entrepreneurs and startup companies. Austin Ventures currently has ten funds which all together add up to $3.9 billion under its management. Furthermore, Austin Ventures is one of the most active vc and private equity firms in the state of Texas and it invests mainly in companies and entrepreneurs who are in the business services, media, tech, software, and internet industries. Some other companies in Austin Ventures’ portfolio include Active Power, Boca, CompUSA, Dazel, McDATA, Star Concrete, and others.

For more information about CrimeReports.com, click here.

Polyvore is a fashion magazine social network where the users to use a virtual styling tool to mix and match various different articles of clothing and shoes from practically any online store. Users can then create fashion collages with the different articles of clothing. Polyvore was founded in 2007 by former Yahoo and Google employees.

Benchmark Capital is one of Polyvore’s original investors, taking part in a $2.5 million series A funding round. Currently the company has already reached 4 million unique users and is attempting to grow its operations. Harrison Metal Capital also participated in the previous series A funding and proceeds from this round of funding will go to help Polyvore achieve its goals.

According to Dana Stalder, general partner with Matrix Partners; Polyvore has an innovative approach to fashion and incorporated its fashion mixing content together with e-commerce to allow creative users to create their own fashion collages and realize their outfits by mixing and matching different articles of clothing from all kinds on online clothing stores. This blend allows both Polyvore and e-commerce companies in the apparel industry to profit from the different fashion crazes that come and go.

Another unique feature that Polyvore has is the ability to imbed newly created fashion outfits onto blogs which people can easily share with each other on other social networks, such as Twitter, Facebook, and My Space.

According to Polyvore’s CEO, Pasha Sadri, Polyvore can be a powerful platform for anyone to promote specific brands or styles and start whole new trends throughout the fashion industry. Mr. Sadri further added that Polyvore outfits are user generated advertisements for brands that are contained in those outfits. Furthermore, Benchmark Capital’s Peter Fenton went on to add that name brands have always become popular by positive word of mouth. Furthermore, being a social media site, Polyvore can along with Twitter and the other social networks that have appeared provide an effective broadcasting platform that amplifies word of mouth marketing.

Founded in 1977, Matrix Capital is a vc firm that primarily invests in early stage companies who are in the communications, consumer internet, mobile, semiconductor, and software industries. Matrix Partners invests for the long term and likes world-class entrepreneurs. Some other companies in Matrix’s portfolio include Apple Computers, Anjuke, Apollo Computer, Alteon WebSystems, Aruba Networks, Arroyo Video Solutions, Clarify, and others.

Founded in 1995, Benchmark Capital is an international vc firm that mainly invests in companies who are in the tech industry. Benchmark Capital invests for the long term and its general partners like to take a team approach when investing. Some other companies in Benchmark’s portfolio include 1-800 Flowers, Art.com, America Online, Conduit, Power Challenge, Ruba.com, and others.

For more information about Polyvore, click here.

MobileIron is a company that is dedicated to upgrade smart phones and make them enterprise ready. MobileIron works with the smart phones and their manufacturers to cooperate with CIOs to help solve problems that arise when enterprise data comes to the smart phone and other small mobile devices. One of the first solutions that MobileIron has come up with is the MobileIron Virtual Smart Phone Platform, which combines the data driven smart phone with real time smart phone wireless costs. This platform is very innovative, because it allows for cooperation with IT and end users.

According to Gaurav Garg, partner with Sequoia Capital; the opportunity in the smart phone industry is enormous. Furthermore, MobileIron has an innovative proprietary technology which has the potential to play a pivotal role in the expansion of smart phones in the enterprise world. Matt Howard, partner at Norwest Venture Partners also added that Norwest has backed MobileIron before because their management team has the experience in both the mobile and enterprise industries and the team at Norwest Venture Partners feels confident that this would be a great opportunity for a successful investment.

According to the managing director of Storm Ventures, Tae Hea Nahm; Storm Ventures has been a supporter and an investor of MobileIron since the company was founded. Storm Ventures started to incubate MobileIron in 2007 and the vc firm sees the opportunity in MobileIron and its innovative technology, which would coordinate the enterprise world with the smart phone.

According to MobileIron’s CEO, Bob Tinker; MobileIron has a mission to enable its clients to embrace smart phones throughout their organizations.

Founded in 2000, Storm Ventures is a vc firm that is comprised of a team of seasoned tech industry veterans. Storm Ventures is a vc firm that primarily invests in early stage companies who are in the tech industry and have a proprietary technology that is innovative and can potentially disrupt the markets. Some other companies in Storm’s portfolio include Qwaq, Lighterra Networks, Access360, SandForce, Storm Watch, Kineta Wireless, Cell Fire, Picateers, and others.

Sequoia Capital is a prominent vc firm that is run by some of the United States’ most well known entrepreneurs, such as Steve Jobbs of Apple Computers, Len Bozack of Cisco Systems, Laqrry Ellison of Oracle, and other key people in the US tech industry. The people at Sequoia believe in funding those creative and innovative entrepreneurs who have the desire and the passion to turn their ideas into great companies. Some other companies in Sequoia’s portfolio include A123, Dropbox, Linkedin, Loopt, Meebo, Infoblox, and others.

Norwest Venture Partners is a large vc firm that invests in all stages of a company’s life. Norwest Venture Partners is an international vc firm with offices in Palo Alto, California, and in Mumbai and Bangalore, India with over $2.5 billion in committed capital under its management. Some other companies in Norwest’s portfolio include 3Jam, Brand.net, Jigsaw, Kayak, LendingClub, Nanotex, Nearby Now, Picateers, UnisFair, and others.

For more information about MobileIron, click here.

Zendesk is an online help desk company that provides tech support to all companies, both large and small. Having been around for two years, Zendesk helps businesses with their help desk and customer support by moving all operations to the internet. Zendesk has been taking off in the marketplace by already acquiring many well known companies as customers, which include Twitter, MSNBC, IDEO, Books-a-million, and Scribd. All these companies use Zendesk to improve their tech support. Zendesk is successful, because of its flexible platform that allows companies to set their business rules, service targets, and to track and consolidate requests from all channels. As part of the service that Zendesk offers, all Zendesk clients get a native email support system and Zendesk also offers a whole set of APIs to its customers. Zendesk also offers its customer companies $19 per agent and also has a special offer of $39 for the first three agents as an introductory fee.

Zendesk also provides a service to small businesses and home-based businesses that starts at an affordable $9 per month. This service provides a professional grade fully featured tech support, but onle supports one agent. This service for the small and home-based businesses as called the Zendesk Solo package.

According to the CEO of Zendesk, Mikkel Svane; Zendsesk has disrupted the entire tech support industry because it brings a product to the marketplace that is solid as that of the competition, yet at the same time it is user friendly and very easy to use, being a real treat for those in the social networking industry. Furthermore it is because of Zendesk’s products and services, that the company has received all the vc backing that it has been receiving. Devutte and Charles River Ventures were the first ones to see this potential and later, Peter Fenton came on board together with his team of investors at Benchmark Capital, who also realized the potential of Zendesk’s products and services. Mikkel Svane further stated that the team at Zendesk is thrilled at the fact that the unique combination of SaaS, or Software as a Service, and the consumer technology experience that the team at Benchmark Capital has can be brought to the company and can create a dream team of Zendesk’s corporate executives and knowledgeable partners to build a powerful company.

According to Mr. Fenton, who is a partner at Benchmark Capital, the era that we live in today is enveloped in technology and information. People today cannot function without technology or computers and electronics. Furthermore, Mr. Fenton stated that two of Benchmark’s portfolio companies, Twitter and Engine Yard were both raving about Zendesk and how Zendesk’s products and services are used by these two companies for their help desk and customer support services. Right away, the team at Benchmark Capital saw an amazing opportunity in Zendesk.

Founded in 1995, Benchmark Capital is a leading vc firm that mainly invests in innovative entrepreneurs who want to build successful companies in the tech industry. Benchmark Capital has its partners work together with entrepreneurs as a team and has a team approach to venture investing. Currently, Benchmark Capital has over $2.8 billion in committed capital under its management and some other companies in its portfolio include Twitter, Atrica, Mazu Networks, BlueLane, Securify, CTERA Networks, Decru, Skybox, and others.

Charles River Ventures was founded in 1970 and is one of the oldest vc firms in the United States and is also one of the most successful vc firms that invests in early stage companies. Charles River Ventures currently has over $2.1 billion in venture capital under its management and is dedicated to find talented entrepreneurs and help them build their ideas into large successful companies. Some other companies in Charles River Ventures’s portfolio include Acopia, Virtusa, Flarion, Pirus, Basis, Flycast, and others.

For more information about Zendesk, click here.

Founded in 2007, Boxee is the brainchild of Avner Ronen, who is also the founder of Odigo Messenger, which was later sold to Comverse Technology, Inc. Boxee is a media software developer that develops media software for the internet based on open code. On the company site, Boxee advertises itself as providing a new way to enjoy entertainment on your TV and PC. Boxee has a unique application that allows users to take what ever video or entertainment that is on the net, download it to their PC and then watch it on their television set in the living room, making internet entertainment fun for the whole family.

The team seems to be very happy to have General Catalyst as a new partner and had stated on its own blog that the reason that Boxee chose to partner with General Catalyst is because the vc firm brings more to the table than money. The people at Boxee wanted a partner that understands the media software industry. Furthermore, Mr. Sequeira and General Catalyst have many years of experience in the internet media industry.

General Catalyst Partners is both a vc and private equity firm that mainly invests in outstanding entrepreneurs who are building excellent companies in the tech industry. General Catalyst Partners was founded in 2000 and advertises itself as a vc firm that is a leader in innovation and industry transformation. Besides the tech industry, General Catalyst Partners also invests in the clean tech, media, communications and wireless, software, and systems industries, should entrepreneurs in those industries have the product or service that would be able to disrupt those markets. Some other companies in General Catalyst’s portfolio include Advanced Electron Beams, LumenZ, Modular Wind, JumpTap, Go2Media, Big Fish Games, DECA, OnForce, Roost, ScanScout, and others.

Spark Capital is a vc firm that believes that convergence and disruption generate each other. The team at Spark likes convergence, because this is where they believe that some of the greatest opportunities can arise. Furthermore, Spark likes the disruption, because disruptive companies can upset the marketplace and generate great revenues for the vc firm. Furthermore, the team at Spark Capital believes that motivation, and groundbreaking ideas can spark success both for the entrepreneur and Spark Capital.

Based in New York City, Union Square Ventures is a vc firm that primarily invests in early stage companies that are in the media, marketing, financial services, telecommunications, and healthcare industries. Having been around for over 17 years, Union Square Ventures has invested in over 120 companies. Some other companies in Union Square’s portfolio include 10gen, AdaptiveBlue, AMEE, Bug Logs, Clickable, and others.

For more information about Boxee, click here.

Shocking Technologies is a company that develops polymers for dielectric circuits. Currently, Shocking Technologies is developing a unique dual-use voltage switchable polymer that is under the trademark name of Voltage Switchable Dielectric or VSD. This is basically a polymer nano-composite, that in normal circumstances behaves like an insulator, but when the voltage in the circuit crosses the threshold of the VSD, it becomes a conductor. Once the voltage drops below the set threshold, the polymer again behaves like an insulator. This innovative technology can revolutionize the electronics industry because it can completely change the way circuitry can function in certain electronic devices. One of the applications for this polymer is designed for embedded electrostatic discharge or ESD protection in printed circuit boards and semiconductors.

Along with this round of funding, Shocking Technologies also announced that it has appointed a new member to its board of directors. Simon Michael, from Balch Hill Partners will be joining the company’s board of directors and continue advising the company in future business strategies.

According to Vista Venture’s Jim Hogan, the polymer nano-composite that Shocking Technologies is developing is going to solve a problem that has been in the electronics industry for a long time. It will also make the design of both chips and electronic systems much easier and more effective.

According to Shocking Technologies’ president and CEO, Lex Kosowsky; Shocking Technologies has been very fortunate that it was able to identify the cause of a major problem in the electronics industry. Furthermore, the company has developed an innovative solution and was able to get it patented by the US government. Proceeds from this funding will allow the company to continue the development of this solution and build out its manufacturing infrastructure. The company also works on these innovative technologies for its customers, who make everything from cellphones to flash drives. Shocking Technologies plans to have its VSD out to market in next coming months.

Based in Boulder, Colorado, Vista Ventures is a vc firm that mainly invests in early stage companies in the tech industry. The major part of Vista’s strategy is to invest in companies that have an innovative product or service which would make those companies be potential market leaders. Vista prefers to be early investors in a companies which demonstrate that their product is a “must have” in the industry. Some other companies in Vista’s portfolio include DAFCA, Dante Software, Mx Logic, News Gater, Rally Software, and others.

For more information about Shocking Technologies, click here.

Pacific Biosciences is a DNA engineering company which is currently doing research with the end goal being the development and commercialization of transformative SMRT technology, which is single molecule real time DNA sequencing that the company hopes to eventually become the gold standard of genetic analysis. One of the greatest achievements that Pacific Biosciences boasts of is that it has won the Advance Sequencing Technology Award from the Human Genome Project, which was intended to develop the $1,000 genome. The SMRT technology that Pacific Biosciences is currently working on is in research stage and the company plans to launch its SMRT technology in 2010.

According to the Chairman of the Board of Governors at Monsanto and the Wellcome Trust, Bill Castell; the team at Monsanto and the Wellcome Trust ecstatic about making investments in a company that is developing a new generation in DNA sequencing technology. What is especially amazing about this technology is that it has the potential to be able to unlock all the inheritance and environmental factors that affect the health of human beings.

According to the company’s CEO, Hugh Martin; the fact that Pacific Biosciences has been able to raise large sums of moneys, which sums to the total of over $188 million since the past summer during difficult economic times, is a testament to the fact that the company’s disruptive technology shows great promise in the marketplace. Mr. Martin also stated that he is very excited that such strategic global investors, such as Monsanto and the Wellcome Trust and Sutter Hill Ventures are joining the company’s growing list of investors.

Sutter Hill Ventures is a vc firm that invests in technology based entrepreneurs who are pioneers in the development of important products and services and devote the Sutter Hill vc team’s time and money to build their companies into world-leading industries. Sutter Hill Ventures was founded in 1964 and has been funding startup companies in the tech industry since that time. Along with the necessary funding, the vc firm also provides entrepreneurs with the expertise and sound advice. Sutter Hill Ventures invests in both private and public companies. Some other companies in Sutter Hill Ventures’ portfolio include Acceleron Pharma, AKARx, Aspect Medical Systems, BARRX Medical, Info Medics, Kalypto Medical, Threshold Pharmaceuticals, and others.

For more information about Pacific Biosciences, click here.

NiTi Surgical Solutions is an innovative surgical device developer that primarily focuses Bio-Dynamix, which is natural healing and has the potential to have a much better outcome for both patients and physicians. This financing comes on the heals of NiTi’s marketing efforts of its new flagship product, the ColonRing, which is used in the colon.

The ColonRing is a new technology that has just been approved in the United States and it employs Nitinol leaf springs, which is placed in the colon and then stretch to be put in place open up the colon and then close back up to heal the colon and return the colon tissue thickness back to a healthy thickness.

Furthermore, there have been human clinical trials in which the ColonRing and BioDynamix Anastomosis has shown great potential to provide good anastomosis and reduce complications. Furthermore, after trial patients had colonoscopies done after six months after the experimental surgery have shown stellar healing of the colon and seamless anastomosis. In animal trials, the ColonRing has shown a zero percentage of rupturing of the colon where the surgery took place.

Proceeds from this funding will go to aggressively market the new ColonRing BioDynamix technology and to further the advance of both ongoing and future research on the company’s BioDiynamix platform. Recently, NiTi Surgical Solutions launched the ColonRing technology in the United States and this new surgery has been very well received in the medical community due to its amazing healing capabilities. Furthermore, the ColonRing has shown excellent closure results and has already been performed in 2,200 patients.

According to the Managing Director of Israel Healthcare Ventures, Dr. Hadar Ron, MD; this round of funding is a result of NiTi’s effective and successful business strategy. Furthermore, the company has had a rapidly growing market presence with its proprietary BioDynamix technology. Furthermore, because NiTi Surgical Solutions has developed revolutionary technology which has optimized the healing after gastrointestinal surgery. Dr. Ron further added that with the technology that NiTi has to offer and its commercializing of these biological healing technologies and developing these new devices are meeting an unmet surgical needs.

Some of the other products that NiTi Surgical Development has developed include surgical rings, clips, and appliers which have become the next generation of surgical devices available to speed up the post surgical healing.

Other news that NiTi Surgical Solutions has along with this round of funding is the appointment of Dr. Avi Molcho, MD; who is a venture partner of Forbion Capital Partners. Dr. Molcho went on to state that the team at Forbion Capital Partners truly believes that the technology which NiTi Surgical Solutions offers provides surgeons with devices that can optimize the healing process after the surgery has been performed.

Forbion Capital Partners is a leading vc firm that is completely dedicated to the healthcare industry and invests in companies that have solutions which can disrupt the markets within the healthcare industry. Forbion especially specialize in drug development and medical devices throughout Europe, the United States, and Canada. Some other companies in Forbion’s portfolio include Acadia Pharmaceuticals, Accelerated Technologies, AM Pharma, Argenta Discoveries, Argos Therapeutics, and others.

For more information about NiTi Surgical Solutions, click here.

iMemories is a company that provides a website which allows families to share their family photos online and can share their memories together. iMemories is unique to the market because it is the only company that has software, which allows consumers to upload, share, and preserve their family photos and it does not even matter what file format these photos are. iMemories also allows consumers to upload their home videos as well.

Proceeds from this funding will go to help iMemories solidify its leadership and management as well as to solidify its position in the emerging social media markets. There is a market niche for the service that iMemories provides. The ability for families to be able to upload, preserve, and share both photos and videos online with an internet based software that includes analog and digital formats. Furthermore, because consumers are always looking for more unique and effective ways to both preserve and share their memories with friends and family, this market is growing an explosive rate.

According to the founder and CEO of iMemories, Mark Rukavina, though personal images have always been important, nowadays, personal images have become more important than ever before. In this digital age, photos and videos have become an inseparable part of people’s lives. To most people, images have always had irreplaceable value, but because of digital imaging technologies and social media networks coming up on the horizon, images have become more important than ever.

How iMemories works is that consumers use the iMemories software and online database as a central location to hold all their photos and videos. What makes iMemories one of a kind is that it does not matter how people capture their memories. They might be shooting their family videos with an old camcorder and the video is captured on video tape, they might still capture their photos on film, or they could be using the newer digital format to capture their memories on videos and photos. With iMemories, that does not matter. The consumer can use what ever format they wish and it works.

As far as Mr. Ashbaugh is concerned, iMemories has all the criteria that the team at Capital Southwest looks for to make a successful investment. The fact that iMemories has a product and a service that can meet an insatiable demand in the marketplace, as well as having a top-notched management team makes the company poised for success in the future.

Capital Southwest is a business development company that is publicly owned and is capable of making indefinite investments. Capital Southwest is dedicated to business development and currently has over $418 million of capital under its management. Capital Southwest was founded in 1961 and Capital Southwest states that it is not a private equity or vc firm. Some other companies in Capital Southwest’s portfolio include Alamo Group, ACI Group, BankCap Partners, Boxx, Blue Magic, and others.

For more information about iMemories, click here.

Amalfi Semiconductor is a company that manufactures low cost and low power mixed signal CMOS RF for cellular applications. The company has strong backing from both the above mentioned vc firms as well as private investors. Amalfi is currently anticipating rapid growth, because of the demand of the company’s CMOS technology. Proceeds from this round of funding is intended to help Amalfi Semiconductor handle this rapid growth when it happens. Furthermore this round of funding will also help the company boost its product development and build an aggressive marketing campaign.

According to the CEO and founder of Amalfi Semiconductor, Jim Finch, over the past several years, the company has been able to secure a good client base and since Amalfi introduced its first product in 2008, the company has proven to several cellular manufacturers that its CMOS technology offers a much higher grade front end system, compared to the competing technology currently available. Mr. Finch further stated that this round of funding provided by these prominent venture firms will allow the company to further advance and expand its market presence with its proprietary technology that the management team at Amalfi will lead to a paradigm shift to the new CMOS technology. Furthermore, the fact that the cost of this technology is reasonable and that its operational functions are energy efficient, this technology will greatly improve wireless communications and greatly improve battery life in the cell phones that employ this technology.

According to Ken Lawler, General Partner at Battery Ventures, the team at Battery Ventures has researched this particular market for over a year, and has been watching all the emerging players in this market to find a good opportunity for an investment. Furthermore, investors know that CMOS technology is a multibillion dollar market and that Amalfi’s position in this market has a positive outlook and the company’s management team makes Amalfi poised for success.

Battery Ventures is a vc firm that has been around for over 25 years and mainly invests in companies within the tech industry and focuses its investments in all stages of a company’s life. Battery Ventures invests globally and the vc firm has over $3 billion under its management. Battery Ventures also deals with private equity as well as venture capital. Some other companies in Battery’s portfolio include Akamai, SpotRunner, FingerHut, BladeLogic, Tejas Networks, Nova Technologies, and others.

DMC is a vc firm that invests in early stage companies and likes to partner with entrepreneurs who can bring disruptive products to the marketplace. Currently DMC has over $1.6 million under its management and is based in Silicon Valley, but also has offices in Beijing, China; and Tokyo, Japan. Other companies in DMC’s portfolio include @Motion, 2Wire, About.com, Bill.com, Brickfish, Cortina, Hudong, and others.

Globespan Caqpital is a global vc firm that is based in Boston, Massachusetts; Palo Alto, California; and Tokyo, Japan. Currently Globespan has over $1 billion under its management and invests in companies throughout the United States, China, and Japan. Some other companies in Globespan’s portfolio include Airgate, Aptis, Argon Networks, Arkivio, Cerulean, ClearWire, and others.

Having been around for 22 years and with experienced investors, Trinity Ventures has over $1 billion under its management and mainly invests in early stage companies who are in the digital media, internet services, mobile, security, and software industries. Other companies in Trinity’s portfolio include 24/7 Real Media, AllData, Aruba Wireless Networks, Avaak, BackWeb, BabyCenter, and others.
For more information about Amalfi Semiconductors, click here.

At eHarmony, Mr. Eagle currently serves as the company’s CMO and is in charge of all of eHarmony’s marketing operations. Mr. Eagle also has deep experience in marketing and customer acquisition in which he has gained while working for various Fortune 500 companies. Mr. Eagle graduated from the Wharton School at the University of Pennsylvania with a BS in Economics.

Besides being a tech veteran from Silicon Valley, Mr. Youstra is also a venture partner at Kohlberg Ventures. Mr. Youstra has deep experience in helping startup companies in the mobile, virtual worlds, e-commerce, and media/marketing industries. Before becoming a venture partner with Kohlberg Ventures, Mr. Youstra worked at AOL, where he was in charge of products and content. During his tenure at AOL, Mr. Youstra was able to get AOL to grow from 500,000 customers to over 20 million. Mr. Youstra graduated from Stanford University with a Masters Degree in Business Administration and an MA in Education, then he went on to study at the University of Maryland, where he received degrees in Film, Computer Science, and Marketing.

Akademos is an online service that links online bookstores to colleges and universities throughout the United States and the main benefit that Akademos offers educational institutions is its turnkey function, linking them to online bookstores, and reducing the operational costs of running a campus bookstore.

According to the managing director of Kohlberg Ventures, Jim Kohlberg, the online bookstore is changing the way college students are getting the required textbooks needed for their courses. In the past, the campus bookstore was the major and sometimes only source for textbooks, but with the online bookstores, students are able to get on their computer, go online, and be able to find the textbooks they need for a lot cheaper. Furthermore, Akademos has streamlined the online book shopping experience and presents a good opportunity for Kohlberg Ventures.

According to Akademos’s CEO, Brian Jacobs, the team at Akademos is thrilled to have Kohlberg Ventures supporting the company. Furthermore, Akademos is undergoing a massive market change since more and more brick and mortar bookstores are going online, this partnership with Kohlberg Ventures along with Mr. Eagle and Mr. Youstra joining the company’s board of directors will provide Akademos with access to valuable experience and help as the company grows.

Kohlberg Ventures is a vc firm that mainly invests in early stage companies who are in the digital media, clean tech, and consumer products industries. Kohlberg cares about the customers of its partner companies’ customers and invests in entrepreneurs who have unique solutions to serve their customers. Kohlberg is interested in what customers will buy, how much they will buy, and how much they are willing to pay for. Kohlberg Ventures is an active investor but portray themselves as not being intrusive and recognize where they can help and where they cannot. Other companies in Kohlberg’s portfolio include Blue Bottle Coffee, Lookery, Silicon Alley Insider, Socialmedian, Wordlock, Clear Edge Power, and others.

For more information about Akademos, click here.

Paymetric leads the market in secure online payment solutions. Though the company’s headquarters are in Atlanta, Georgia, Paymetric also has offices in Austin, Texas and Houston, Texas. The types of solutions that Paymetric has can cover a variety of problems with online payment systems. The company’s solutions are versatile and support practically all online payment types of any business. Furthermore, Paymetric’s secure and integrated online payment solutions also help client companies streamline order to cash processes and also reduce the financial burden from companies when being in PCI compliance.

According to Paymetric’s CEO, Larry Wine, despite the difficult economic times, the fact that Austin Ventures providing funding and a new investor coming on board is a testament to the fact that Paymetric has an effective proprietary technology, strong business strategy, and the strength of the company.

Proceeds from this funding round will go to be used to manage Paymetric’s shift in cash flow because of a SaaS or Software as a Service that the company has launched for its clients to use to improve their online payment systems and for Paymetric to go on doing research to develop more products in the online payment field.

Jim Gauer, managing director at Palomar Ventures, stated that he was convinced that Paymetric has a unique position in the marketplace to succeed with its solutions in online electronic payment systems. This statement was later backed up by Michael Rovner, partner at Austin Ventures, who stated that the team at Austin Ventures is excited about the opportunity that Paymetric’s new SaaS will provide in the marketplace. Furthermore, Paymetric over the years has been gaining customer loyalty and this particular round of funding demonstrates the confidence that the two vc firms have in their investments of Paymetric.

Founded in 1999, Palomar Ventures is a vc firm that was created by seasoned venture capitalists who specialize in early stage companies. Since its inception, Palomar Ventures has built over 50 companies and currently has over $500 million in capital under its management. Furthermore, the fact that the partners at Palomar Ventures have experience running private companies backed by venture funding, they fully understand the frustrations that entrepreneurs have when trying to get the necessary capital they need to get their idea off the ground. Some other companies in Palomar’s portfolio include Ace Metrix, Akonix, AlterPoint Applimation, Bigfoot Networks, Bubble Motion, and others.

Austin Ventures has been around for more that 25 years and currently has $3.9 billion under its management. Austin Ventures will partner with talented entrepreneurs who are committed to succeed and have a value building strategy in the tech and service industries. Other companies in Austin’s portfolio include Active Power, Boca, MetaSolve, Mission Critical, Pentasafe, Orion Marine Group, SolarWinds, and others.

For more information about Paymetric, click here.

Angioslide is a medical device company that developed the angioplasty balloon that is designed to prevent embolisms caused by cholesterol deposits clogging up the arteries and veins. The angioplasty balloon is inserted into the artery with a camera and gets inflated in the fatty deposit and removes the plug of loose fatty particles that could have the potential of creating a fatal embolism. Angioslide was founded in 2005 by Eran Hirszowicz and the Degania Silicon Company. Since its founding, Angioslide has had sales in Europe and will begin sales in America soon.

According to Angioslide’s CEO, Doron Besser, the common practice for dealing with embolisms today is by inserting a filter into the affected area in the artery and prevents particles to travel further in the bloodstream. The filter, however, can be a problem and needs special expertise to be implanted. Furthermore, the filter is only approved for the arteries around the heart and the neck area, and is not always successful and does not protect the kidneys and limbs from embolisms. The product that Angioslide offers is not the typical angioplasty balloon, but a balloon with a solution inside. The Angioslide balloon is inserted into the affected area where it is then inflated. After the balloon is inflated, it then gets folded back and removes the harmful particles from the affective area, therefore preventing the particles from moving further into the cardio-vascular system, potentially causing an embolism. The way this solution works is by having a hook on the guide line at the far end of the balloon and as the balloon is folded back it forms a hollow cone that can then scoop out the fatty particles.

The first product that was designed by Angioslide was originally designed to open blocked blood vessels within the limbs. The blocking of blood vessels in the limbs is not always given its due attention as is that of blocked vessels to the heart and brain get, which is the leading cause of heart attack and stroke. Blocked blood vessels to the limbs, however, can lead to necrosis of the limb and eventually require that limb to be amputated. Furthermore, unlike for arteries near the heart or neck areas, there is no filter designed for the limbs, therefore Angioslide does not need to do any comparative trials with its new balloon.

Agate Medical Investments is an Israeli vc firm that has a vision of becoming a leader in the medical and healthcare industries by investing exclusively in companies that can revolutionize the medical industry. The partners at Agate Medical Investments are dedicated to the belief that healthy returns can be created over a short period of investments. Other companies in Agate’s portfolio include Tulip Medical, Navotek Medical, BrainsGate, and others.

For more information about Angioslide, click here.

WeFi was founded in 2005 and since then it has grown to the point where it currently employs over 40 people in both Israel and the United States. WeFi is a company that provides WiFi connections and software to aid WiFi connectivity with computers and wireless devices. The company’s software is unique because it detects all WiFi hotspots and qualifies them giving the user the information to find the best internet connection possible in areas where WiFi is available. Another benefit of WeFi’s software is that when one WeFi user is online, it will detect other WeFi users when they are online, allowing for WeFi users to be able to see if their friends are online as well.

Currently, the company’s founder Yossi Vardi sits on its board of directors along with other people involved with the company’s founding, who include the two brothers, Shimon and Tamir Shertzer, and Amon Kohavi.

Potango Venture Capital is a leading Israeli vc firm and it mainly invests in seed, early and expansion stage companies in the tech industry. Potango Venture Partners has been around for over 14 years and currently has over $1.3 billion of committed capital under its management and is also on the global stage with offices not only in Israel, but also in Silicon Valley as well. Some other companies in Potango’s portfolio include AeroScout, Axis Mobile, Go Networks, MobileAccess, E4X, Neocraft, and others.

Lightspeed Venture Partners is a vc firm that has a leading global presence and has over $2 billion under its management. The team at Lightspeed is large and spread over several countries with a strong presence in the United States with its headquarters in the Silicon Valley, but Lightspeed also has offices in India, China, and Israel. Lightspeed Venture Capital primarily invests in early stage companies within a broad range of different industries. Some other companies in Lightspeed’s portfolio include 99Bill, AMEC, AeroHive, Aprius, Bling Nation, CarDomain, and others.

Founded in 1993, the Gemini Israel Fund was created by the Israeli government through the Yozma Program with the intent to invest in Israeli entrepreneurs who are in the communications, wireless, consumer electronics, enterprise software, internet, and semiconductor industries. The fund primarily invests in seed and early stage companies. Some other companies in the Gemini Israel Fund’s portfolio include Contextream, Massive Impact, RADLive, Schema, Modu, and others.

For more information about WeFi, click here.

TRAFFIQ is an online media marketplace that provides an end-to-end self service which links ad advertisers together with publishers. TRAFFIQ’s unique platform basically allows both advertisers and publishers to find each other online and always provides maximum returns for users of the marketplace. Since its inception, TRAFFIQ has already acquired accounts from large companies, such as Yellowpages.com and Glam.

As part of the agreement for this round of financing, the managing director of Greenhill SAVP, Brian Hirsch and Grotech’s general partner, Steve Friedrick will join the company’s board of directors.

According to TRAFFIQ’s CEO, Mark Kahn, this current round of funding supports the company’s vision that there need to be changes made in the online ad buying industry. One of these changes that needs to be made is to give ad agencies control of the placement of their ads. Practically all of the ad publishing platforms that are online today do not give advertisers the control of the placement of their ads and this is one of the things that TRAFFIQ plans to change. Furthermore, many publishers have plenty of inventories that are going unsold because of this problem. What makes TRAFFIQ different from other online advertising platforms is that TRAFFIQ has a visual interface that allows both advertisers and publishers to see how the ad can be placed, giving advertisers the full control of ad placement and generating the revenue desired by the publishers.

What makes TRAFFIQ stand out from other networks or exchanges is that TRAFFIQ provides an interface that allows both advertisers and publishers to consolidate planning, RFP distribution, order execution, optimization, and billing. This consolidated interface in short renders full control to the people that need to have that control in their hands — the advertisers and publishers.

According to the Senior Vice President of Corporate Partnerships of media giant, Havas Digital, Marta Martinez, TRAFFIQ definitely delivers what it claims to offer, an end-to-end management platform. Martinez further added that the platform that TRAFFIQ has created gives buyers direct access to all kinds of publishers and is completely transparent, as well as providing access to the control over everything from the planning of placement to actual publication and payment process.

According to Mr. Fredrick, partner at Grotech Ventures and new member of TRAFFIQ’s board of directors, TRAFFIQ has a platform that truly changes the game in the online advertising marketplace. The platform deserves the investment it received because of its transparency and the fact that it allows advertisers and publishers to work with content in real time.

Mr. Hirsch of Greenhill SAVP and newly appointed board member further stated that because TRAFFIQ has automated the buying process in the advertising industry, it has brought relative ease in the market; much like Google did with its search engine.

Grotech Ventures is a vc firm that primarily gives investments ranging from $500,000 to $5 million to early stage companies that are rapidly growing in the technology industry. Grotech Ventures was established in 1984 and has a team that knows what it takes and works to make big things happen. Other companies in Grotech’s portfolio include Advertising.com, ARPU, Aztek, Broadsoft, buySAFE, and others.

Greenhill SAVP was founded in 1998 and joined together with Greenhill & Company. Greenhill SAVP currently manages a fund that is around $102 million for early stage companies in the technology enabled services and business services industries. Greenhill SAVP only invests in companies that are geographically located within the tri-state area of Pennsylvania, New York, and New Jersey. Other companies in Greenhill’s portfolio include AllCovered, BD Metrics, Flat World Knowledge, HomeSphere, Pontiflex, and others.

Court Square Ventures is a vc firm that mainly focuses its investments on early stage companies that are in the communications, IT, and media industries. Court Square Ventures aims to have partnerships with entrepreneurs who are passionate about their business and diligent to get their business off the ground. Some other companies in Court Square’s portfolio include BugLabs, Jitterbug, Echo360, Imagine Communication, Market Maker Interactive, Pipeline Trading, and others.

For more information about TRAFFIQ, click here.

Questar Assessment is an educational assessment firm that provides assessments for states, schools and school districts and mainly assesses the performance of schools from grades kindergarten or K through the twelfth grade. For states, Questar offers a large-scale statewide school assessment and for smaller entities, such as single schools or school districts, a smaller-scale English proficiency assessment. Questar has its main headquarters in Apple Valley, Minnesota, but also has regional corporate headquarters in New York as well.

The funding round that Questar closed was closed in two stages. The first stage was closed in December of 2008 and the second stage was closed in March of 2009. With those two stages and the current investment from New Market Venture Capital, the company closed a total of $4.6 million.

According to Questar’s president and CEO, Roy Lipner, the reason for Questar to raise this investment was to supply enough funds for Questar, so it could have enough working capital over the next few years and to be prepared and have enough backing for any credits that may arise in these difficult economic times.

According to the chairman of Questar’s board of directors, Andrew L. Simon, the board members look forward to be working together with New Markets Venture Partners, because of their track record of being successful and their unique approach and understanding of how business functions.

According to Frank Bonsal III, partner with New Markets Ventures, Questar is a nimble player in today’s markets. Together with the experience of New Market Ventures has in building high growth education companies, Questar poses a great opportunity for the vc firm.

New Markets Ventures is an early stage vc firm that mainly invests in companies who are in the education, IT, and healthcare industries. The team of investors at New Markets Investors is highly experienced in building high growth companies with a successful track record. Other companies in New Markets Ventures include Adegen, Apex Learning, ARPU, Artifact, Bioset, Headsprout, and others.

Camden Partners is a private equity firm that invests its equity in companies who are in the education, business services, healthcare, and financial services industries. Some other companies in Camden’s portfolio include American Public Education, Aradigm Corporation, LipoScience, ArtiCure, BioMedical Enterprises, and others.

For more information about Questar Assessments, click here.

XDx is a molecular diagnostic company that develops and commercializes noninvasive diagnostic testing for all kinds of different biological disorders. The specialty products that XDx develops are mainly for the treatment and monitoring of organ transplant rejection and autoimmune diseases. The one product that XDx is currently developing is a diagnostic process that can monitor the immune system activity by observing genetic activity. This type of testing will be done by XDx’s new flagship platform, the AlloMap Molecular Expression Testing. This new platform already provides physicians who are in the transplant sector of the medical field with a new tool in monitoring the immune system of transplant patients and be able to accurately observe immune activity to identify acute cellular rejection in heart transplants.

Heart transplant medicine, however, might not be the only problem that XDx’s AlloMap Molecular Expression Testing might be of use. This testing system can also be used in other organ rejections involving the immune system at the molecular and cellular level. XDx currently has other tests going on involving the AlloMpap technology. One of the other tests that XDx is conducting is in the IMAGE, or the Invasive Monitoring Attenuation through Gene Expression, from which XDx anticipates to have results soon.

According to the chairman of XDx’s board of directors and partner at KPCB, Brook H. Byers, the interest of investors in XDx’s technology by many venture capitalists is because XDx stands out from other companies that are involved in biopharmaceuticals. The main thing that is attracting such a large number of investors to XDx is because of the success of its AlloMap proprietary technology and the positive impact from clinical trials with heart transplant patients. Furthermore, Mr. Byers added that this current round of funding shows the confidence that KPCB has in XDx and that the company’s technology would be able to expand into other organ transplant testing as well as in autoimmune diseases.

Other information that makes XDx attractive to investors is that in August of 2008, the company has received clearance from the FDA in the United States for its AlloMap Molecular Expression Testing, which is an in-vitro diagnostic multivariate index assay or IVDMIA. This is a testing service that is performed in a laboratory and assesses the gene expression profile of RNA that is separated from the mononuclear blood cells. The AlloMap testing system currently is intended for heart transplant patients that have a low probability for organ rejection at the time of testing.

According to Dr. Jeremy Levin, MD, PhD, senior vice president of the Strategic Transaction Group of Bristol-Myers Squibb Company, the team at Bristol-Myers Squibb is very pleased at the progress that XDx is making with its gene expression diagnostic testing. Furthermore, the team at Bristol-Myers Squibb is looking forward to be working together with XDx on its new testing system to treat Systemic Lupus Erythematosus, or SLE. SLE is an autoimmune disorder that affects roughly 300,000 people in the United States and the treatment for this disease is rather complicated due to the recurrence of disease flares that can range in severity and often require the patient to be hospitalized and eventually lead to more serious problems such as kidney and other organ failure.

According to the president and CEO of XDx, Pierre Cassigneul, this round of funding is very important for XDx because it helps the company create a financial long term strategy for business success. Mr. Cassigeul further added that both he and the company are very happy that Bristol-Myers Squibb and the company’s other existing investors are continuing to back XDx.
Based in New York City, Bristol-Myers Squibb is a large medical firm that has the motto of “Helping patients prevail in their fight against serious disease.” Bristol Myers Squibb has been a leader in the big pharmaceuticals industry throughout the United States and has developed medicines for the effective treatment of cancer and HIV/AIDS along with other diseases.

For more information about XDx, click here.

MediaMath is a digital media company that has an automated buying platform which provides advertisers with tens of billions of dollars in impressions on a daily basis along with a simple workflow that allows for the management of powerful analytics and the rich data that is necessary to get the maximum use of the impressions provided by MediaMath’s platform. MediaMath was founded in 2007 by veteran entrepreneurs, marketers, and technologists.

According to the vice president and managing director of the Technology Group at Safeguard Scientific, Erik Rasmussen, Safeguard’s partnership with MediaMath demonstrates the core focus that Safeguard Scientific has when investing in growth stage companies in the tech industry, which have a competitive edge in their respective markets. Mr. Rasmussen further added that MediaMath is a true leader in the digital media industry and already having over tens of millions of dollars worth of advertising campaigns going through its system. Furthermore, the company’s approach is combining raw performance, research, and precise targeting — all of which are crucial for successful internet advertising.

Erik Rasmussen’s main function at the Technology Group, run by Safeguard Scientific, is to work closely with companies that are partners of Safequard Scientific and provide both operational and strategic support to them. Mr. Rasmussen is experienced in all aspects of equity funding, and before joining Safeguard Scientific, he worked for WWC Capital Group, which is an investment banking and private equity firm.

In conjunction with the investment from Safeguard Scientific, Mr. Rasmussen will also joing MediaMath’s board of directors.

The MediaMath advertising platform provides advertisers with both a digital interface and back office services for its clientele to easily be able to run their advertisements effectively. MediaMath has gotten some rather prominent internet advertisers to use its platform, which include RightMedia, Google’s DoubleClick Advertising Exchange, and Microsoft’s AdECN.

According to the CEO of MediaMath, Joe Zawadzki, MediaMath has developed the first demand-side media trading platform that helps ad agencies deliver increased client performance and insights at much lower costs. Furthermore, Mr. Zawadzki added that over the past two years, the tech team at MediaMath has been working on developing a much more effective and sophisticated software and services offerings in the internet advertising industry.

Safeguard Scientific was founded in 1953 and its headquarters are in Wayne, Pennsylvania, and is a holding company that provides investments to cutting-edge growth stage companies in both the life sciences and tech industries. Safeguard also plays roles in buyout and acquisition financing. Some other companies that partner with Safeguard Scientific include Advantage Healthcare Solutions, Advantium, Portico Systems, Swap Tree, Garnet Bio Therapeutics, and others.

For more information about MediaMath, click here.

FiberLight is a company that provides internet service providers with fiber optic ethernet, wavelengths, IP, SONET, and dark fiber optical transport solutions. Some of FiberLight’s clientele include telecom companies, wireless, government and international agencies. Furthermore, FiberLight has over 500,000 miles of fiber optic networks throughout key growth areas in the United States, and the company offers a robust network throughout several states on the Atlantic sea board and in the Deep South including Georgia, Maryland, New York, Florida, Virginia, and Texas; as well as Washington DC. FiberLight also has intercity connections in Chicago, San Francisco, Boston, Denver, and Seattle.

According to Jim Lynch, who is both the company’s chairman and also managing partner with FiberLight’s primary investor, Thermo Capital, FiberLight has shown a great deal of financial discipline in the market for the past four years and this is what got the company to be eligible for this funding that it had raised today. Mr. Lynch further added that raising this funding shows how sound the company’s business practices and financial strategies are. Furthermore, as far as Thermo Capital and FiberLight’s board of directors are concerned, this will also allow FiberLight to add another 500,000 miles to its fiber optic network.

According to FiberLight’s president, Kevin B. Coyne, the team at FiberLight wants the company to grow in a responsible way that would not only demonstrate 20% in annual growth, but also to have similar growth in the company’s EBITDA. There is one sound way that FiberLight can achieve these goals and that is to own up to its assets, which are the company’s fiber optic networks, which deliver customer satisfaction to both the company’s private and government clients. Proceeds from this funding will go to the above mentioned items that are of FiberLight’s concern. Mr. Coyne further stated that it is exactly this strategy that has kept FiberLight able to exceed the averages for growth in its respective industry.

CoBank is a cooperative bank that helps business in the rural United States and its net worth is over $63 billion. CoBank is based on the outskirts of Denver, Colorado, and serves all fifty states in the United States. The bank provides loans, leases, and financing to communications, energy, and water companies.

For more information about FiberLight, click here.

General Fusion is an energy company that serves British Columbia and western Canada, and is experimenting with fusion technology. General Fusion is based in Burnaby, British Columbia, and is currently developing a fusion prototype that is designed to create energy more efficiently than the conventional coal-burning power plants are able to.

As far as the company’s prototype is concerned, General Fusion is actually working on two fusion projects, which are magnetic and inertial confinement fusion. Magnetic fusion uses large magnets to force particles to fuse and therefore powering the generators that produce electricity. The second fusion project is designed to work by implementing inertial confinement fusion, which is when high-density fuel pellets are shot by lasers, generating power that way. General Fusion hopes that it can combine both fusion methods into its prototype and drastically cut cost in energy production. Furthermore, since fusion is an energy generator that does not consume any type of fossil fuel, it is also clean and friendly to the environment.

According to the vice president of Growthworks Capital, Rolf Dekleer, General Fusion is basically trying to change the game, and if people were talking about developing this type source of energy ten years ago, there would be no global warming today. Furthermore, Mr. Dekleer added that should General Fusion get to the point where their product prototype can produce significant net gain, then there could be the possibility that large companies, such as General Electric could buy out all investors.

Mr. Dekleer’s comments were also backed up by General Fusion’s CEO, Douglas Richardson, who stated that General Fusion is speeding up this technology up a thousand fold. Furthermore, this technology has been around for almost 30 years, but the sophisticated technology that would be governed by computerized processing controls and plasma technology was still in its infancy and there was no way to be able to sustain such a strong power source. Furthermore, Mr. Richardson added that the main goal is to develop this technology to the point where General Fusion can produce net gain.

The current economic times, however, made life difficult for Mr. Richardson and the other people on the management team of the fledgling company. When shopping around in Silicon Valley, Mr. Richardson found many doors were slammed in his face and many of the Silicon Valley investors were too afraid that the risk in investing in this type of technology was too high. Many investors were not sure that this type of technology would fly. However, after much diligence, General Fusion did get the backing it needed to start developing its prototype.

Braemar Energy Ventures is a vc firm that is dedicated to help invent new alternative energy sources. Founded in 2002, Braemar Energy Ventures solely dedicates its investments to those companies in the energy industry who have a proprietary technology that would disrupt the energy market. Some other companies in Braemar’s portfolio include CoalTek, PowerGenix, Afina, Fractal, CirisEnergy, Climos, and others.

Growthworks Capital is one of Canada’s leading vc firms and has over $1 billion of regional venture capital under its management. Growthworks Capital has been helping Canadian entrepreneurs for over 17 years and mainly invests in companies that have a high growth potential. Some other companies in Growthworks’ portfolio include Layer7, Sutus, Inimex, Lighthaus, NxtGen, BuildDirect, Protiva, Schneider Electric, and others.

Chrysalix Energy Ventures is a vc firm that is dedicated to the development of alternative energy and clean fuels. Chrysalix mainly focuses on next generation solar energy, next generation bio-fuels, using waste to create energy, and new disruptive energy generation processes. Chrysalix Energy Ventures mainly invests in early and mid stage companies with effective management teams. Some other companies in Chrysalix’s portfolio include Angstrom Power, Ardica Technologies, Day4 Energy, EnerWorks, H2Gen, HydroPoint, and others.

The Entrepreneurs Fund is dedicated to the entrepreneur and invests in early and growth stage companies. Along with providing the financing that entrepreneurs need, also provides these entrepreneurs access to the valuable entrepreneurial expertise that the entrepreneurs need to get their companies off the ground. Other companies in the Entrepreneurs Fund’s portfolio include CPT, Exosect, OptiNose, t2cure, Technolas, and others.

For more information about General Fusion, click here.

Panaya was founded in 2006 and is a company that provides software tools that are designed to save SAP customers over one half of their upgrade and maintenance costs, while reducing the risks in doing so. Panaya’s tools are basically a SaaS or Software as a Service that simulates the SAP environment and shows which SAP program would work best on a particular client’s SAP system. Furthermore, Panaya’s software also has diagnostic tools that show what is going wrong with the SAP and how to fix the problem. When a user upgrades their SAP with Panaya’s software service, the Panaya software, while upgrading the SAP, will also automatically show all errors that could cause the SAP system not to function properly and provide them with solutions to fix these errors.

Proceeds from this funding will go to help Panaya expand its sales and marketing, and product development. Because Panaya’s system is user friendly and growing in popularity, more work needs to be done to efficiently and effectively deliver its services to customers.

According to Panaya’s founder and CEO, Yossi Cohen, Panaya’s customers and partners have validated the company’s market strategy and product, and with this new round of funding, Panaya will be well positioned to expand its leadership as being the future of application life cycle management tools.

According to the director of investment at the Tameres Group, Meirav Har-Noy, the team at Tameres is amazed at how Panaya is able to maintain such an aggressive sales growth during the past year by adding several well known household names to its list of clients. These clients include Bosch, Sony, and Volvo. The development of Panaya’s unique platform which is very cost effective compared to other SAP diagnostic and upgrade services is truly ingenious and key to the company’s success in a time when most people are looking to cut costs where ever they can.

Based in Lichtentstein, the Tameres Group is a global private equity firm that has offices in New York, Tel Aviv, Las Vegas, London, Gibraltar, and Helsinki. Besides dealing in private equity, the Tameres group also deals in real estate on an international scale.

Benchmark Capital is a vc firm that is dedicated to helping talented entrepreneurs in the tech industry. Benchmark currently has over $2.3 billion in committed capital under its management and some other companies in Benchmark’s portfolio include Ariva, Axium Global, Avamar, Catapulse, Odesk, Red Hat, and others.

For more information about Panaya, click here.

iSyndica is a cloud-based internet platform that distributes digital media, such as video and other graphics. On the iSyndica corporate website, iSyndica advertises itself as a company that can be useful to people in the business industry and need graphs to chart stocks and for photographers and film makers as well. iSyndica’s platform is designed to upload once and sell many times over again. The platform employs multiple established channels and helps the user generate revenue. The iSyndica platform does have a patent pending and is based on the Amazon Web Service and operates as a SaaS or Software as a Service application.

Proceeds from this funding will go to help iSyndica to improve its marketing strategies and accelerate product development. As far as the CEO of iSyndica, Gwyn Jones, is concerned, the company is continuing to move to its goal of creating a multi-category platform for digital media marketers. This current round of funding will greatly help iSyndica provide a multi-content platform to its vectors, eBooks, and music.

To add to the company’s assets is iSyndica’s CTO, Sebastian Coursol, who has over nine years of experience in the field while working for Channel Velocity and Vistaprint. Mr. Coursol commented that already some major content sites are beginning to partner with iSyndica and this is a clear indication that the company’s efforts have been very rewarding. Mr. Coursol further stated that, though content networks want to partner with iSyndica is a good sign, however, the company still needs to scale up, and this round of funding will provide the needed capital to do so.

The funding came from two angel investors who are both veterans in the digital media industry. One of the angels, Jayesh Parekh was the founder of Sony Entertainment and also sits on its board of directors. Sony Entertainment is one of the largest cable and satellite television network and is in collaboration with Sony Pictures Entertainment, which is a subsidiary of Sony Corporation of Japan. Mr. Parekh is also very active with some of the major vc firms based in Silicon Valley. Mr. Parekh is also a member of the investment committee of SONG, a Soros backed social impact fund for India.

The other angel investor, who participated in this round of funding, is Greg Blackwood. Mr. Blackwood is an active investor and venture capitalist who has invested in both Asia and Europe. Mr. Blackwood had a banking career and also worked in France for a private equity advisory firm that offered investment sourcing, structuring, and execution to prominent investors in Europe. Later on, from 2000 to 2008, Mr. Blackwood worked out of Singapore, where he worked for a US family owned office. In between 2004 to 2006, Mr. Blackwood went on to lead large corporate mergers for UPS in Tokyo, Japan. In 2008, Mr. Blackwood went back to Singapore to join the management of Mitsui & Co. and worked there as the senior manager of investments for the company’s Asia-Pacific headquarters.

For more information about iSyndica, click here.

KODA.us is a recruitment startup company that had just recently launched its first platform in May 27 of this year. Its platform is a recruitment platform that has social networking properties. What is so unique about KODA is that it makes it very convenient for employers to participate in the system by providing seamless integration with company profiles, eliminating the need for employers to manually post job offers. As of today, KODA.us is growing and now has opportunities posted from companies throughout the United States.

According to KODA’s CEO and cofounder, Jeff Berger, KODA.us is designed to be more professional that Facebook and have a more personal affect than Linkedin. This makes KODA.us unique, because it allows both the employer and prospective candidates for the job to get to know each other. Mr. Berger further added that using a traditional job board can be like finding a needle in a haystack; however, using KODA.us makes the search so much easier and allows both employers and their candidates for the job offered to find more needles in less hay. Furthermore, KODA has developed proprietary technology that would actually facilitate the recruitment process and make it much easier and less stressful for both the employer and the prospective candidates for the job offered.

This funding round came in several different stages and as of today, KODA.us has secured an additional $1 million from angel investors, which totals the entire round of funding to $3 million. The entire round of funding was financed by private angel investors who saw the potential of KODA’s proprietary technology. Furthermore, this round of funding has been going on for some time unannounced and the proceeds from this round of funding has enabled the company to run its public beta testing of its platform.

Mr. Berger continued to add that today’s job seekers often do not know where to turn, and KODA.us provides a line of focused information that allows this generation of job seekers to explore opportunities that they otherwise would not have known existed. KODA.us offers today’s generation of job seekers the key information about how today’s corporate world functions, and also informs them about corporate culture and the do’s and don’ts on searching for and successfully getting that needed job. Furthermore, the information provided to prospective candidates for jobs on KODA allows these job seekers to be fit candidates for the corporate environment. Mr. Berger also emphasized that in today’s difficult economy, being “fit” counts heavily in getting that job.

Even though KODA’s headquarters are based in San Francisco, the company also has an office in New Orleans, Louisiana, and KODA is also actively involved in the post-Katrina rebirth of the city. KODA was also named Innovator of the Year in 2009 by New Orleans CityBusiness.

For more information about KODA.us, click here.

GE Commercial Finance is the financial arm of General Electric, and invests in companies that provide an interest for General Electric.

CMEA Capital is a vc firm that mainly invests in companies that are in the life sciences, energy and materials, and tech industries. Typically, an investment from CMEA goes to companies that have a cutting-edge business model and proprietary technology. CMEA Capital was founded in 1989 and has offices in both San Francisco and Menlo Park, California. During his tenure at CMEA Capital, Mr. Kim played a key role in leading major investments, such as in A123 Systems. Some other companies in CMEA’s portfolio include A123 Systems, BioLight Harvesting, Cnano Technology, Codexis, Luminus Devices, and others.

Khosla Ventures is a vc firm that is dedicated to the entrepreneur. According to Khosla Ventures, an entrepreneur is a person who dares to dream impossible dreams and foolish enough to make those dreams come true. Khosla Ventures is dedicated and focused in helping entrepreneurs with innovative ideas build strong companies by having a history of leveraging relationships to build teams and providing strategic advice to entrepreneurs with creative ideas or products. Some companies in Khosla’s portfolio include Distributed Solar, Utility Scale Solar, K2 Network, RingCentral, iSkoot, and others.

For more information about Khosla Ventures, click here.

PanGeo Subsea is an innovator of acoustic imaging for oil and gas searches under water. Besides its headquarters in St. John’s, Newfoundland, the company also has offices in Norway, Denmark, Brazil, Southeast Asia, and Houston, Texas.

PanGeo mainly develops both 3D and 4D imaging which is mainly applied in the oil and gas industry and its imaging is used for searching for oil and gas deposits on the sea floor. Some of the technologies that PanGeo has under its trademark include the Acoustic Corer, the Sub-Bottom Imager, and the Acoustic Zoom. The only one of PanGeo’s products, however, which is currently available commercially, is the Acoustic Corer, which is an imager that can detect geo-hazards in a drilling area for undersea gas and oil deposits. The Acoustic Corer can detect potential hazards, such as boulders, cemented layers, shallow gas deposits, etc. The machine can detect such hazards as deep as 20 to 80 meters, depending on soil density. The Acoustic Corer is attached to a 12 meter boom to be able to image a 360 degree image of the entire sea bottom.

According to the president of PanGeo Subsea, Moya Cahill, the demand for more accurate imaging technology which has the ability to accurately image what is below the sea bottom. Furthermore, the team at PanGeo is very excited to receive an investment for the future business ventures.

Proceeds from this funding will go to further the company’s global expansion and to commercialize the other products that PanGeo is planning to bring to market. Already to meet the demand for better imaging tools, PanGeo will be introducing the Sub-Bottom Imager to the market later on this year. The Sub-Bottom Imager is a 3D acoustic imaging tool that is attached to a mechanical automatic submersible. The Sub-Bottom Imager was evolved from the Acoustic Corer but because it is mounted to a robotic submersible, it is much more effective in image the sea floor.

Founded in 1998, Lime Rock Partners is a vc firm that mainly invests in companies that are in the energy and oil and energy service technology industries. Lime Rock Partners is a global vc firm with over $3.8 billion in private capital under its management. Lime Rock Partners has locations in Houston, Texas and in Westport, Connecticut within the United States, and globally the vc firm has offices in Dubai and Scotland. Other companies in Lime Rock’s portfolio include Arena Exploration, Aden Exploration, Bridge Energy, Gas2, Hercules Offshore, IraCore International, and others.

CTTV Investments, LLC is the vc arm of the Chevron Corporation and it mainly invests in companies that would have a positive return or a product that would serve Chevron’s interests.

For more information about PanGeo Subsea, click here.

Before coming to Skyline Ventures, Mr. Reicin worked at Morgan Stanley, where he held the position of managing director at Morgan Stanley’s research department. The main focus of Mr. Reicin’s job at Morgan Stanley’s research department was to research medical devices and supplies. Mr. Reicin was also ranked in the Institutional Investor as an All-America team from 1994 to 2008. Mr. Reicin also worked at Oppenheimer & Company, Inc., where he was Senior Vice President.

Founded in 1997, Skyline Ventures is a vc firm that has become well known as an investor in healthcare companies in all stages of their life. Skyline Ventures currently has roughly $800 million under its management and primarily invests $15 million to $30 million per investment round. Some companies in Skyline’s portfolio include AcelRx Pharmaceuticals, Advion, Arca Biopharma, Calibra Medical, Discoverx, and others.

For more information about Skyline Ventures, click here.

As part of the agreement of this round of funding, Convey Computers also announced that two people will join the company’s board of directors, who are Dr. Jiong Ma, PhD of Breamer Energy Ventures and Joshua Ruch of Rho Ventures.

Convey Computer is a company that is disrupting the computer industry by building the first Hybrid-Core Computer, which is designed to break the barriers in power, performance, and programmability. Furthermore, Convey’s products also marry cost efficiency and a simple programming model that is of a commodity system that has the performance of a customized hardware architecture. Convey Computers is a unique company in that it brings to the market many years of experience and intellectual assets. Furthermore, Convey Computer has experienced executive and design teams who have built other known companies, such as Hewlett-Packard and Convex Computer Corporation.

According to the Chairman of Convey Computer’s board of directors, Philip Gianos, this large investment that Convey Computer has closed today is a great feat in these current difficult financial times. Mr. Gianos further stated that Convey Computer is one of the most interesting computer companies that have emerged over the past decade. Furthermore, the company’s ability to raise money speaks to the size of the market that is out there for this type of product that Convey Computer offers.

Another addition to the success that Convey Computer is experiencing can be attributed to the energy efficiency of its hybrid computers, which are able to conserve more energy that the conventional high-performance computer does. Furthermore, the computers created at Convey Computer are also much easier to program by reducing many programming challenges that exist with conventional computers and this further allows the user of Convey’s computers to easily adapt to current and new applications.

According to Dr. Jiong Ma, principal at Braemar Energy Ventures and new board member, having a data center can cost millions of dollars to run with energy and cooling costs counting for half of the costs in operating the system. Basically in operating a server that can handle today’s bandwidth requires a watt of energy for cooling for every watt of energy for system operation. What Convey Computer has done is in fact reducing energy costs by minimizing the number of server requirements in running its HC-1 computer. As a result of this, the typical Convey Computer customer anticipates to reduce operating costs up to 92% by using Convey’s HC-1 computers.

Braemar Ventures is a vc firm that mainly invests in entrepreneurs in the clean-tech industry. The vc firm has over 55 years of experience in both operating and financing power technology companies. Braemar Energy Ventures mainly makes early stage and growth stage companies which have market leading technologies. Some other companies in Braemar’s portfolio include EnerNoc, Solicore, PowerGenix, CoalTek, CirisEnergy, and others.

For more information about Convey Computer, click here.

LibreDigital provides a service that makes it profitable to manage and market digital content. LibreDigital does this by digitally warehousing content in a large internet-based digital warehouse and distribution platform that serves six of the top ten book publishers and over 175 newspapers and other periodicals. What makes LibreDigital so profitable for publishers is that its on-demand solution allows publishers to post its content digitally and publish it on any marketplace, which the publisher sees fit, and the content can also be forwarded in any format, to any consumer, or on any device. LibreDigital is a global company with its headquarters in Austin, Texas and also has offices in New York City and the United Kingdom.

Along with this funding round, LibreDigital also announced that it has appointed David L. Pesikoff, cofounder of Triangle Peak Partners, to the company’s board of directors. Mr. Pesikoff will be joining existing board members, who include Martin Neath, board chairman and general partner at Adams Capital Management; Brian Murray, CEO of HarperCollins Publishers; Scott Heekin-Canedy, president of the New York Times; and Jeremy Halbreich, CEO of the Sun Times Media Group.

According to Mr. Pesikoff, as consumers continue to adopt both mobile devices and digital print media, the demand for digital books and newspapers is growing at such a fast pace that it is even outpacing the supply, hence the platform that LibreDigital provides can be a solution to accelerate in this exciting new market. Mr. Pesikoff further added that the platform that LibreDigital provides allows for media companies to deliver and meet the growing demand on e-periodicals and books.

According to Scott Heekin-Canedy, with the expanding universe of digital publishing, the technology that LibreDigital provides publishers the ability to publish their content successfully to all kinds of different markets and mobile devices on a global scale.

Triangle Peak Partners is a private investment firm that invests private equity and venture capital in companies that are poised for success in their markets. Triangle Peak Partners invests in both illiquid and liquid markets. The firm’s philosophy states that when markets are illiquid, the firm will work with the management of the companies they invest in to help create value and the investors at Triangle Peak Partners mainly invest in companies who are in the tech, alternative energy, and energy industries.

When the markets are liquid, the team at Triangle Peak Partners invests in low cost baskets to enhance diversity in investment.

For more information about LibreDigital, click here.

Egnyte is a company that provides an on demand file server for small and medium sized businesses, where they cannot only store their files online, but also collaborate on those files online as well. Even though there are many online file storage services out there, providing stiff competition to Egnyte is difficult. Egnyte has the upper hand over the competition because of its focus on replacing the traditional server for small companies with a server that gives these small companies the full advantage of the internet. Besides allowing small businesses to simply store their files online, Egnyte also allows its clients to save multiple versions of their files, so there are several back up files available and providing businesses that extra security for their important data. Another one of Egnyte’s features allows business administrators to control who can read these files as well as write and delete a particular file from the Egnyte server. Furthermore, Egnyte also allows businesses a way to send links to embedded large files.

For all of its services, Egnyte does charge a monthly $10 fee to all of its users, providing a much lower cost, which is important for small businesses.

Despite the difficult economic times of these days, Egnyte has reported that over the past six months, the company has reported its revenue to be growing over 15%. This also shows that there is a growing niche in the cloud industry and a growing interest in small and medium businesses to use cloud computing to access their applications and files online and be able to have their workers and managers collaborate on those files in a safe online environment. Egnyte’s current high, however, could be threatened by the bigger companies with Google launching its Google Apps and Microsoft working on its web-based version of its Microsoft Office 2010. The main threat that this could pose to Egnyte is the core of its business platform, with the potential of Egnyte to lose a good portion of its clientele. This threat could be that serious because if there is such an office suite, as the ones Google and Microsoft are developing could render Egnyte’s service obsolete by providing a user all of the benefits of cloud computing and yet being able to use all the office applications available, such as word processors, spread sheets, and presentation software and being able to save their files directly to a safe and secure server online.

Polaris Venture Partners is a vc firm that mainly invests in seed, early and mid stage companies in the IT and life sciences industries. Polaris Venture Partners is an active investor and usually co-invests together with other vc firms and takes an active role in the companies it invests in. Some other companies in Polaris’s portfolio include Emo Labs, Living Proof, BlackArrow, Experience, Thing Labs, Art.com, Ice.com, and others.

Maples Investments is a vc firm run by Mike Maples, Jr. and was recently awarded the Rising VC Star Award from Fortune Magazine. Mr. Maples is currently a full time investor. However, before becoming an investor, he was an entrepreneur and a CEO who held senior positions in several high growth companies. Mr. Maples has experience in several industries and their related markets, which include consumer technology, small business, and the enterprise. Some other companies in Maples Investments’ portfolio include 750 Industries, Aggrogate Knowledge, Bazaarvoice, B-Side Entertainment, Business Connect China, Circle of Moms, Digg.com, and others.

For more information about Egnyte, click here.

With Chacha, users can send almost any question over their mobile phone or device and users can get answers to those questions from other people on the Chacha network. What makes Chacha stand out from other mobile search query services is that it is human powered and not automated. Members on Chacha can actually read a question and answer that question. This makes it much more interesting because with different people answering a question, a user can get an answer that is completely unique and not the same automated robotic answer as one would get with another search query.

Just six months before this round of funding, Chacha managed to close a $30 million round of funding, also from an undisclosed investor. The intent of the funding was first to fulfill a requirement from the Security and Exchange Commission, and the proceeds from the funding were to go to pay off Chacha’s debts to Citigroup.

For more information about Chacha, click here.

TxVia is a company which develops advanced systems that process prepaid credit cards and TxVia has acquired as clientele several of the world’s largest bank issuers and program managers, who see TxVia’s platform to enable their prepaid card programs. The reason why these large bank issuers use TxVia’s platform is because the company offers its clients a superior and unparalleled quality in both product and service, and furthermore TxVia’s product is also easily manageable and configurable.

Along with the agreement for this funding, TxVia will take Paul Zurlo on to join the company’s board of directors. Mr. Zurlo is a partner with Bain Capital Ventures and according to him, the team at Bain Capital Ventures has discovered that TxVia is one of the best in prepaid credit card processing after conducting extensive diligence in the prepaid card industry. Furthermore, Bain Capital Ventures also noticed that many managers and card issuers, who have a wide range of complex requirements, have chosen TxVia to process their cards.

According to the president and CEO of the New York City Investment Fund, Maria Gotsch, TxVia is a great asset to New York City because it strengthens the city’s position as the world’s financial services technology center. Ms. Gotsch also added that the people at the New York City Investment Fund are pleased to be able to have the opportunity to invest in TxVia, which shows to provide good returns and is an asset to New York’s business community.

Based in Boston, Massachusetts, Bain Capital Ventures is the vc arm of the much larger financial institution, Bain Capital, which has over $75 billion in assets under its management. Bain Capital was founded in 1984 and has made over 250 investments, some of which have been major successes. Some other companies in Bain Capital’s portfolio include AMR Interactive, CMC, DoubleClick, E5 Systems, eCredit, Eschelon, Gartner, and others.

The New York City Investment Fund is a private investment fund, which has a mission to help better New York City’s business community and enhance New York’s position as a world leader in business and commerce. The New York City Investment Fund was founded in 1996 and was established as a fund under the auspices of a partnership with New York City. Some other companies in the New York City Investment Fund’s portfolio include 7th Online, ImageSpan, Harlem Lanes, Intra-Cellular Therapies, and others.

For more information about TxVia, click here.

Kontera offers a unique platform that brings relevant in-text advertising and other similar information solutions online. Kontera’s platform is based on a technology that performs real time semantic analysis of content and other information related to the content and incorporates into hyperlinks throughout the text. The platform that Kontera uses also enhances the user’s experience by using a higher grade of phrase relevance, generating increased user interaction, and increasing the publisher’s profitability. Furthermore, the success of Kontera’s technology is quite evident in the fact that it had attracted over 100 million unique users per month.

Proceeds from this funding will go to accelerate the company’s network growth, scale the next generation of real time semantic analysis solutions, and expand the company’s presence into new markets worldwide.

According to Michael Moritz, partner at Sequoia Capital, Kontera has ventured into new territories in the internet with its real-time content relevant text advertising. Along with the content relevant text platform that is the proprietary technology of Kontera, and the content on the website, users are now able to find information that was once hidden from view. Mr. Moritz further added that Kontera has made new leads and incredible headway with its platform and this is the compelling reason for Sequoia Capital to support Kontera.

In 2008, Kontera had an exceptional year and already well into 2009, the company continues to gain momentum. Furthermore, in May of this year, ComScore reported that Kontera had become the fifth fastest growing internet advertising company with an audience that has increased up to 40% within the past twelve months.

According to the CEO and Kontera’s cofounder, Yoav Shaham, in order to have success in this new market, it is crucial for you to have a sophisticated semantic analysis solution. Furthermore, the only way that in-text advertising can work is if the content of the entire text body and all of its nuances are clearly understood and the advertising is relevant to the content of the text. In the case of Kontera, the company also uses algorithms and predictive real-time analysis to figure out the user’s intent.

Sequoia Capital is a global vc firm which is based in Menlo Park, California and also has international offices in China, Israel, and India. Sequoia Capital is a vc firm that is founded by some of the world’s top entrepreneurs to help other entrepreneurs succeed. Some of the best known entrepreneurs who are partners at Sequoia include Apple’s Steve Jobbs, Oracle’s Larry Ellison, and Yahoo’s Jerry Yang and David Filo to name a few. Some other companies in Sequoia’s portfolio include online shoes and clothing retailer, Zappos.com; Peak Sport, ThinkCash, AdBrite, DropBox, and others.

For more information about Kontera, click here.

RPX Corporation is a company that provides a patent defense service. For an annual fee, RPX subscribers can access valuable resources to aid in their patent defense and help fight against patent litigation from non-participating entitles. Furthermore, RPX’s patent aggregation does not require client companies to participate in acquisitions, nor does RPX enforce the patents that it purchases.

The idea of a defensive patent aggregation service was first introduced by RPX Corporation in 2008 and was intended to reduce the cost of patent litigation, which is often initiated by non-participating entities or NPEs. Furthermore the problem with patent litigation with NPEs has been a problem that has been plaguing the tech industry for many years and RPX provides a solution that could solve most of the problems and costs that are incurred by patent litigations.

According to Giuseppe Zocco, partner with Index Ventures, RPX Corporation has created a great business opportunity with its new innovative services. Furthermore, RPX’s Defensive Patent Aggregation Service will provide a compelling solution for a problem which has cost the tech industry and innovators of new technologies millions of dollars.

Since the founding of RPX’s Defensive Patent Aggregation Services in November of 2008, over 14 new companies have joined the company’s service and up to date RPX Corporation has reported over $90 million in patent rights.

According to Izhar Armony, General Partner with Charles River Ventures, the fact that RPX Corporation has been only up and running for less than a year and has been such a success is truly amazing. The growth that RPX has experienced is quite a feat and is definitely a company worth attention. Mr. Armony further added that one of the driving forces of RPX’s success is the fact that many companies are waking up to the fact that there needs to be a solution to solve the ever growing problem of patent litigation which Defensive Patent Aggregation Service provides.

Index Ventures is one of Europe’s leading vc firms that actively invests in the tech, biotech, and clean-tech industries. Index Ventures was founded in 1996 with the purpose of turning European and American companies into global corporations. Some other companies in Index’s portfolio include Skype, AlertMe, B-hive, Boku, Dropshop, and others.

Founded in 1972, KPCB is a prominent vc firm that has backed over 600 entrepreneurs. KPCB is a global vc firm with its headquarters in the United States and offices in China. Some other companies in KPCB’s portfolio include 3-V Biosystems, 3DV Systems, 3VR Security, Aerohive, AltaRock Energy, and others.

One of the oldest early stage vc firms in the United States, Charles River Ventures was founded in 1970 and mainly invests in early stage companies and has over $2.1 billion in venture capital under its management. Some other companies in Charles River’s portfolio include Acopia, BigBand, Sonus Networks, FlyCast, and others.

For more information about RPX Corporation, click here.

Vorx Graphene Technology is a technology that uses graphene as an electrical conductor. It has been a known fact for a long time that graphene is a very good conductor of electricity and the incorporation of graphene in the company’s inks and other micro electronic components can greatly improve the quality and cost effectiveness of any given product that employs micro electronics.

Along with the financing, two new people will join Vorbeck’s board of directors. These two people are the Honorable Kristen V. Silverberg, former ambassador of the United States to the European Union; and Dr. Robert Hirsch, former Global Managing Director for the vc arm of DuPont.

Stoneham Partners is a privately owned vc firm that works together with the Maryland Economic Business Development Department along with a syndicate of private investors.

For more information about Vorbeck Partners, click here.

Advanced Telemetry is a power company that creates energy resource management systems for both residential and small business outfits. The main system that Advanced Telemetry has developed is the EcoView system. According to the company website, EcoView comes in two packages. The first package is the EcoView Residential, which is the energy resource management system solely for residential uses and helps homeowners make the decisions to reduce useless energy consumption and saving the homeowner money and makes the home more green.

The second package is the EcoView Commercial, which is designed to save businesses extra money in energy costs by providing the necessary software to manage the business’s energy consumption without the costly time wasted in calculating everything.

Proceeds from this round of funding will go to help Advanced Telemetry increase production and broaden the sales channels of the company’s flagship EcoView, both residential and commercial versions.

According to Advanced Telemetry’s CEO, Gus Ezcurra, the team at Advanced Telemetry is overjoyed to have both the Quercus Trust and 21 Ventures on board for this round of funding. These two vc firms have supported the company in the past and as far as Mr. Ezcurra is concerned, the two vc firms have been strong supporters of Advanced Telemetry since the company’s inception.

Advanced Telemetry is already doing very well and its EcoView Commercial is already in use in several well known franchises, including Taco Bell, Burger King, Arby’s, and Bar-B-Q along with other businesses. All of these firms have stated that Advanced Telemetry has helped them tremendously in conserving energy and saving both time and money. Furthermore, the above mentioned franchises also state that the EcoView package helps them energy costs, and installation of the EcoView Commercial package was quite easy. Furthermore, the benefits that these businesses reap from this system can be endless, freeing up more money that would normally go to paying energy costs.

21 Ventures is a vc firm that literally advertises itself as being an “incubator for technology companies.” The criteria for receiving an investment from 21 Ventures is that your company must be in the energy or tech industry and you must have a product that is unique and innovative with the potential of dominating your industry through the 21st century. 21 Ventures was founded in 2003 and has since funded seed and early stage companies globally. Some other companies in 21 Ventures’ portfolio include CPT, Energy Focus, ETV Motors, Free Green, ReGen Power Systems, and others.

For information about the Quercus Trust, you must email them by clicking on their website, which only has the company logo on it.

For more information about Advanced Telemetry, click here.

LBO is a privately owned company that specializes in laser based miniature projection. LBO stands out from other miniature projection companies because of its patented holographic laser projection technology, which can project high quality images very sharply focused from all distances possible. Furthermore, because the projector is a small size and very efficient, it can be employed in all kinds of different industries, including the automotive and consumer electronics industries. Furthermore, LBO’s technology is very easy to use. The fact that it uses laser technology to project the image, it eliminates the need to have to focus the image, in order to make it sharp and crisp. The laser light itself is a very accurate and sharp to-the-point light that enables for images to be projected in focus from any distance without the need to turn a lens to focus the image every time the projection screen changes distances.

According to Dr. Claus Schmidt, Managing Director of Robert Bosch Venture Capital Gmbh; Robert Bosch mainly invests in companies that have unique technologies that can revolutionize the industry and the technology that LBO is the right candidate and fits all the criteria for investments from Robert Bosch. Dr. Schmidt added that when his team at Robert Bosch Venture Capital GmbH saw what LBO had to offer, everyone was impressed and agreed to go forward with the investment.

Along with this round of extra funding, LBO also announced that it has hired Mr. Paul Goodridge as the company’s CFO. Mr. Goodridge will be a great asset to the company because he brings over 20 years of experience in financial management and has the track record for impressive company growth at every company he has worked for. Before coming to LBO, Mr. Goodridge worked as the Director of Finances at CSR for over 8 years.

As far as Mr. Goodridge is concerned, finding an early stage company that has the rapid growth rate and the competitive edge that LBO has is a rarity and Mr. Goodridge is delighted to become part of LBO’s management team.

Robert Bosch Venture Capital GmbH is the vc arm of Robert Bosch GmbH, which is a German based privately owned company who’s net worth is about $60 million. Robert Bosch Venture Capital, GmbH mainly invests in early stage companies that are in the tech industry and have proprietary technologies inline with the product line of Robert Bosch GmbH. Some other companies in Robert Bosch’s portfolio include SynapSense, and others.

For more information about LBO, click here.

Aloqa is a pioneer in the mobile industry, because it is the first to provide users with context relevant alerts over the mobile communications network. The service that Aloqa provides for mobile users eliminates two basic problems which are both time consuming and tedious. The first problem that is eliminated by employing Aloqa’s service is the need to make searches for a particular item. Searches on mobile devices are similar to making a search on a search engine on a regular computer, most smart phones have to have a specific browser or application to type in a search for something, but Aloqa’s unique platform brings the search to the user by bringing in content relevant information that would bring all the information that the user would be interested in directly to his phone. Furthermore, Aloqa’s service also brings local opportunities to the user. Aloqa does this by taking into account all of the users interests by reading the content of the data on the user’s phone. Aloqa looks at the music that a user might have on his phone or mobile device, where the user resides, what job the user has, etc. For example, Aloqa can look at a user’s taste in music and then send a message about concerts in that user’s local where his type of music would be played.

The new CEO, Sanjeev Agrawel will bring a wealth of industrial experience to Aloqa. Along with having been the Vice President of Products at TellMe Network, which was later acquired by Microsoft; he was also worked at Google as the global head of product marketing.

According to Mr. Agrawel, the service that Aloqa provides makes cellphones all that much more useful. From a user’s perspective, launching browsers to make a search can be agonizingly slow and typing or speaking into apps can be very tedious. Furthermore, doing searches on the phone is not the only issue that mobile users face. There are many opportunities out there and people do not even know about them. There has been a time where we perhaps missed that job opportunity, or there was a great concert nearby, that we could have attended. Well, Aloqa also solves that problem by bringing all the opportunities in a user’s locale directly to the user. Aloqa can find job opportunities that fit the personality of the user and also can bring concerts to a user’s attention. Aloqa does this by going through all the user’s mobile data and finds information over a network and lets the user know about all kinds of things as they happen in real time.

According to Ram Srinivasan, managing partner at Wellington Partners; the proprietary technology that Aloqa has to offer is very attractive to the investors at Wellington Partners. The ability of Aloqa’s technology to track all kinds of objects, both moving and static, without draining the user’s phone’s battery has the potential to disrupt the mobile industry. Furthermore, what makes Aloqa’s technology stand out is that also does not tie up the networks with extra data and does not breach users’ privacy.

For over ten years, Wellington Partners has been one of Europe’s most successful vc firms. The vc firm has over €800 million ($1,128,592,496.93) under its management. Wellington Partners mainly invests in companies that are in the clean-tech, digital media, IT, and life sciences industries. Some other companies in Wellington Partners’ portfolio include Amiando, eCircle, Goom Radio, OrderWork, SMS Guru, and others.

For more information about Aloqa, click here.

Founded in 2006, ProtonMedia is a company that helps businesses overcome limitations of online collaboration tools available to team people up over the internet. The main product that ProtonMedia uses to do this is the ProtoSphere, which is a social network that provides a good business environment that allows businesses to collaborate with their teams effectively and efficiently. ProtoSphere is actually a second-generation collaboration tool that allows for effective teaming. The clientele of ProtonMedia are mainly companies in the pharmaceutical and energy industries. Some of the companies that are already using ProtonMedia’s services with its ProtoSphere platform include AstraZenica, Comcast, Johnson & Johnson, BP, Chevron, and others.

The benefits experienced by ProtonMedia’s customers by using the ProtoSphere platform are that they can have a virtual meeting online that are more engaging and immersive than the different telecommuting or web-based conferencing services available today. Furthermore, the ProtoSphere platform allows for those who need to bare subject matter to other company officials to be able to do it from their offices or homes, eliminating the need for burdensome and tiresome travel. The highly graphic interfaces of the ProtoSphere platform can allow for vivid presentations and allow for a more effective transfer of knowledge to all of the meeting participants.

According to Ron Burns, CEO and founder of ProtonMedia; despite of the tough economic times, the company’s pipeline, growth, and profitability were what was the most crucial to attracting investors to ProtonMedia. Mr. Burns also stated that he was pleased that both Originate Ventures and Osage Partners were willing to provide this round of funding in these uncertain financial times that we find ourselves in today.

One of the reasons that ProtonMedia’s ProtoSphere platform is so popular with the business community is that the graphics are absolutely amazing. Some of the graphics that the ProtoSphere incorporates in the virtual meeting include holograms, interactive avatars and bots, voIP sound, and document and file sharing capabilities to name a few.

Originate Ventures is a Pennsylvania based vc firm that focuses on early stage companies in the services industry and are located within the state of Pennsylvania. Originate Ventures also invests in companies who are in the healthcare, consumer, software, and IT industries. Some other companies in Originate’s portfolio include Adhezion Biomedical, SouthSolutions, NayaTec, and others.

Based in Bala Cynwid, Pennsylvania, Osage Capital is a vc firm that is a prominent provider of venture capital and private equity to entrepreneurs in the Mid-Atlantic region. Along with the necessary capital, the vc firm also brings board experience to diligent entrepreneurs who want to build successful companies. Some other companies in Osage Capital’s portfolio include HardMetrics, Instamed, Landslide, Moda, and others.

For more information about ProtonMedia, click here.

Nexage is a leader in mobile advertising and allows companies to maximize their advertising revenues by using an effective mobile advertising platform. Some of Nexage’s flagship products is the AdMax Gateway, which is an ad optimization platform that is hosted and allows carriers and advertisers to completely control and monetize their mobile advertising channels. Nexage’s AdMax Gateway platform can serve most ad media on mobile phones today, including text, banners, in-applications, and video advertisements with much higher fill rates than previously achieved.

Along with this round of funding, Nexage also announced that Mike Baker will be appointed the chairman of the company’s board of directors. Mr. Baker is a veteran in the mobile communications industry. Along with Mr. Baker, others will also join Nexage’s board of directors, who are Matt Golden, partner with Blackberry Partners Fund; and Ryan Moore, partner with GrandBanks Capital.

Mr. Baker will be a great asset to Nexage because while working for Nokia, he was the company’s vice president and he also worked for Nokia Interactive, which is Nokia’s mobile advertising arm that was formed when Nokia acquired Enpocket, where Mr. Baker was both a founding investor and CEO.

According to Mr. Baker, the potential for mobile advertising is quite big, and in order to fulfill its full potential; the industry needs the types of technologies that Nexage has to offer. The unique thing about Nexage’s platform is that it enables both media sellers and buyers to reach a targeted audience at a scaleable rate. Furthermore, not all cellphones are the same. Some are basic and the only way that advertisers are able to reach their audience with simple text SMS messages, whereas others are more advanced, like the Blackberry or the Apple iPhone. Both of these phones are more like pocket computers and have a more vivid display that can allow for advertisements to be either text, banners, applications, or even video. Furthermore the ability to have media companies cut costs through the AdMax Gateway is another positive for Nexage.

AdMax Gateway is unique in that it enables media companies to save money by being able to interconnect with other networks and is also in use by advertisers and publishers worldwide.

The Blackberry Partners Fund is the vc arm of Blackberry and was established to deliver investments which are compelling in the mobile applications industry. The fund is designed to invest in innovative companies which develop and commercialize applications for smart phones, such as the Blackberry. Other companies in the Blackberry Partners Fund’s portfolio include Buzzd, Digby, Neuralitic, Worldmate, Xobni, and others.

GrandBanks Capital is a vc firm which has a geographic area of focus in the Eastern United States and Canada. GrandBanks mainly focuses on early stage companies in the tech industry. GrandBanks Capital was originally established in a partnership with SOFTBANK Corporation, which is a known investor in the software, security and business applications, media and wireless technology, and financial industries. Some other companies in GrandBanks Capital’s portfolio include Enpocket, SendMe.com, I Love Rewards, and others.

For more information about Nexage, click here.

Accuri Cytometers is a company that is dedicated to the life sciences industry, which develops and markets novel high performance cell analysis systems that are designed to aid research conducted by medical and life sciences researchers by delivering the power of flow of cytonemetry into their laboratories throughout the world. Accuri’s flagship product is the Accuri C6, which is a transformative cytometer that is easy to use, yet is also has a fully featured bench-top cell and bead analysis system.

Proceeds from this round of funding will go to marketing the Accuri C6 Cytometer and provide more growth and working capital.

According to Jennifer Baird, CEO of Accuri Cytometers; the company’s first two products are experiencing amazing market growth and Accuri Cytometers is also pushing ahead with their new European operations. Furthermore, the team at Accuri Cytometers is excited to have new investor, Invest Michigan on board. Invest Michigan is run by Credit Suisse and endorsed by Michigan’s governor, Jennifer Granholm. Ms. Baird went on further to say that Accuri Cytometers is has acquired great customer support, which allows for a strong manufacturing base in Michigan and a strong global presence in the future.

The Accuri C6 Cytometer is specifically designed for the biomedical community for use in their laboratories and this device can provide rapid results at the fraction of the cost of conventional cytometer testing.

Proof of the efficiency of the Accuri C6 Cytometer can be provided by the senior biological scientist at the Flow Cytometry Core Laboratory of the University of Florida, Steven McClellen, who stated that the Accuri C6 Cytometer has the capability to provide high performance flow cytometry at an affordable cost and the transformative abilities of the Accuri C6 Cytometer that are easily accessible to scientists researching cytometry.

Invest Michigan is a vc firm that is operated by Credit Suisse and endorsed by Michigan’s governor, Jennifer Granholm aimed to help Michigan’s industry. Invest Michigan is a fund that is worth about $300 million and also aids Michigan’s retirement community. On the Invest Michigan homepage, it states that the fund invites managers of companies who are interested in investments from the joint fund between the state of Michigan and Credit Suisse. Invest Michigan has two programs for companies to enroll in for investments. The first program is the Growth Capital Program, which targets lead and co-investment opportunities that would benefit Michigan based companies. The Growth Capital Program also inquires about limited corporate buyouts and is managed by Credit Suisse. The second program that Invest Michigan offers is the Michigan Opportunities Program, which is a program that targets lead buyout opportunities for Michigan based companies and also deals in growth equity investments in established Michigan companies. This program is managed by Glencoe Capital, LLC.

For more information about Accuri Cytometers, click here.

The fund was provided by investors, who are entrepreneurs that include Michael Birch, founder of Bebo and BirthdayAlarm; Brent Hoberman, founder of Lastminute.com and Mydeco; Peter Dubens, founder of Okley Capital and Freedom4 Group; and Jonathan Goodwin, founder of AchrePartners.

According to one of the general partners of the fund, Rogan Angelini-Hurll, PROfounders is a vc firm that provides a one of a kind mix of entrepreneurial knowledge as well as the venture capital needed for entrepreneurs to build successful companies.

PROfounders Capital will plan to be a vc firm that will be dedicated to early stage companies in Europe, which are in the digital media and tech industries and the types of investments that PROfounders will make will be the types of investments in between angel investments and traditional venture funding.

Sean Seaton-Rogers is a top of the line entrepreneur and will be a great asset to the vc firm. In his partnership, Mr. Seaton-Rogers will be working together with Rogan Angelini-Hurll on the vc firm’s investment team. Mr. Seaton-Rogers has extensive experience in venture capital and entrepreneurship throughout the United States and Europe; coming from Balderton Capital, which was formerly known as Benchmark Capital of Europe. During his tenure at Balderton, Mr. Seaton-Rogers worked together with companies such as Bebo, Wonga.com, MoveMe, and others.

For more information about PROfounders, click here.

Borqs was founded in 2007, and it is a high-tech company that develops end-to-end mobile technology for mobile devices. Borqs has a wide range of products for the mobile industry, from mobile server operators to components for handset manufacturers. Borqs also develops mobile software for wireless communication service providers and the company’s technology platform is also being used more and more by smartphone manufacturers and software developers.

Furthermore, Borqs IP and software allows mobile service providers and cellphone or mobile gadget manufacturers to launch the Android-based 3G phone, or the services for these 3G phones within six months. This innovation can positively affect both the consumer and the mobile service provider by cutting down the cost of services, by reducing the cycle time, and at the same time, this can provide savings to the consumer.

According to Mohan Kumar, in this day and age, the mobile industry is ever changing and more and more consumers are using smart phones and the emerging 3G network. Mobile service providers need to keep up with this demand, and Borqs provides both service providers and mobile device manufacturers. The technology that is based on Google’s Android software, can allow for Borqs to deliver service providers and manufacturers. This kind of technology is needed for this competitive emerging market.

As far as Borqs’ CEO and president, Pat Chan is concerned, having Norwest Venture Partners as a partner is of great benefit to the company. Norwest brings to Borqs not only the necessary capital needed to expand the company’s business, but also a strong mixture of advice and extensive industrial knowledge in the mobile industry as well as the right connections to the right networks to provide the company with the resources needed to be successful in the marketplace.

Norwest Venture Partners has been around for over 48 years and is an active partner with entrepreneurs who are serious about turning their ideas into successful global companies. Norwest Venture Partners invests in all stages of a company’s life and invests in companies in the IT, business services, financial services, and consumer industries. Norwest Venture Partners is a global vc firm that is based in Palo Alto, California and also has offices in Mumbai, India and in Herzelia, Israel. Some other companies in Norwest’s portfolio include 41st Parameter, AmberPoint, Cast Iron, ClairMail, Pontis, Think3, and others.

For more information about Borqs, click here.

SolFocus is a leading solar panel contractor, which has its main offices in Mountain View California and its European offices in Madrid, Spain. The specialty of SolFocus are the solar panels that employ CPV or concentrator photovoltaic technology. CPV is an innovative form of solar technology that allows for the solar panels to generate the maximum amount of electricity using solely solar panels, eliminating the need for using fossil fuels to power conventional generators. The mission of SolFocus is to level the cost of electricity generation using this new CPV technology incorporated in its solar panels, creating a competitive cost compared to the cost incurred with conventional electricity generation with the use of fossil fuels or nuclear fuel.

Proceeds from this round of funding will go to ramp up the sales and production of SolFocus’s CPV solar panels and rapid manufacturing. Furthermore, this large sum that SolFocus has raised shows the confidence that the company’s investors have in the rapid growth of the company and the potential for success in the marketplace. In this age of environmental awareness, there is always a need to develop innovative technologies which offer a cleaner alternative to the use of conventional fossil fuels.

According to the CEO and president of SolFocus, Mark Crowly, the fact that SolFocus was able to close a round of funding with a sum of money that exceeds $77 million is no ordinary feat. Furthermore, such a large investment from the company’s investors is a good indication of the market expectations that SolFocus has for its CPV solar panals. Furthermore, the funding will help SolFocus to commercialize CPV technology this year and meet the demands of manufacturing on a global scale.

According to Wayne Boulais of Apex Venture Partners, SolFocus shows the right mix of innovation and executive determination to be able to provide low cost solar energy in high sun areas worldwide. In today’s environment, with the financial crisis and a tight venture capital market, finding a right blend of original technology that works well in the marketplace can be a challenge. However, as far as Apex is concerned, SolFocus fits the criteria for a good investment opportunity. The technology that SolFocus is developing is truly innovative and the low cost in running it can disrupt the alternative energy markets.

As part of the agreement with Apex Venture partners, Mr. Boulais will join SolFocus’s board of directors.

Apex Venture Partners is a vc firm that is based in Chicago, Illinois and invests in companies that have a high potential for value creation in the tech, software, IT, communications, and infrastructure industries. Apex Venture Partners was founded in 1987 and since its inception the vc firm has invested in over 130 companies. Today Apex is one of the most prominent vc firms in Chicago and has over $600 million of capital under its management. Some other companies in Apex’s portfolio include 42 Friends, Agami Systems, BFG Technologies Bitwave Semiconductor, Bloom Energy, Cogency Software, and others.

For more information about SolFocus, click here.

Rapid Micro Biosystems is an innovator in the detection of microbial contamination in the manufacturing of pharmaceuticals, biotechnology, and personal care products. Rapid Micro Biosystems began the launching of its Growth Direct System in 2008. The Growth Direct System is a unique product in the industry, because it detects contamination earlier and its ability to do so allows for more compelling economic results, generating revenue and making Rapid Micro Biosystems highly attractive to investors.

Rapid Micro Biosystems has had such great results with the Direct Growth System, that it has become the lead product of the company. The way Direct Growth Biosystems works is by its proprietary digital imaging and can bypass the human eye, that has difficulty spotting microscopic organisms. The Direct Growth System uses the digital imaging technology to accurately detect the contamination as well as automating all the manual steps in the detection systems used today, therefore eliminating the risk or error and inaccurate results.

According to Steve Delity, Rapid Micro Biosystems’ CEO, the company is very proud to have the types of lead investors investing in the company and see the great potential of Rapid Micro Biosystems’ revolutionary main product, the Direct Growth System. A rapid detection system for contamination is definitely needed in the big pharma, biologics, and personal care products industries. Furthermore, industrial standards in these industries are getting to be higher and higher, so there are many unmet needs for more rapid detection for microbial contamination detection. The current methods to detect microbial detection are slow and there are many manual steps that are prone to error. The Direct Growth System eliminates these manual steps and provides a quicker and more accurate result.

According to Thomas P. Monath, Partner at KPCB, Rapid Micro Biosystems so far has outmatched the competition with its superior proprietary technology and its Direct Growth System platform. Furthermore, this unique blend of high throughput technology has a good opportunity to meet the unmet needs in the detection and testing market. Furthermore, this technology and the company’s stellar management team are addressing many of these unmet needs in the marketplace and the future looks very good for Rapid Micro Biosystems.

KPCB is a global vc firm that is dedicated to build serious companies on a global scale. KPCB was founded in 1972 and has invested in over 500 companies, some of which are household names, including Amazon.com, AOL, and Symantec. KPCB is based in Menlo Park, California and also has offices in Beijing and Shanghai, China. Some other companies in KPCB’s portfolio include 3V Biosciences, 3VR Security, AeroHive, AltaRock, and others.

For more information about Rapid Micro Biosystems, click here.

NanoBio is a company that designs revolutionary vaccines for the healthcare industry in the United States and Canada. NanoBio is a private company that was founded by professors at the University of Michigan’s Medical School with the sole intent to develop and commercialize biological dermatological products and anti-infective vaccines. The vaccines that NanoBio produces are all based on NanoBio’s patented NanoSat platform, which is developed on nano biotechnology. Many of the biological dermatological products that NanoBio produces are for effective treatments of common skin ailments, such as cold sores and acne. Vaccines that are being developed by NanoBio include the nasal flu vaccine and vaccines that treat genetic disorders, such as cystic fibrosis.

According to Dr. James R. Baker, Jr., NanoBio’s CEO; the funding that NanoBio has just secured the company’s ability to independently fund its operations for the next two years. Furthermore, the company’s investors see the potential in NanoBio’s products and the value of the company’s platform technology. Furthermore, the medical needs keep being more and more apparent that new technologies and vaccines are needed for genetic disorders. Some of these vaccines may not necessarily be injectable, but many are nasal vaccines, making them safer and more effective.

Proceeds from this round of funding will go to further advance clinical and preclinical trials of new products that NanoBio is producing, which are effective treatments for herpes labialis, acne and cystic fibrosis. This summer NanoBio plans to enter Phase I of clinical trials for acne, and Phase III of clinical trials for herpes in the fall of this year.

According to George Arida, managing director for Venture Investors, NanoBio is very attractive to investors because of its unique technological platform and strong scientific basis, as well as promising results from its research. Currently we are in a time where the financial climate is not the best, so the need for companies with outstanding management and novel technology are imperative for investors to get more bang for their buck. NanoBio fits into all these criteria and therefore the investments keep coming in. Furthermore, NanoBio’s biological dermatological products and anti-infective vaccines have the potential to drastically change the healthcare industry.

For more information about NanoBio, click here.

Founded in 2006, Qliance Medical Management is a company that runs insurance-free primary care clinics within the state of Washington, primarily in the Seattle area. Qliance offers people of all ages and all walks of life the primary care needed in their primary care clinics. Furthermore, Qliance allows access to all preventative care and treatments to anyone, regardless of their income for very reduced prices that can range from $39 to $79 depending on the age of the patient. Qliance also does not discriminate people due to preexisting medical conditions and offers care seven days a week. What makes Qliance Medical Management so revolutionary is that it is a primary care provider that provides top quality basic medical care and patients and employers can save over 20 to 50% of their medical costs, compared to the costs of a regular healthcare provider. Furthermore many healthcare providers do look for patients with insurance, leaving many people who cannot afford health insurance being deprived of the medical care they need.

According to Nick Hanauer, managing partner of Second Avenue Partners, the direct primary care model, or insurance-free primary care model, that Qliance provides people within the state of Washington is one of the most important transformation option to healthcare reform. The innovative healthcare model that Qliance provides reduces costs at an amazing rate for both businesses and individuals.

Qliance Medical Management also allows for in-hospital treatment for a slightly higher fee, but still affordable compared to the hospitalization costs in a conventional hospital without insurance coverage. Furthermore the benefits that Qliance offers includes no preexisting conditions, unhurried 30 to 60 minute office visits with a primary care physician, same or next-day care for more urgent medical attention, clinics open 24-7 along with round-the-clock cellphone access to physicians, onsite x-ray and lab work, and a first fill pharmacy.

Furthermore, Qliance does not abandon its patients in the rare incidents where an outside specialist or hospitalization might be required. Should these medical services need to be rendered, Qliance physicians and nurse practitioners serve a Qliance patient as his or her medical home and will coordinate all other care and services. Qliance also provides its patients a low cost hospitalization insurance policy to cover the necessary catastrophic hospital care for emergency room care or trauma care, along with treatments for cancer and other serious illnesses.

According to the cofounder and chief medical officer of Qliance Medical Management, Dr. Garrison Bliss; most people don’t know that health insurance should not be necessary for most of the primary care needed. Qliance is efficient because it operates without the costly insurance overhead.

Currently, Qliance has one clinic in downtown Seattle, Washington and has plans to open a second clinic in Kent, Washington. Furthermore, Qliance is also having discussions with some major medical groups to open clinics in other parts of the United States.

Second Avenue Partners is a vc firm that is based in Seattle, Washington and invests in early stage companies that have a business model that can transform their respective industry. Some other companies in Second Avenue Partners’ portfolio include CoolSpotters, GotVoice, Fantasy Moguls, RealSelf, Inkd, and others.

For more information about Qliance Medical Management, click here.

Proceeds from this round of funding will be used for InfoNow to bolster up its leadership in the channel performance optimization.

InfoNow is a SaaS provider that has its patented Channel Performance Optimization platform which has been used by the Fortune 1000 companies and component manufacturers for the optimization of their channel relationships and interaction in real-time allowing these companies to gain insight to find the best mix of channels to use in their networks, which run efficiently, reduce cost and provide a high return in revenues.

According to Mark Geene, CEO of InfoNow, the fact that InfoNow has received this financing in such difficult and uncertain economic times is a testament to the confidence that the company’s existing investors along with the new investor, Vedanta Capital has in the products and service that InfoNow has to offer. Furthermore, this confidence from the company’s investors validates the urgent unmet needs of networks to have an optimized channel network that can work smoothly and efficiently in real-time, and InfoNow’s Channel Performance Optimization Platform seems to be meeting those needs.

With the proceeds of this new funding, InfoNow can bolster its platform by expanding its product into new markets and be in a stronger global presence. Furthermore, InfoNow has just released its more advanced channel performance optimization program with its InfoNow 2.0, which includes leading solutions in the industry, such as Channel Incentives Optimization, Pricing Compliance, and Channel Inventory Optimization.

According to Michael Patterson, General Partner of Vedanta Capital, more companies are looking for indirect sales channels to market their products and this provides a growth opportunity for the team at Vedanta Capital. As far as Mr. Patterson is concerned, InfoNow’s patented technologies give the company an edge in the market and give the company’s clients more influence and control over the channel activities.

Vedanta Capital is a vc firm that is built on a team of experienced individuals who have industrial experience in the life sciences, internet, software, and IT industries. Some of the companies that are in Vedanta’s portfolio include 2Wire, Arcot, Augere, Cast Iron Systems, LiteSpace, and others.

Based in Boulder, Coorado, Sequel Ventures is a vc firm that focuses on early stage companies which are developing emerging technologies based in the Rocky Mountain area of the United States. Some companies in Sequel’s portfolio include Aztec Networks, Dante Group, HighGround Systems, Prostore Systems, and others.

Sevin Rosen Funds is a high-class vc firm that has a track record of funding successful companies since its inception in 1981. Sevin Rosen mainly invests in early stage companies that either possess or are developing pioneer technologies. Some other companies in Sevin Rosen’s portfolio include BIAP Systems, Invodo, Kabira, Market6, Splunk, YouSendIt, and others.

For more information about InfoNow, click here.

SpineGuard is a new medical device company that is dedicated to making spinal surgery safer. SpineGuard’s sole objective is to establish the use of the newest medical device for spinal surgeons known as “PediGruard. This is a hand held device that can diagnose spinal disorders by measuring the tissue’s electrical activity. By testing electrical impulses in the spinal tissue, the spinal surgeon can accurately detect and diagnose problems with the spine. When the electrical impulse in the tissue is too high or too low, they can then tell what is not working right in the spinal cord. The electrical impulses occur naturally in the tissue, since the nervous system functions on electricity generated by the brain and natural electrolytes in your body.

The founders of the company are seasoned physicians in spinal medicine and have also founded other startups in the medical industry. Besides its headquarters in Paris, SpineGuard also has offices in San Francisco, California.

The $4 million in funding that SpineGuard raised today is the final tranche in the first round of funding for the company. SpineGuard has also raised $11 million in funding from Crédit Agricole Private Equity, Innoven Partners, and A Plus Finance on April 9, 2009.

According to Pierre Jérôme, CEO of SpineGuard, this extra funding from Delta Partners along with their support and the support of Maurice Bourlion, one of the co-inventors of PediGuard, will accelerate the company’s mission to make spine surgery safer. This innovative device is becoming a rather significant solution to spinal surgeries, especially those surgeries involving the insertion of the pedical screw.

Founded in 1994, Delta Partners is one of the largest and most active vc firms in Europe. Delta Partners mainly invests in early stage companies in the healthcare and tech industries. Delta Partners has over €230 million ($322,258,581.08) under its management. AGI Therapeutics, Biotrin, NeuroCure, Two-Ten Health, and others.

For more information about SpineGuard, click here.

The service that Cognitive Match provides is unique in that the cognitive data it provides its clients in real time can be anything from a product or offers of special deals for products to editorials and advertising. Furthermore, the way this is designed, it can also be offered for larger social networks, such as Twitter.

Proceeds from the funding will go to accelerate the development of its product and build a client base for this revolutionary product. Furthermore, as part of the contract that was signed, Chad Raube, an investment partner with Dawn Capital, will join Cognitive Match’s board of directors.

Alex Kelleher, who is both the founder and the CEO of Cognitive Match has quite a bit of entrepreneurial experience under his belt. Mr. Kelleher is also the co-founder of Touch Clarity, which has become a leading data mining company. Touch Clarity was acquired by Omniture in 2007. Mr. Kelleher also founded Vivid Ecge, which is a London-based web agency that was acquired by Framfab in 2000.

Things look good for Cognitive Match, since there are many vc firms that are looking to invest in real-time web-based companies, including the Godfather of Silicon Valley, Ron Conway.

For more information about Cognitive Match, click here.

Founded in 2004, Small Bone Innovations is an innovator in orthopedic therapies and was founded by Viscogliosi Brothers, LLC, which is a merchant banking firm that is based in New York and specializes in the healthcare industry, mainly in the muscular-skeletal and orthopedic sector of the healthcare industry. Small Bones Innovation was the first of companies founded by Viscogliosi Brothers to develop therapies that are aimed specifically for small bones and joints. Some of the products that Small Bones Innovations has developed include the Avanta CMC implant with ball and socket for the thumb. This implant is designed to treat basal arthritis of the thumb. Another product that Small Bones Innovations has developed is the RE-MOTION wrist system, which is an implant to treat problems with wrist movement. Small Bones Innovations also have devices for the hands, elbows, feet, and ankles.

According to the CEO and Chairman of Small Bones Innovation, Anthony G. Viscogliosi; despite the difficult times the global economy is having these days and that vc firms are not investing as they had in the past, this large round of funding from the company’s investors shows confidence that Small Bones Innovations has a good business model and that the innovations developed at Small Bones Innovations will revolutionize the orthopedic sector of the healthcare industry. This funding also demonstrates that the company’s investors also see great potential of the devices that Small Bones Innovations has available to treat problems with small bones in the hands, fingers, wrists, feet, and ankles and give the patients more movement than previous treatments could offer.

Furthermore, in 2008, Small Bones Innovations received a $36 million in series C funding from most of the investors that have participated in this round of funding announced today.

Proceeds from both the series C and series D funding have been used to finish the acquisition of Scandinavian Total Ankle Replacement or S. T. A. R., which was a part of a system from Waldemar Link GmbH in Hamburg, Germany.

For more information about Small Bones Innovations, LLC, click here.

Other investors participating in this round of funding include Invus Financial Advisors, BASF Venture Capital GmbH., and other private investors.

SDCmaterials is a company that is based in Temple, Arizona and has unique nano-material fabrication and integration processes that deliver significant benefits to customers who are reaching the limits of more orthodox production.

The catalysts that are manufactured by SCDmaterials are unique in that they reduce the consumption of precious metals and improve performance, as well as increasing the longevity of emissions and chemical production applications. Furthermore, SDC ceramics additives also make their ceramics components stronger and more fracture resistant and therefore more appealing to military armor applications. The company was founded in 2004 and has been dedicated to improve the automotive industry with its nano-material fabrications and processes.

According to Maximilian Biberger, CEO of SDC Materials; having VTT investing in the company is a very significant event for SDCmaterials. Because VTT is the world’s second largest truck maker, SDCmaterials will have access to accounts that can generate enormous profit from its catalysts. The fact that VTT has chosen to invest in SDCmaterials means that they believe in the company and have confidence in the technology that SDC Materials produces for them.

According to Anders Brannstrom, CEO of VTT; the materials that are manufactured by SDCmaterials are a great opportunity for VTT to reduce their manufacturing costs, by incorporating their catalysts into the trucks that VTT manufactures. Furthermore, the technology that SDCmaterials offers also makes a good investment opportunity for VTT and Volvo.

VTT or Volvo Technology Transfer AB is the corporate vc arm of the Volvo Group and is part of the Swedish automotive complex, building heavy-duty trucks as well as cars. Volvo has had a strong presence in Europe and North America for over 80 years and over that period of time, the Volvo Group has built a reputation of making transportation vehicles that are of high quality and good performance.

Invus Financial Advisors is the sister firm of Invus Financial, LLC and mainly invests equity in companies that have the aim to transform their industry. Invus is based in New York, but also has offices in London, Hong Kong, and Paris. Invus was founded in 1985 and has over $4 billion in capital under its management.

Emerald Technology Ventures is a vc firm that is dedicated to investing in the clean-tech industry. The vc firm was founded in 2000, and has been very active in the rapidly growing clean-tech industry and investing in companies that have new innovative solutions for clean technology. Some companies in Emerald’s portfolio include Advanced BioNutrition, AgraQuest, AquaSpy, Catalytic Solutions, CTP Hydrogen, and others.

BASF Venture Capital GmbH, or BVC is actually the vcd arm of the BASF Group and primarily invests in companies that have the potential to develop products for BASF or be of interest to BASF. Some companies in BVC’s portfolio include ChrySolix, AgION, FGI, Heliatech, and others.

For more information about SDCmaterials, click here.

Founded in 2006, Stentys is a medical device company that is devoted to develop the next generation of stents to treat acute myocardial infarction and coronary artery bifurcations. Stentys has its headquarters in Paris, but it also has a presence in the United States, with offices in Princeton, New Jersey.

It is reported that acute myocardial infarction is treated with the insertion of a stent about 50% of the time throughout the world and it is a market worth over $5 billion. However, the type of stent that is commonly used in today’s surgeries is usually inserted with a catheter and then expanded with a balloon within the catheter. The problem with this type of stent, however, is not very effective and does not guarantee that it can successfully expand the arterial wall. Furthermore, clotting can also occur in between the arterial wall and the stent. The unique thing about the stents that Stentys is developing is a self expanding stent, which is constantly fixed to the arterial wall and will expand while being affixed to the surface of the arterial wall.

According to the CEO of Stentys, Gonzague Issenmann, Stentys has just finished a clinical trial involving 40 patients that clearly demonstrates the safety and efficacy of the Stentys stent. Furthermore, proceeds from this series B funding round will go to continue the clinical trials of this revolutionary new self expanding stent and will also allow Stentys to receive the European CE marking and will then be able to begin marketing the stent within the European Union.

SEP is one of Europe’s largest vc firms and is based in Scotland. The partners at SEP primarily invest in entrepreneurial and innovative companies that have the potential to revolutionize the markets with a product or service that can drive change. Primarily, SEP’s investments can range from £1 million ($1,663,671.42) to £10,000,000 ($16,635,228.11), and SEP mainly invests in the healthcare, IT, and energy technology industries. Other companies in SEP’s portfolio include Heartscape, Voxar, Biovex, Adgen, and others.

For more information about Stentys, click here.

ParAccel is a company that has developed and is the provider of the ParAccel Analytic Database, which is a high-speed parallel for data warehousing. Besides its headquarters in Cupertino, ParAccel also has offices in San Francisco. ParAccel has been known for not only top of the line quality in analytic database development, but ParAccel’s systems are also cost effective. ParAccel has also received big names as customers, such as Merkle and TRX; which use ParAccel’s systems to expand their analytic performance.

Proceeds from this funding will go to expand product development and to accelerate sales and marketing, as well as to ramp up services and customer support to accommodate the company’s rapid growth.

According to Mr. Jarve, ParAccel has shown a superior performance in the business analytic markets. So far the product and services that ParAccel provides is some of the best that the industry has to offer. Menlo ventures primarily invests in young companies that are prominent in their industry and have a plan or product that can disrupt the market.

Mr. Jarve has been a partner at Menlo Ventures for since 1985 years and during his tenure at the vc firm, he has invested in over 40 different companies, which are mainly in the communications, storage, semiconductor, internet, and software industries.

According to ParAccel’s CEO, David Ehrlich; the team at ParAccel is thrilled to have Menlo Ventures become an investor and welcomes Mr. Jarve to the company’s board of directors. Furthermore, this current round of funding from Menlo Ventures has added some more significance in the current investment climate. Moreover, ParAccel will use the proceeds from this funding to continue the development of its flagship product, the PaqrAccel Analytic Database, which is already one of the world’s fastest databases and soon companies of all industries and geographies have already shown interest in ParAccel’s product.

Founded in 1976, Menlo Ventures has invested in entrepreneurs who “think big.” Menlo Ventures has over $4 billion of committed capital under its management and the team at Menlo Ventures wholeheartedly believes in big ideas that have the potential for market disruption. Menlo Ventures mainly invests in companies who are in all sectors of the communications, IT, internet, and software industry. Some other companies in Menlo Ventures’ portfolio include Aspect, Divitas, Gronix, Hotmail (acquired by Microsoft), Basis, Latitude, Liveops, and others.

For more information about ParAccel, click here.

MailExpress is one of the largest private curriers and provides formidable competition for the United States’ other major curriers, such as UPS and FedEx. MailExpress is a currier and shipping company that mainly delivers large quantities of small parcels and non-letter mail. MailExpress is also very good with its services related to the parcels it curries with customer services features, such as online tracking, first-class speed, realtime analytics, and customized reporting.

As part of the agreement for this round of funding, Eric O’Brien, Managing Director of Lightspeed Venture Partners will join MailExpress’s board of directors.

Proceeds from this round of funding will be used to further MailExpress’s endeavors and support the company’s amazing customer growth and invest in marketing and business development. Proceeds will also go to fund MailExpress’s expansion of its operations in the United States and enhance its distribution centers to meet the growing shipment count. MailExpress delivers over a million parcels per day.

Mr. O’Brien stated as he was appointed to MailExpress’s Board of Directors, that MailExpress has an immense market and with the innovative technologies that MailExpress has developed, the growth potential is very attractive to investors. Mr. O’Brien further stated that when the founders of MailExpress had brought their platform to Lightspeed Venture Capital, and the vc firm evaluated the company’s platform, the partners at Lightspeed noticed that this was a great opportunity and chose to invest in MailExpress.

MailExpress was founded in 2005 by veterans in the industry who worked at SmartMail, which was acquired by DHL; a German shipping company which currently picks up parcels in the United States to deliver internationally, but does not ship within the United States.

The key to the success of MailExpress is that it has made a unique merger of its capabilities with processing and distribution network together with the US Post Office as a final link in the chain and make mail and small parcel delivery much more efficient.

According to Jim Watson, managing general partner at CMEA Capital, MailExpress is continuously showing a 100% growth rate and has created a new logistics service that establish new customer applications as well as in setting new standards for reducing costs and delivery times. Mr. Watson is also a founding investor of MailExpress and he continued to state that because MailExpress is agile in its mail processing and has an amazing reputation for top quality customer service is one of the reasons that CMEA Capital continues to invest in the company.

Lightspeed is a global vc firm with its main headquarters based in Menlo Park California and internationally has offices in both Shanghai and Beijing, China; New Delhi, India; and Hewrzliya Pituach, Israel. Lightspeed has over $2 billion in committed capital under its management and mainly invests in the tech, internet, and e-commerce industries. Some other companies in Lighsspeed’s portfolio include 99Bill.com, Aerohive, AMEC, Apptera, Avamar, Bling Nation, and others.

For more information about MailExpress, click here.

Proceeds from the funding will go to support growth initiatives and to provide equity dividends to its equity holders. Hirschfeld fabricates over 100,000 tons of steel each year and serves a large variety of markets, including transportation infrastructure, industrial development, and power generation. Hirschfeld has over 11 facilities across the United States and serves both public and private enterprises.

LBC Credit Partners is a middle market lending fund which provides secured loans and mezzanine debt for companies, as well as providing equity. LBC’s EBITDA is over $10 million and LBC Credit Partners also has over $1 billion of committed capital under its management. LBC Credit Partners has offices in both Philadelphia and Chicago and invests throughout North America.

Insight Equity is a private equity firm that invests in controlled private equity in strategic middle markets. Insight Equity invests in companies that have challenging problems and is based in Dallas, Texas.

For more information about Hirschfeld, click here.

Founded in 2007, Sensible Medical Innovation was the brainchild of Amir Ronen, who also serves the company as its CEO.

Currently there is no noninvasive diagnostic procedure to detect congestive heart failure, however, Sensible Medical Innovation has developed an imaging device that will soon replace the need for exploratory surgery to detect congestive heart failure. The device already succeeded in its testing on animals and is now ready for testing on humans. The way this device works is that it uses a uniquely Israeli imaging device that can view and examine internal organs, but the way this technology works is not being revealed by Sensible Medical Innovation. However, this marriage of medical and information technology is a rather attractive innovation and has attracted both the Vitalife and Genesis Partners. Furthermore, should this device come to market, it will replace the need to implant diagnostic devices used by hospitals and cardiologists for the detection of congestive heart failure today.

The Vitalife Fund is a vc firm that is dedicated to companies in the life sciences industry. Some companies in Vitalife’s portfolio include Mediguide, SideLight, Procognia, Florence Medical, TransPharma, Denx Ltd., and others.

Founded in 1996, Genesis Partners is a leading vc firm based in Israel and focuses on early stage companies in the communications and information technology industry. Genesis Partners has over $600 million in four funds, and the vc firm has already invested in over 80 new companies and made 28 successful exits. Genesis also has good standing with Israel’s entrepreneurial community and the global tech industry. Some other companies in Genesis Partners’ portfolio include Advasense, bSolar, Colbar, Lucid, Modu, and others.

AdMeld is an ad network optimizer that optimizes ad networks for over 65 premium online publishers and AdMeld’s technology helps these companies to save money and increase ad revenues. AdMeld’s technology works by optimizing ad networks and is designed to generate the best and highest yields for publishers and also provides publishers a whole suite of tools that can give them the transparency and control of the ads. AdMeld was founded in 2007 by Benjamin Barokas, who is also the company’s CRO and Brian Adams, who also works at AdMeld as the company’s CTO. AdMeld’s management team also includes Michael Barrett, who is the company’s CEO and has deep experience with premium advertising publishers.

According to Michael Barrett, AdMeld has had an amazing response. AdMeld’s technology is a real solution for real problems that ad companies are experiencing and as more ad companies have used this technology, the demand has been growing at a rapid pace, since ad networks have proliferated at a rather fast rate.

Furthermore, Mr. Barrett has stated that the proceeds of this funding will go to continue to solidify the company’s market leadership and to continue to evolve its ad network optimization solutions. AdMeld also announced that it is building a presence in the United Kingdom by opening new offices and data centers in London.

According to Seth Levine, Managing Director of the Foundry Group, AdMeld’s rapid growth is a testiment to its early market success and makes it very attractive to investors. Furthermore, AdMeld has a vision built on a technological solution for real problems that ad publishers have and with these solutions have been able to reduce their costs and increase their revenues. This is one of the reasons that the Foundry Group has decided to participate in this round of funding. The Foundry Group believes that AdMeld will use this investment to plow further ahead and maintain its market leadership.

Spark Capital is a vc firm that is focused on market disruption and supports entrepreneurs who have the driving will to succeed in their market. Spark Capital is based in Boston, Massachusetts and mainly invests in companies in the tech industry. Some companies in Spark’s portfolio include Boxee, Buzz Wire, Covestor, Inform, Intune, Manara, SendMe, and others.

The Foundry Group is a vc firm that mainly invests in early stage companies in the IT industry. The Foundry Group also invests in the internet and software industries. The Foundry Group is based in Boston, Massachusetts and has the philosophy of turning great entrepreneurs with great ideas into great companies. Other companies in the Foundry Group’s portfolio include Pogoplug, Emsence, FirstDocs, Gist, Gnip, Medialets, and others.

For more information on AdMeld, click here.

Intrexon is a company that is developing innovative bio-therapeutic solutions to cure all kinds of diseases, including cancer to reduce toxicity and improve clinical results. This particular technology works by employing genetic components and activator ligands to control the delivery of biologics.

Intrexon’s R&D and SVP, Dr. Sunil Chada, PhD states that the team at Intrexon is encouraged by the results of the company’s clinical and preclinical trials of the modular inducible cancer immunotherapeutic platform or MICI. Proceeds from this funding will help Intrexon in their quest to develop this revolutionary biotechnology and leverage its MICI preclinical studies to develop this solution for other therapies as well.

According to Robert Patzig, Senior Managing Director and CIO of Third Security LLC, the technology and product platform that Intrexon has been developing is reaching a pivotal point with the initiation of a study in 1b melanoma and continues to show that the in-vivo control of bio-molecules by applying modular DNA systems is very important. Furthermore, Third Security believes that the technology platform that Intrexon is developing is going to play a major role in the way cancer and other genetic diseases will be treated in the future. The fact that Intrexon’s immunotherapeutic approach to treat cancer can seriously enhance the efficacy and safety of treating cancer, while at the same time maintains centralized distribution and production of efficiencies. Furthermore, Third Security is convinced that Intrexon’s product and technology can also be used in other sectors of the life sciences industry as well.

Founded in 1999, Third Security LLC is a vc firm that manages investments in both public and private companies. When investing in companies, Third Security evaluates the opportunities in a wide variety of industries, but the main industries that Third Security mainly invests in are the life sciences and communications industries. Furthermore, the approach that Third Security takes when making an investment, the vc firm invests in only a select few companies that are most likely to have success in the marketplace. The patient approach that Third Security takes in investing is to focus on having the highest returns on investments. When Third Security does invest in a company, it provides that company with hands-on support in all of its ventures.

For more information on Intrexon Corporation, click here.